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           There is significant variation between individual patients in the magnitude and pattern 
of their systemic response to cardiac surgery. Poor outcomes in these patients have been 
associated with a dysfunctional host response. This thesis seeks to define such variability at 
the level of gene expression by sequential analysis of transcription before and after surgery 
for a low risk group of patients undergoing elective cardiac surgery and cardiopulmonary 
bypass (CPB) patients using expression microarray profiling. To that aim, we analysed 
sequential global gene expression patterns in circulating peripheral blood leukocytes. We 
also investigated the role of DNA sequence variation in modulating the observed changes in 
gene expression. This approach allowed us to identify important genetic modulators and 
novel biological pathways and gain new insights into the mechanisms that regulate the host 
response to surgery. 
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Background: 
Despite advances in surgical, anaesthetic and cardio-protective techniques, cardiac 
surgery continues to be associated with a considerable risk of postoperative 
complications and significant mortality (2% to 8%)4-6. Moreover, patients undergoing 
elective cardiac surgery are increasingly elderly, with more severe cardiac disease 
and multiple co-morbidities8. Much of this morbidity and mortality is related to a 
dysfunctional host inflammation that can predispose to nosocomial infection and 
multiorgan failure in as many as 10% of cases, of which up to 40% can be fatal 9. 
Specific complications which are often attributable, at least in part to a dysfunctional  
inflammatory response, include acute lung injury and acute respiratory distress 
syndrome (ARDS) in 1 to 2% of patients, renal impairment (8%), cognitive 
impairment (up to 65%), cerebrovascular accident (1.5 to 5.2%) and myocardial 
injury (7 to 15%)10-13. 
 
The host response to cardiac surgery is triggered by a number of distinct events, 
including the initiation of cardiopulmonary bypass (CPB) during which blood is 
exposed to foreign material, ischaemia/reperfusion of vital organs such as the heart 
and lungs, the re-warming period and surgical tissue injury2. This response involves 
the triggering of innate immune pathways, a systemic inflammatory response and 
immune compromise that can predispose to infectious complications and organ 
failures14. The ability to successfully regulate the propagation and resolution of this 
inflammatory response is now considered to be one of the principal determinants of 
individual patient outcome following cardiac surgery15, 16 and involves an 
orchestrated pattern of changes in gene expression that is designed to protect the 
host and promote recovery17. Current understanding predicts that individual 
differences in this response are mediated by DNA sequence variation and 
modulation of gene expression by epigenetic changes. 
The evolution of the host response is orchestrated by multiple genes, the activity of 
which must be sequentially regulated in a coordinated manner to produce a reaction 
commensurate with the trigger. Differences in gene expression between individuals 
have been shown to be heritable and to be regulated to a significant degree by 
underlying genetic diversity at the DNA sequence level. Expression quantitative trait 
studies involving genome-wide expression profiling have demonstrated that genes 
involved in immunity and inflammation show particularly strong evidence of 
modulation by genetic diversity18. Recent advances in our understanding of gene 
function have highlighted the importance of a diverse array of regulatory 
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Aims and objective of this research: 
My hypothesis is that individual differences in the host response to cardiac surgery, 
as reflected by temporal changes in gene expression, are modulated by DNA 
sequence variation. I will be using the insult of cardiac surgery as a “probe” to 
unmask large effect sizes of genes that would not be detectable by other means.  
 
The aims of this proposal, therefore, are: 
 
1. To define sequential, genome-wide patterns of differential gene expression 
and their individual variability post cardiac surgery. 
2. To identify important, novel biological pathways involved in the host response 
to cardiac surgery. 
3. To define the role of DNA sequence variation in modulating gene expression 
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Chapter- 1. Cardiac Surgery 
 
Surgical procedures consume a significant proportion of the costs and human 
resources of health care systems worldwide. In England, 4.2 million operations are 
carried out every year, of which 30.000 are cardiac procedures (Royal College of 
Surgeons, database). The NHS annual budget allocated to work in operating 
theatres in England and Wales is over £1 billion, while in the US 40 million people 
undergo surgical interventions every year, at a cost of  $450 billion 20. 
 It is expected that by 2020 the number of surgical interventions will increase by 25% 
and given that the population is ageing, the number of cardiovascular, renal and 
cerebro-vascular complications are predicted to increase  as much as 100% during 
the same period 21. 
Advances in pre-operative risk assessment and peri-operative management may 
serve not only to identify patients at higher risk of peri-operative events but also to 
improve outcome. Moreover, targeting interventions to those patients may reduce 
harm and ensure that resources are used cost-effectively. 
This Thesis will cover 
1. Main pathophysiological host responses after cardiac surgery and its main 
systemic associated complications. 
2. Review of previous evidence: genetic variants  association studies in cardiac 
surgery, sepsis and critical illness. 
3. Study of gene expression profile in a cohort of patients undergoing elective 
cardiac surgery and cardiopulmonary bypass (CBP). 
4. Expression quantitative trait (eQTL) study in a cohort of patients undergoing 
elective cardiac surgery and cardiopulmonary bypass (CBP). 
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1-1 Elective cardiac surgery as a model of the host response to 
injury 
 
Cardiac surgery triggers a strong and diverse physiological response that involves 
the immune system, coagulation cascades and multiple biological systems required 
for tissue repair and maintenance of homeostasis. Furthermore, cardiac surgery is 
associated with the highest incidence of postoperative morbidity  of any elective 
surgical procedure 7. 
Elective surgical procedures provide a useful opportunity to investigate the human 
response to injury. Furthermore, there are unique features of cardiac surgery that 
make this procedure a particularly suitable model of the host response to tissue 
injury including: 
 
1-Surgery can be viewed as an experimentally induced injury; there is a clear 
starting and finishing point. Pre-insult samples can be obtained. 
2-The response to injury is vigorous and generalized. 
3- The degree of injury can be graded (length of surgery, duration of 
Cardiopulmonary Bypass (CPB) and/or aortic cross clamp time). 
4- Post-operative complications are well understood and easily recognised.  
Finally, human responses to surgery and sepsis are strikingly similar, so that 
advances in understanding as a consequences of  investigations in cardiac surgery 
patients are  potentially applicable to the host response to sepsis20.  
 
1-2 The host response to cardiac surgery 
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The host response to surgery, trauma and inflammatory diseases such as 
pancreatitis is clinically similar to that induced by invasive infections. This 
observation has lead led to the concept of the “Systemic Inflammatory Response 
Syndrome”(SIRS)22, the aetiology of which may be infectious or non-infectious 
(Table 1  )Mortality rates in patients who appear to have sepsis but have negative 
cultures  are  similar mortality to those seen when infection is proven23 and SIRS 
may lead to complications such as acute lung injury (ALI)/ARDS, shock, renal 
impairment and  multiple organ dysfunction syndrome (MODS).The principal triggers 
of the inflammatory response after cardiac surgery are surgical trauma, blood loss 
and hypothermia, as well as activation of hematopoietic cells (polymorphonuclear 
cells and monocytes) and vascular endothelial cells by the passage of blood through 
the cardiopulmonary bypass circuit 24. Furthermore, splanchnic hypoperfusion during 
CPB is common and the presence of Ecoli  bacteremia detected by (PCR) 
(Polymerase Chain Reaction  ) has been shown to correlate with gastro-intestinal 
mucosal hypoperfusion in cardiac surgery patients25. Metabolically sepsis, trauma 
and surgery induce a catabolic response characterised by muscle breakdown and a 
negative nitrogen balance. Hyperglycemia is common. .Pro-inflammatory cytokines 
such as IL-6 are released by monocytes and plasma levels of IL6 correlate with 
mortality and length of stay in the intensive care unit (ICU) after paediatric cardiac 
surgery26. The use of tight glycemic control in critically ill and cardiac surgery 
patients has been  shown to reduce mortality up about one third 27, although later 
trials failed to confirm these findings28. Moreover, the pathophysiological 
disturbances induced by sepsis may have long lasting effects on mortality and 
survival,  increasing the risk of death even 5 years after the event29. 
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The host response to cardiac surgery and cardiopulmonary bypass mirrors the 
reactions elicited by infectious pathogens, trauma and exposure to foreign bodies  
The tissue injury caused by cardiac surgery triggers a robust inflammatory response 
that involves an intricate cellular network and a complex humoral component. The 
exposure of blood to the surface of the extracorporeal circuit activates the 
complement cascade through the alternate pathway acting on C3 and generating 
anaphylotoxins C3a , C5a  and C3b that in turn activates the common complement 
pathway.  Contact activates    Factor XII, generating thrombin, and promoting clot 
formation, plasmin activation and fibrinolysis. In addition, tissue factor liberated from 
damaged endothelial cells activates plasmin . Complement activation2  and tissue 
factor 21 stimulate the production of cytokines that are released into the circulation by 
monocytes/macrophages, lymphocytes and/or endothelial cell and are responsible 
for the propagation and regulation of the inflammatory response. Cytokines may 
stimulate inflammation (TNF-alpha, IL-1β and IL6) or have an anti-inflammatory role 
(IL-10, IL1 -ra). Moreover, an anti-inflammatory response defined by a high IL10/TNF 
mRNA ratio, has been found to be an independent predictor of an uncomplicated 
outcome in cardiac surgery30 . 
 The reported plasma levels of cytokines after cardiac surgery have been variable, 
perhaps in part because of the heterogeneity of the procedures and/or the 
anaesthetic and surgical techniques. Furthermore, plasma levels may not be a  
reliable representation of cytokine activity, as many cytokines bind to receptors and 
exert their action locally.  Nevertheless, Roth-Isigkeit et al studied a group of 20 
males undergoing CABG and showed that the distribution of allelic variants at the 
promoter regions  of IL-6 and TNF correlate significantly with plasma cytokine 
levels31. The concept of individual variability in the host response to an inflammatory 
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stimulus is supported by a study of monocytes collected  from 60 healthy volunteers 
which identified  high and low responders to lipopolysaccharide (LPS) as determined 
by TNF gene expression 32. Cardiac surgery may be complicated by varying degrees 
of systemic inflammatory response, leading to multiple organ dysfunction (MODS), 
the mortality of which may be as high as 40%9. The pathogenesis of postoperative 
complications is not completely understood but preoperative co-morbidity, surgical 
complications and genetic predisposition are contributing factors, often in 
combination. Specific aspects of the inflammatory response to cardiac surgery may 
affect specific organs, resulting in organ dysfunction. Genetic predisposition may 
also in part explain this variability. 
There is evidence that cardiac surgery and cardiopulmonary bypass precipitate not 
only a pro-inflammatory response but also a transient period of immunosupression 
that develops during or after a SIRS 33.  There is also up-regulation of immune cell 
receptors   that “prime” immune cells so that they are readily available to invade 
peripheral tissues and amplify inflammation in response to a second insult such us a 
nosocomial infection or persistent hypo-perfusion. This second immunological “hit” 
can trigger organ damage leading  to MODS and death14, 34. 
 
1- 4 Renal Dysfunction 
 
 Many of patients after cardiac surgery develop some degree of renal impairment as 
measured by discreet elevation of  plasma creatinine levels during the post-operative 
period6. Renal dysfunction as defined by an increase in plasma creatinine levels of 
>1mg/dl occurs in approximately 8% of patients and renal failure requiring dialysis in 
1 to 3%6. Those patients who develop renal dysfunction have a 20 fold increase in 
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mortality risk, as well as prolonged ITU and hospital stay35, 36. In addition, a 
proportion of those who develop renal impairment are not discharged to their homes 
but to intermediate care facilities 36. 
During cardiac surgery there is a decrease in renal blood flow of between 25% and 
75%, and because of the narrow balance between oxygen delivery and metabolic 
demands, the kidneys are particularly vulnerable to hypoxia/ischaemia at low partial 
pressures of oxygen15, 36. In addition cytokines and endotoxin released after cardiac 
surgery have been implicated in the aetiology of renal dysfunction. Although age, 
diabetes, black ethnicity, and preoperative serum creatinine have been consistently 
identified as being associated with high risk of renal impairment after cardiac 
surgery, these risk factors failed to predict the magnitude of increase in creatinine in 




1-5 Neurological dysfunction 
 
Postoperative cognitive dysfunction (POCD) after cardiovascular surgery manifests 
as memory loss and impaired concentration during the post-operative period. POCD 
has been identified in up to 80% of patients 7 days after cardiac surgery and in 
between 10% and 60% 3 months after cardiac surgery 37. 
The high incidence of POCD after cardiac surgery has been traditionally considered 
to be the consequence of microembolism generated by the manipulation, cross 
clamp and cannulation of the aorta. However, similar levels of cognitive decline were 
detected  at 12 months follow up in a group of 281 patients when randomized to “off 
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pump” or “on pump” cardiac surgery38. Moreover, recent data collected from patients 
undergoing  total hip replacement (n:162) and cardiac surgery (n:281)  using eight 
neuropsychological tests failed to find significant differences in the incidence of 
POCD independently of the operation and the anaesthetic technique employed (16% 
for both groups at 3 months)39. 
It has been hypothesized that the inflammatory response triggered by surgery, 
together with  high levels of stress hormones (glucocorticoids are known to affect 
cognition) contribute to the development of  POCD37. Platelet activation during CPB 
promotes platelet aggregation and fibrin deposition, local thrombosis and 
thromboembolism have all been postulated to be contribution factors40 . 
 
 
1-6 Post-operative bleeding  
 
Major bleeding occurs in 10% of patients after cardiac surgery41 and  one in three 
bleeding patients will require surgical re-exploration 42 The mortality of patients 
undergoing CABG who develop coagulopathic bleeding is increased five times43. 
Tissue factor is one of the initiating molecules responsible for the activation of 
coagulation   during CPB 44. Tissue factor is expressed by monocytes and 
endothelium and is  contained in  alpha granules7. Recombinant IL-6 and Il-8 have 
been shown to increase the levels of Tissue Factor m-RNA in monocytes harvested 
from healthy volunteers45, highlighting  the close relationship between coagulation 
and inflammation. Furthermore, pro-inflammatary cytokines activate endothelial cells 
and neutrophils to express cell adhesion molecules: E- selectin (endothelial cells) 
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and L-selectin (in leukocytes) , thereby facilitating the transmigartion of leukocytes to 





1-7 Atrial Fibrillation (AF)  
 
AF is the most common complication associated with cardiac surgery, with an 
incidence of 27% to 40%. Cost and length of stay are increased and AF is 
associated with a higher risk of stroke, renal and infectious complications. 
 The pathogenesis of AF is still not well understood but inflammation has been 
considered to be one of the main triggers for new onset AF. High levels of CRP have 
been associated with an increased risk of postoperative AF after CABG (OR :4.6) 
both when CPB was used and  following off pump surgery (n:73 with CPB, 79 off-
pump CPB)46. Atriotomy (in a canine model) was found to increase the 
inhomogeneity of atrial conduction predisposing to induced AF (burst pacing). An 
increase in the activity of tissue myeloperoxidase as a marker of inflammation was 
also observed. Interestingly the preoperative administration of methyprednisolone 
prevented the inflammation and conduction abnormalities47. 
 
1-8 Lung dysfunction 
 
Around 25% of patients develop temporary respiratory impairment during the first 
week after cardiac surgery. Acute Respiratory Distress Syndrome (ARDS) develops 
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in only 1 % to 2 % of patients but is associated with a high mortality (15% to 50%). 
Even though the pathogenic mechanisms that cause ARDS have not been 
completely elucidated recognised contributing factors include the use of 
extracorporeal circulation, hypothermia, hemodynamic instability , lung-ischemia-
reperfusion and  transfusions of blood and blood products. The SIRS triggered by 
CPB and surgical trauma increases capillary permeability and predisposes to 
pulmonary oedema. In addition, pro-inflammatory cytokines (TNF-alpha, IL-1, IL-2,IL-
6,IL-8) and endotoxin arising from the gastrointestinal tract encourage the 
entrapment of inflammatory cells in the pulmonary capillaries. In short, the action of 
proteolytic enzymes originating from the inflammatory cells, combined with 
endothelial swelling and increased capillary permeability lead to interstitial pulmonary 
oedema and respiratory dysfunction24, 48. 
  








The fundamental rules of inheritance were established in the middle of the19th 
century by the Austrian Monk Gregor Mendel who studied the hereditary 
transmission of 7 traits in peas. He observed that each trait (allelic variant of a single 
gene, for example colour) was inherited unchanged from each parent and 
transmitted individually. Mendel enunciated three laws of inheritance; 
1- The law of segregation: Each individual carries a pair of alleles for each particular 
trait. Each parent passes a copy (allele) to its offspring. 
2-The law of independent assortment: Separate traits are passed independently of 
one another from parent to offspring. 
3- The law of dominance: Some alleles are dominant and others are recessive; an 
organism with at least one dominant allele will display the effect of the dominant 
allele.  
The value of his work remained unrecognized until the 20th century.  In 1903 
Sutton49 proposed that the genes were contained in chromosomes, while Avery in 
194450 first demonstrated that deoxyribonucleic acid was the main component of 
genetic material. The definitive helicoidal double helix DNA structure was defined by 
Watson and Crick in 195351, prompted by Rosalind Franklin’s X crystallographic 
studies (Figure 1). During the following decade the dynamic function of DNA was 
revealed by elucidating the process of transcription and translation. Frederick Sanger 
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in 1977 described  Chain DNA Sequencing 52 making it possible to read DNA  
nucleotide  sequences. Kary Bank Mullis developed the Polymerase Chain 
Reaction(PCR) 53 allowing  amplification of  very small amounts of DNA .This 
laboratory technique rapidly became a standard tool for microbiological  detection  
and  diagnosis. The completion of the first sequencing and mapping of the entire 
human genome (2003) paved the way for the rapid expansion of Genomic Medicine. 
Today human genomic research aims not only to identify the genes that cause 
disease but to understand how the interaction of multiple gene networks with 
environmental factors contributes to disease pathogenesis. There are good reasons 
to hope that this recently opened chapter in medicine will lead to the discovery of 
novel therapeutic targets as well as new biomarkers for early diagnosis, risk 
stratification and finally effective treatment of many diseases 
 
 
2-2 Basic principles: 
  
Human beings are multi-cellular eukaryotic organisms the principal component of 
their nuclei being DNA. DNA is packed with lysine and arginine rich proteins called 
histones named H1, H2A, H2B, H3 and H4 that form together a complex structure 
called chromatin. The activity of histones is influenced by the addition of methyl or 
acetyl groups and such histone modifications are important for regulating  
transcription and DNA repair .54During mitosis chromatin aggregates into 
chromosomes. Each chromosome consist of two strands of chromatids that are 
linked in the middle (centromere) acquiring the shape of a cross. Figure 1 
 
 










Figure 2-1: Fibre diagram of deoxypentose nucleic acid by Watson, J.D. and Crick, F.H.C., 
Nature 195351 
 
Humans possess 22 pairs of chromosomes, the 23rd pair are called the sex 
chromosomes and consist of two X in females  and one X and and  a small Y 
chromosome in males. 
DNA contains four nucleotide bases: Adenine(A), Thymine(T), Cytosine(C) and 
Guanine(G) that link together in pairs (AT-CG) to form a helical double stranded 
structure. Each gene is a sequence of DNA that codes for a protein. An allele is a 
sequence variation in a gene that arises at the same site on a chromosome.  The 
transmission of the information contained in the DNA to mRNA is called transcription. 
Translation is the process by which a protein is synthesized.  The sugar (ribose) 
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phosphate DNA backbone gives a direction to the DNA chain with the 5’ pentose 
carbon being the beginning and the 3’ the end. Transcription of DNA into mRNA 




Figure 2-2: DNA structure 
The basic repeating units of DNA are nucleotides. Each nucleotide compromise a 
five carbon sugar, which is linked to a nitrogenous base; adenine (A), guanine (G), 
and thymine(T) or cytosine(C) and phoshodiester group (P) from carbon 3’ of a sugar 
to carbon atom 5’. Two strand of DNA are held together by hydrogen bonds between 









The m-RNA is generated thorough the action of three RNA polymerases: 
RNA Pol I transcribes the r-RNA genes 
RNA Pol II transcribes the protein coding genes.  This enzyme interacts with the 
promoter region, its actions are “fine-tuned” by other proteins  
RNA Pol III trancribes the t-RNA genes. 
The primary RNA transcript unit is the precursor of the m-RNA and incorporates the  
5’untranslated region(UTR) , the exons(coding DNA) , the  introns (intervening 
sequences) and the 3 UTR. (Figure 3).  The precursor RNA undergoes several 
modifications before leaving the nucleous as m-RNA: 
Capping: addition of a nucleotide cap 
Polyadenylation: addition of adenosine residues 
Alternative splicing: The introns are removed and the exons are bound together. 
Only 1 % of the human genome encodes proteins. To elucidate the function of the 
remaining “non-coding regions” is the main objective of investigators participating in 
the  ENCODE project 5556. 
A mutation is a nucleotide substitution that occurs in less than 1% of the population. 
Mutations that are seen in more than 1% of the population are called Single 
Nucleotide Polimorphisms(SNP). SNPs are the most common DNA sequence 
variation; more than 10 million have been identified. SNPs can involve substitution, 
deletion or addition of single bases.  Other types of variants are called structural 
variants, which include copy number variants (loss or gain), chromosomal 
rearrangement (translocation, inversion or uniparental disomy) and numerical 
variants (cellular genomes are polyploidy or aneuploidy). 













Figure 2-3: Transcription and Translation 
Coding regions (exons) are interrupted by noncoding regions(introns). During 
transcription the entire gene is copied into a pre-m RNA which includes exons and 
introns. During the process of RNA splicing, introns are removed and exons joined to 
form a contiguous coding sequence. This “mature” m RNA is ready for translation. In 
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translation, messeneger RNA (m RNA) produced by transcriptions from DNA is 
decoded by a ribosome to produce a specific amino acid chain or polypeptide. 
The rediscovery of Mendelian concepts during the 20th century encouraged the 
search for individual alleles with a clear phenotypic effect. This approach has proved 
extremely successful in revealing the molecular bases of some inherited diseases 
such as Haemoglobinopathies (e.g Sickle cells disease, Thalassemias).  
Recent advances, however, suggest that the classical distinction between 
monogenic diseases associated with high penetrance and oligogenic or multi-genic 
diseases (in which the influence of the environment is more marked) is no longer so 
clear. 
For example, phenylketonuria (PKU) is caused by a lack of the enzyme 
phenylalanine hydroxylase (PAH) that converts phenylalanine to tyrosine leading to 
an abnormal accumulation of phenylalanine, high plasma levels of which cause 
neurological damage. Although inheritance of this disease follows Mendelian rules, 
the resulting phenotype is variable, highlighting the importance of the environment 
and other genetic factors in this disease. 
Cystic fibrosis follows an autosomal-recessive pattern of inheritance. Unfortunately, 
mapping of the CFTR gene (cystic fibrosis transmembrane conductance receptor 
regulator) in 1989 did not enable clinicians to predict the outcome of these patients. 
Patients who are heterozygous for this mutation may develop rhinosinusitis and 
some suffer from milder forms of CF without carrying CFTR  mutants57. 
Many genetic disorders that were previously considered to be monogenic are 
increasingly found to be associated with mutations in a number of different loci. 
These findings have encouraged the  development of new statistical tools such as 
32 | P a g e  
 
Linkage Analysis; This strategy has only proved successful in Mendellian diseases 
where a major genetic  locus is known to be the causative region58. 
The availability of low-cost, high throughput technologies for genotyping hundreds of 
thousands of genes has made it possible to perform genome wide association 
studies (GWAS). These studies focussed on SNPs   have advanced our knowledge 
of polygenic disease responsible such as diabetes, prostatic cancer and breast 
cancer. GWAS have been useful in identifying common variants contributing to the 
inheritance of common disease, Most of them with modest or  low penetrance 59. In 
addition, the biological function and clinical significance of many of the SNPs 
identified still remained to be demonstrated. Furthermore, many of the loci identified 
by GWAS are located outside coding regions in areas previously known as “junk 
DNA” or “gene deserts” but now know many of these areas code for micro RNA etc. 
60. One of the main current hypothesis is that polygenic common diseases are 
greater extend being caused by low frequency variants with intermediate 
penetrance. These ideas  have encouraged the application of new tools aimed at 
elucidating the ways in which DNA sequence variation can influence phenotype 
variation, through performing GWAS meta-analysis  as well as functional analysis 
integrating gene expression  with genotype mapping61 . Finally in vitro and in vivo 
(model organism) experiments are increasingly used to validate the biological 
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2-3 DNA sequence variation and complications after cardiac 
surgery 
 
A number of candidate gene studies have been performed in the hope of finding a 
link between the possession of single allelic variants and specific postoperative 
outcomes. Most papers published in the last 10 years have based their primary 
hypothesis on extrapolation of data relating to predisposition to cardiovascular 
disease. Consequently, the most frequently investigated genes have been those 




2-3-1 Renal Dysfunction 
 
Genetic predisposition may in part explain individual variability in susceptibility to 
renal impairment following cardiac surgery. Brull et al26 studied 127 patients after 
CABG and found that two IL -6 promoter region polymorphisms -572C and -174CC 
were associated with higher postoperative  plasma levels of IL6  .In another study 
possession of the IL-6 -167allelic variant (in 117 patients having CABG) was 
associated with higher levels of IL-6, an increased incidence of renal impairment, 
and greater use of diuretics and “low dose” dopamine63. However a larger study 
(1671 patients undergoing CABG) assessing 12 candidate polymorphisms failed to 
confirm the association between renal impairment and IL-6 -167 but found that the 
34 | P a g e  
 
combination of Il-6 -572(OR 20.04) and angiotensinogen (AGT) -842 was associated 
with a 121 % increase in the mean peak rise in creatinine64. 
ApoE is a protein that is involved in lipoprotein metabolism. The APOE e allele has 
been associated with a higher risk of coronary disease and thoraco-abdominal 
arteriosclerosis, which is a predictor of renal failure after cardiac surgery. It is 
assumed that the manipulation of the aorta during cannulation and cross clamping 
detaches atheromatous plaques that embolise to the kidneys. Patients that lack the 
APO e allele have a lower risk of renal impairment (OR -0.13) after cardiac surgery, 
independently of  the same  of ascending aortic atheroma as measured by 
transesophageal echocardiogram(TEE)65.    
Postoperative fluid overload is associated with increased incidence of acute kidney 
injury, cardiorespiratory dysfunction and mortality. A large study including 1026 
patients undergoing elective cardiac surgery were genotype for 31 SNPs associated 
previously with inflammation and poor outcomes to cardiac surgery found a 
protective positive association of the allele rs12917707 of the uromodulin gene and 
fluid overload (which known function influence Henle’s loop cell surface events and 
renal reabsorption of Na and K). However, the relative effect of this finding of this 
results, after adjusting clinical variables, was very modest (OR, 1.15)66. 
Renal blood flow represents 20% of the cardiac output and oxygen extraction is 79% 
(the highest of any organ in the body).  Blood supply is tightly controlled by neuro-
hormonal and vasomotor renal and extra-renal mechanisms. Any alteration in the 
normal renal microcirculation due to haemodynamic instability or release of stress 
related hormones (catecholamines, serotonin) may expose the kidneys to a high risk 
of hypoxic/ischaemic injury. 
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Nitric oxide (NO) is an endogenous vasodilator that is synthetized by a constitutive 
NO synthetase (c-NOS), while an inducible NOS (i-NOS) is upregulated by cytokines 
including TNF. Pathologically increased synthesis of NO may contribute to 
vasodilatation and hypotension after CPB which may in turn lead to acute kidney 
injury. Inotropes and/or vasopressors are often required to maintain blood pressure 
and ensure adequate perfusion of vital organs. There is evidence that vascular 
responsiveness may be influenced by genetic variability. A study of 68 patients 
undergoing CABG or valve surgery showed that patients possessing the 894T allele 
in the endothelial e-NOS gene were more responsive to increasing doses of 
phenylephrine67, while Yates et al found that the combination of e-NOS 894T and 
AGTR1( angiotensine II receptor type I) was associated with the development of 
renal dysfunction6. 
Finally, a meta-analysis of three GWAS studies 68(validation cohort of 873 non-
emergent CABG and two replications studies totalling 380 patients undergoing 
elective cardiac surgery) revealed that two genetic regions; GRM7/LMCD-AS1; p= 
2.49 × 10-11 and the Bardel-Bredl syndrome 9 gene (BBS9); p=6.51 × 10-08 were 
associated with the percentage of variation of plasma level of creatinine during the 
postoperative period with. Even though BBS syndrome includes renal structure 
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2-3-2 Neurological dysfunction 
 
Several published studies have investigated the influence of candidate genes 
involved in inflammation, thrombosis and antigen presentation on the incidence of 
POCD after cardiac surgery. 
Plasminogen activator inhibitor -1 (a negative regulator of fibrinolytic activity) 
polymorphism 4G/4G(OR 3.1) has been associated with an increased risk of 
postoperative encephalopathy and cognitive impairment in a group of 260 patients 
undergoing CABG surgery. Supporting  the role of thrombosis in the pathophysiology 
of POCD a link between cognitive decline and a polymorphism of platelet GPIIIa 
(glycoprotein constituent of the platelet integrin receptor) was found by Mathews et 
al, although this finding was based on the mini-mental  status examinations (MMSE), 
a method that may underestimate the true incidence of POCD69 70.  
 Tardiff et al71  found  an association between APOE ε(neuronal repair gene)  and 
POCD in  63 patients undergoing CABG, although Silbert et al 72in a larger study 
employing neurpsychological testing 3 and 12 months after CABG, failed to 
corroborate this initial  finding. Moreover, Gaynor et al73 found  a positive association 
between ε2(not ε4) and a reduced psychomotor development index one year after 
cardiac surgery  in children . 
The PEGASUS (Perioperative Genetics and Safety Outcome Study) study 
investigated genetic influences on the risk of POCD and included 443 European 
American patients undergoing CABG using CPB. They  analysed a panel of 37 
polymorphisms in candidate genes  in pathways known to be involved in POCD 
based on previous literature .They found that possession of two alleles; CRP 
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1059G/C(OR 0.37) and SELP1087G/A(OR O.51) conferred an  absolute risk 
reduction of POCD of 20.6% for CRP1059 and 15.2%for SELP .In addition these 
allelic variants were associated with a reduction in plasma levels of CRP and platelet 
activation (P- selectin  mediated) in patients homozygous for the minor allele when 
compared with heterozygotos or homozygtes for the major allele74.  The PEGASUS 
investigators failed to confirm the previously described associations between APOE, 
PAI and GPIIIa polymorphisms and the risk of POCD. 
Two genes (from a set of 26) related to inflammatory pathways have been 
associated with an increased risk of stroke (0R 3.3) in 1635 patients after cardiac 
surgery [CRP (3’UTR1846) and IL6 (-174 G/C)] . Surprisingly no genes associated 
with thrombosis/coagulation were found to increase the risk of stroke. Moreover, the 
IL-6 (-174 G/C) polymorphism previously found by the same group of investigators to 
be a risk factor for POCD was not associated with an increased risk of stroke. This 
could be explained by the pathophysiological differences between POCD and stroke 
or could be related to the extra challenge of establishing the diagnosis of POCD in 
comparison with the diagnosis of stroke 75.  
 
2-3-3 Lung dysfunction 
It is considered that lung dysfunction after cardiopulmonary results from a 
combination of the systemic inflammatory response and mechanical stresses 
affecting the lung 24.  
Tomasdottir et al76 studied 95 consecutive, unselected patients undergoing elective 
cardiac surgery. They found that patients homozygous for the TNF-alpha allele 
TNFB2 had significantly higher plasma concentrations of TNF-alpha and IL-6 and an 
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increased incidence of pulmonary dysfunction (OR 5.21 (95% CI, 1.49-18.3)). 
Grunenfelder et al52 studied the role of the apoprotein E (ApoE) allelic variant e4 
(APOE*E4), a SNP associated with higher levels of cholesterol and an increased 
incidence of coronary disease, in the inflammatory responses to cardiac surgery. 
They found in a small group of 38 patients undergoing CABG that carriers of the 
combination of APOE*E4/TNFB*A329G (homozygotes and heterozygotes ) had 
higher levels of TNF-alpha and IL-8 and that mechanical ventilation was prolonged in 
these patients (773+/- 234 vs 1427+/- 841 minutes). 
These two investigations are both limited by the small number of patients studied but 
they do support a link between individual genetic variants, the severity of the 
systemic inflammatory response and impaired oxygenation in the post-operative 
period 
 
2-3-4 Postoperative Bleeding 
Welsby et at43 investigated the role of inflammatory genes in bleeding after cardiac 
surgery. They used a candidate gene approach selecting 17 polymorphisms in 7 
genes (TNF, Interleukin 1β and 6, interleukin 1 receptor antagonist, intercellular 
adhesion molecule-1(ICAM-1), P- selectin and endothelial leucocyte adhesion 
molecule-1(E-selectin). The possession of an E-selectin polymorphism was 
associated with an increased activated partial thromboplastin time (APTT) and  
bleeding at 4 and 12 hours after non-emergency CABG in 759 patients, although this 
difference did not  translate into differences in the number of red blood cells (RBC) 
received by any of the groups (2 each). Carriers of the minor alleles did, however, 
receive more haemostatic products (40%versus 31%). Further Welsby et al 77, using 
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the same database (780 patients undergoing CABG with  CPB recruited between 
2000 to 2002 by the PEGASUS group) tested allelic variants in coagulation proteins 
and found in a multi-variate analysis that seven polymorphisms  correlated with the 
risk of bleeding as determined by chest tube output 12 hours after CABG: ITGA2 
(OR -1.25), GP1BA (-0.22), TF (OR -0.03), TFP1 (OR -0.05), F2 (OR 0.38), ACE 
(OR 0.15). Furthermore, a mathematical predictive model combining these allelic 
variants with clinical predictors (after multivariate analysis) doubled the ability to 
predict bleeding in comparison with clinical predictors alone. This study failed to 
confirm the previously reported association between Factor V Leiden (FVL) and a 
reduced risk of bleeding in patients undergoing cardiac surgery(CABG, valve 
operations and other cardiac procedures).In this study Donahue et al78 found that 
46.2% of FVL positive in comparison with 28.3%negative did not  receive any blood 
products(n:517). This failure to replicate findings could be explained by the different 
percentage of patients with FVL between the two studies (0.02% to 0.05 % 
respectively). Moreover, in the study by Weslby et al all patients received 
prophylactic antifibrinolytic treatment (ε-aminocaproic) in comparison with more 
inconsistent usage of ἐ- aminocaproic and aprotinin in Donahue’s paper. 
 
 
2-3-5 Atrial fibrillation (AF) 
 
A genome wide (Illumina Hap 300 chip (316,515 SNPs) association study of 550 
patients of European/Chinese ancestry (4476 controls) presenting with ambulatory 
AF found a positive association between carriers of three variants in chromosome 
4q25 and the risk of AF(rs2200733;OR 1.75, rs 2220427;OR1.75 and rs2634075;OR 
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1.6 P values here). Body et al in a prospective study of 959 patients undergoing 
CABG with or without valve surgery   found that, of 51 SNPs  that described 98.2% 
variation of the locus (chromosome 4q25) seven (including the 3 SNPs previously 
found in the ambulatory group) were associated with the occurrence of AF in the 
post-operative period : rs4626276;OR 2.1, rs2634073;OR1.57, rs2634071:OR1.58, 
rs2129982;OR;1.75, rs2200733;OR;2.14,rs13143308;OR;1.75, 
rs2220427;OR;2.17.Furthermore a validation cohort confirmed the association 
between 3 of the SNPs  reported as associated with AF  in a further 494 patients79. 
The SNPs identified have no known biological function but they are located 90kb 
from PITX2 (a gene involved in atrial embryogenesis). The authors of this study 
speculated that SNPs, regulate the transcription of genes responsible for the 
electrical susceptibility of atrial tissue to develop AF. 
 
 An Italian group studied 110 patients undergoing CABG and found that patients who 
carried the IL-6 -174 promoter gene variants GG or GC had an increased risk of AF 
in the post-operative period (OR 3.25). Adding credence to the role of the 
inflammatory response in the pathophysiology of AF, the plasma levels of IL-6 were 
significantly higher in those who developed AF (p<0.001).However, CRP plasma 
levels were not significantly different80. 
Other investigators have not, however, corroborated these findings. In addition IL-6 -
174 is in strong linkage disequilibrium with of AnTn (-303), another predictor of IL-6 
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 2-3-6 Adverse myocardial outcomes and graft patency after cardiac 
surgery 
 
As with other investigations of adverse outcomes after cardiac surgery, biological 
pathways associated with oxidative stress, inflammation and thrombosis have been 
the focus of several studies relating to graft patency and myocardial events after 
cardiac surgery. Inflammation is associated with the pathogenesis of atherosclerosis 
and coronary heart disease. There is evidence of a significant degree of heritability 
for inflammatory markers; heritability (h2) for CRP, for example is 0.40 and for WBC 
is 0.35 82. 
 
An excessive inflammatory response induced by cardiac surgery and CPB has been 
implicated in the pathogenesis of postoperative myocardial infarction(PMI). 
Podgoreanu et83 al tested the association between  48 SNPs in  23 genes 
(previously reported  as being involved in inflammation and ischaemia-reperfusion 
injury) and the incidence of PMI,  these investigators found that 3 polymorphisms  
increased the risk of PMI  after CABG; IL6-572 (OR:2.47) and adhesion molecules 
ICAM1 Lys469Glu (OR:1.88) and E-selectin SELE 98G>T (OR:0.16).Interestingly, 
IL-6 plasma levels have been linked with prolonged hospitalization26. Several authors 
have also shown that another variant of e-selectin (Ser128Arg) can affect the 
adhesion of leukocytes to the endothelium and contribute to the pathogenesis of 
artherosclerosis84, 85.  
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 The function of haptoglobin (Hp)  is to bind free haemoglobin (Hb) during 
physiological destruction of erythrocytes, thereby preventing the accumulation of free 
Hb and reducing   oxidative stress is reduced 86 .Several Hp polymorphisms have 
been described (Hp1-1,Hp-2-2 and Hp 2-1). Haptoglobin Hp2-2 contributes to 
hypertension and has been associated with atherosclerosis87. Hp 2-2 has also been 
found  to be a predictor of previous MI before CABG (OR:1.78) and of reduced graft 
patency over time (p<0.05% OR: nr)88.  
 Another group of investigators studied 765 Flemish individuals undergoing CABG 
and found that carriers of the DD genotype of the angiotensin I converting enzyme 
(ACE) gene, had a higher mortality at 2 years after surgery (0%genotype ACE II, 
11.2% ACE ID and 14.1% ACE DD p <0.05 )89.The pathophysiological explanation 
for this association has not been established, but the DD genotype is associated with 
a two-fold increase in the enzymatic activity of ACE and conveys an increased risk of 
coronary disease and myocardial infarction in patients without classic risk factors for 
coronary disease. In addition, local  concentrations of ACE in endothelial and intimal 
layers of vein grafts has been associated with a differential response to angiotensin I 
and II in an experimental graft model90 
Hyperhomocysteinemia is an independent risk factor for vascular disease including 
coronary disease (0R:3.2) 91.A mutation has been reported  in the enzyme  
methylenetetrahydrofolate reductase that intervenes as a methyl donor in the 
conversion of homocysteine to methionine (C677C — T)   . Individuals that are 
homozygous for the alleles TT have high plasma levels of homocysteine. Botto et 
al92 followed up (6.9±0.3 months) a group of 159 patients after re-vascularisation (72 
after percutaneous transluminal coronary angioplasty (PTCA) and 87 after 
CABG).Individuals  with the TT genotype had a higher incidence of major cardiac 
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events; recurrent angina, nonfatal MI ,revascularization , heart failure and cardiac 
death (OR :2.8).Interestingly hypercysteinemia has been associated with DNA 
methylation and lipid deposition in the aorta of mice 93.  
After CABG, angina recurs in up to 10% of patients, mainly due to graft failure. 
Angiographic studies have revealed that after one year 15 to 30% of  grafts are 
stenosed and approximately 50% are not patent 10 years post-surgery94. 
Progression of atherosclerosis and thrombus formation are considered to be the 
main factors that lead to graft occlusion. Platelet glycoprotein IIb/IIIa is a complex 
receptor for fibrinogen and von Willebrand factor and carries the human platelet 
antigen (HPA)1. HPA-1B  codes for a leucine/proline substitution, is a hereditary 
factor for platelet thrombogenicity and is strongly associated with coronary 
thrombosis (OR: 6.2 for patients with coronary disease <60 years old)95.In a 
population of 261 patients after CABG only the possession of the polymorphism 
HPA-1b after logistic regression analysis was predictive of major complications  (MI, 
bypass occlusion or death) 96with an OR of 4.7. 
 Other investigators studied the development of postoperative ventricular dysfunction 
(VnD) after surgery. In a meta-analysis based on one validation study and two 
replication studies by Fox et al 97(188 cases of VnD and 1200 controls), the authors 
found three allelic variant in chromosome three associated with an increased in the 
incidence of VnD: rs17691914 (SNP located near cell death 6 interacting protein 
gene), rs17061085 (located within the intron of MARVEL, a transmembrane  domain 
associated with heart failure), rs12279572 reside near histidine triad (FHIT) which 
expression has been found to be decreased in LVEF. One of the limitations of these 
impressive findings is that the definition of VnD is based only on clinical variables; 
inotropes requirements or ventricular support after CABG, the other is that the 
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positive association (which carries a considerable effect; OR; ≥ 2.1) lack of 
µsupportive evidence about the functional role of the SNPs studied. 
 
2-4 DNA sequence variation and sepsis  
 
Sorensen et al 98 in a landmark paper studied 960   children adopted early in life . 
These authors showed that the risk of premature death (<50 years old) as a result of 
infection had a stronger heritable component (OR:4.5) than cardiovascular and 
cerebrovascular disease (OR:1.19). 
Over the course of evolution infectious diseases may have selected for protective 
variations in the areas of the genome associated with human immunity, explaining 
the large number of polymorphisms in the human leukocyte antigen (HLA) region, for 
example. It is worth noting that selective genetic pressure is only exerted when the 
disease affects mortality and morbidity before the reproductive age 99.  
There is strong evidence of susceptibility to some specific infectious diseases such 
as leprosy, tuberculosis, malaria  and HIV amongst others .Lessons learnt from 
these studies may be applicable and help to unravel the key genes affecting  
susceptibility to sepsis and septic shock in critically ill patients.  
 
2- 4- 1 Malaria 
 
One of the first genetic associations to be investigated was prompted by the 
observation that there was a similar geographical distribution for 
haemoglobinopathies and the presence of plasmodium falciparum100 . 
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HbS is a consequence of an aminoacid substitution ,from glutamic acid to valine in 
the β globulin chain caused by a mutation in chromosome 11p15.5.The HBS allele is 
found particularly in large areas of sub-Saharan Africa, as well as in parts of the 
Middle East and India99. Homozygotes (HbSS) suffer from sickle cell disease but 
heterozygotes are usually asymptomatic. The heterozygous state (HbAS) confers 
>90 % protection against severe and lethal malaria and 50% protection against mild 
attacks 101.There are several theories to explain the mechanisms by which HbS 
results in protection, including an increase in the clearance of infected red blood cells 
by the spleen and a reduction in the growth of the parasite inside affected red 
cells102. Another structural variant of haemoglobin associated with malaria infection 
is hemoglobin C (glutamic acid to lysine aminoacid substitution). Less common than 
HbS, HbC is found in several parts of West Africa, but the protective effect of 
heterozygosity (HbAC) is only 30% in comparison with >90% in homozygotes 101. 
The malaria parasite binds to the erythrocyte surface prior to invading red blood 
cells. The Duffy blood group antigen is a genetic variant encoded by the gene DARC 
also known as FY. A substitution from glycine to asparagine at aminoacid position 44 
inhibits DARC expression on erythrocytes. Those individuals who are Duffy negative 
(lack the antigen) are immune to Plasmodium Vivax99, 100. 
Glucose 6 phosphate dehydrogenase (G6PD) deficiency  impairs the capacity of red 
blood cells to deal with oxidative stress, this deficiency confers in homozygous males 
and heterozygous females protection against malaria, presumably by favouring the 
elimination of red blood cells at an early stage of infection 102. 
Finally, a number of associations have been reported between malaria and 
polymorphisms of host receptors for cytoadherence; endothelium antigen CD36, 
intercellular adhesion molecules ICAM-1, CD31 (platelet –endothelial cell adhesion 
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molecule), cytokine polymorphisms (TNF, IL-4, IL-10) and antigen recognition 
molecules; HLA-B53, HLA-DR. 
 
 
2- 4 -2 Leprosy 
 
Leprosy is a chronic infection caused by Mycobacterium leprae , an intracellular 
bacillus   that affects macrophages and Schwan cells. Humans are the only reservoir 
of the disease. 
One of the unusual characteristics of leprosy is that notwithstanding its 
transmissibility,  90 % of individuals exposed to M.leprae do not  acquire the disease. 
One of the factors that contributes to the risk of contracting leprosy  is genetic 
susceptibility 103. 
In a study of 197 Vietnamese families a region overlapping the 5’ region adjacent to 
PARK2 and the co-regulated gene PACRG was found to be associated with leprosy. 
Individuals carrying at least one haplotype with both risk alleles(PARK2_e01(-2599)-
T and rs1040079-C) have an increased risk of leprosy (OR 5.28). These findings 
were corroborated in an independent sample of 586 unrelated Brazilian unrelated 
cases. In a “meta-SNP” combining the information at SNPs PARK2_e01(-2599) and 
rs1040079 of both studies the PARK2/PACRG 5’ region was associated with 
increased susceptibility to leprosy(OR:2.21)104.PARK2/PACRG are expressed in 
macrophages and Schwan cells. PARK2 is a ubiquitination eligase involved in the 
proteasome complex (ubiquitin-mediated proteolysis). Ubiquitination is a regulatory 
process for immune proteins, including those involved in the TLR signalling pathway 
105. Interestingly, in Salmonella typhi (typhoid fever) and Salmonella paratyphi 
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(paratyphoid fever) , a proteasome mediated protein degradation process has been 
also implicated in the host response  103.  
The same strategy used in the above studies was used to investigate the region that 
includes the HLA class III and class II genes. Lymphotoxin-alpha LTA+80 was found 
to be associated with leprosy in 104 family cases (OR:2.11). In another study of 209 
Brazilian cases of leprosy (192 controls), however, there was no association 
between LTA SNPs and  leprosy. Nevertheless further analysis in which data from 
298 Vietnamese family samples were combined with the Brazilian group confirmed 
the association of LTA-80 and the risk of leprosy, but only when the younger cases 
were considered (OR:5.63)106. These results appear to implicate the LTA+80 variant 





2-4-3 Human immune-deficiency virus (HIV) 
 
HIV infected patients can present three patterns of disease evolution 1: slow 
progression. 2: AIDS develops between 3 to 10 years after seroconversion. 3: rapid 
progression; AIDS develops in 2 -3 years. 3: “elite control” where individuals have 
undetectable viral loads for more than 10 years without any clinical manifestations of 
immunosuppression 107. 
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An improved understanding of the genetic and immunological mechanisms 
underlying “natural resistance” against HIV is one focus of research  aimed at 
developing  the first generation of vaccines against HIV 108. 
In the same manner that plasmodium vivax uses the Duffy antigen to access red 
blood cells, the HIV virus uses the chemokine receptors CCR5 and CXCR4 to invade 
immune cells108. Individuals carrying the 32-p deletion of the chemokine (C-C motif ) 
receptor 5 (CCR5) gene have a lower risk of acquiring HIV infection . Homozygotes 
for the deletion are almost immune to HIV while heterozygotes show a 2 to 4 years 
delay in progression to AIDS 109. Homozygotes or heterozygotes for the chemokine 
CCR2-V641 that results from a change from G to A at position 190 present with a 2 
to 4 year delay in progression to AIDS. Conversely other polymorphisms of CCR5 
have been associated with rapid progression to AIDS(CCR5P1, CCR5-249A)110.HLA 
genes play a key role in the immune response. Heterozygocity at HLA class loci 
HLA-A, HLA-B and HLA-C is associated with resistance to progression to AIDS. 
Other variants of genes coding for cytokines have been implicated in the immune 
response to HIV (TNF-alpha, Interferon alpha receptor 1,IL-4,IL-10, Mannose-
binding lectin and Killer Immunoglobulin-like receptor)108, 110.  
It is expected that in the not very distant future genome wide analysis of patients 
affected with HIV will be used not only as a prognostic tool but also to guide 
treatment, Advances in our knowledge of the mechanisms that the HIV virus uses to 
evade the host immune response are currently being used to develop an effective 
HIV vaccine108, 111. 
 
 
2-5 DNA sequence variation and sepsis in the critically ill patient 
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The traditional approach to studying genetic variants associated with susceptibility to 
sepsis has been based on case-control studies in which the incidence of selected 
SNPs in the septic population is compared with that seen in matched unrelated 
control groups. A similar study design has been used in candidate gene association 
studies investigating the influence of DNA sequence variations on outcome. Most of 
the selected candidate gene loci have been involved with innate immunity, cytokines 
(pro and anti-inflammatory) and thrombosis/coagulation112. 
 
2-5-1 Cytokines  
 
One of the key events in the host response to infections is the production by the 
endothelium, macrophages and leucocytes of pro and anti-inflammatory cytokines 
(e.g. TNF-alpha, IL-1, IL6, IL1-ra, IL-10) that activate the cellular and humoral 
networks that are responsible for eliminating invading micro-organisms. Although an 
oversimplification the conventional view has been that an imbalance between 
inflammation/anti-inflammation may lead to uncontrolled inflammation with shock and 
organ injury or immunosuppression with recurrent sepsis, multi-organ dysfunction 
and death. 
 
2-5-2 Tumour Necrosis Factor 
 
In experimental models administration of TNF induces shock that mimics the 
response to  endotoxin  113. In addition TNF can activate nitric oxide synthase, 
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increasing the production of nitric oxide, a mediator of shock and hypotension in 
septic patients114. 
Higher plasma levels of TNF-alpha have been associated with mortality in patients 
with infection. Two polymorphisms at position -308 of the promoter region of TNF 
have been investigated in relation to sepsis outcome. TNF1 (G allele; guanine at 
position-308) and TNF2 (A allele; adenine at position -308). An early study of 80 
patients with severe sepsis failed to  establish an association between TNF2 and 
sepsis outcome115. However, Mira et al 116 in a case control study found that the 
TNF2 allele was more common in patients with septic shock than in healthy controls 
(39% vs 18% ) and that the probability of death was increased in those with the 
TNF2 allele (OR:3.7). Similarly a Taiwanese case-control study of 112 postoperative 
critically ill patients  confirmed the association of TNF2 with an increased risk of 
death in patients presenting with septic shock, although  patients that  were carriers 
of the  TNF2 allele were not more likely to develop sepsis or  a higher mortality117. 
One of the limitations of these studies was that the patients’ haplotype was not 
known and only a small number of SNPs were analysed. Gordon et al 118 
investigated a larger cohort (n; 213) of patients with severe sepsis or septic shock 
but  failed to find any association between a number of TNF and TNF receptor 
polymorphisms or their haplotypes and the risk of developing sepsis, illness severity 
or outcome. Subsequently   Menges et al119  reinvigorated the debate about the role 
of TNF polymorphisms in sepsis. They studied  159 patients admitted with severe 
trauma of whom 72 developed sepsis and found that  the TNF A allele(rs1800629 ) 
was associated with the development of sepsis(OR:7.14) and a fatal outcome (OR: 
7.65). Sepsis susceptibility and the risk of death are thought to be affected by 
interactions between multiple genes and the environment, the extremely high odds 
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ratio reported in some studies are very unusual for what is considered to be a 
polygenic disease. Patients with trauma have a severe systemic inflammatory 
response that It is very difficult to differentiate from sepsis based on microbiological 
cultures alone120. In addition, a link between the TNF -308 allele and an increase in 




IL-1a and IL-1b are pro-inflammatory gene products while IL-1ra (IL-1 receptor 
antagonist) is an anti-inflammatory acute phase protein that binds to but does not 
activate the IL-1 receptor 112.In addition IL-1ra allelic variants regulate the production 
of IL-1b123. In a study of 93 patients the development of severe sepsis was 
associated with the possession of the IL-1raA2 (plasma levels of IL-1ra were not 
measured), although no survival difference was detected124 , Contrary to these 
findings,  Ma et al 125 found a positive association between IL-1raA2 and an 
increased risk of death  in 60 patients with severe sepsis (plasma levels of this 
molecule were not measured), while a similar study in 78 patients with severe sepsis 
showed that patients homozygous for IL-1raA2 had a higher risk of death (OR: 
6.47).Interestingly, PBMC collected from patients that carried the IL-1raA2 allele 
produced less IL-1raA2 after LPS stimulation 126.  Disappointingly, in a randomised, 
controlled trial the administration of recombinant interleukin -1 receptor antagonist to 
patients with sepsis was associated with increased mortality127. 
 
2-5-4 Interleukin 6 
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 In a landmark paper Roger Bone et al 128 studied  97 patients with severe sepsis 
and showed that plasma levels of IL-6 were a better predictor of outcome than were 
TNF and IL1β. 
A polymorphism (G to C) in the promoter region of IL-6 (-174) has been associated 
with increased production of IL-6 in an ex vivo study in healthy adults129. In a 
German case control study that included 326 critically ill patients (hospitalized for 
major abdominal , cardiothoracic, head or trauma surgery) of whom 50 developed 
sepsis, the investigators failed to associate this IL-6 (-174 G/C) polymorphism with 
increased susceptibility to sepsis or survival rates, although they found that GG 
homozygotes were represented  more frequently amongst the non survivors. 
Interestingly, these investigators confirmed Bone et al’s finding of an association 
between IL-6 levels and an increased risk of death.  The lack of association between 
(-174 G/C) polymorphisms and IL-6 production was replicated in an ex vivo study in 
trauma patients130. These conflicting findings between ex-vivo studies have been 





2-5-5 Interferon-γ (INF-γ) 
 
INF-γ is produced by natural killer cells, its main actions being to promote T cell 
differentiation, up-regulate the major histocompatibility complex(HLA) class 1 and 2 , 
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and increase the production of enzymes in monocytes responsible for the respiratory 
burst, INF-Ƴ  also regulates  IL-12 131 . 
Stassen et al132 studied the expression of HLA –DR (major histocompatibility 
complex class II receptor) in a group of patients (n= 61) after trauma (ISS: 16) of 
whom 30 became septic Patients homozygous for the D allele (DD) were more 
susceptible to sepsis (OR: 2.09). Furthermore, in a case control study of 24 patients 
undergoing elective laparotomy and 21 patients suffering severe sepsis, a 
postoperative reduction in HLA-DR expression (measured by fluorescent-labelled 
monoclonal antibody) was associated with a higher risk of sepsis, while in the 
surgical patients reduced expression of HLA-DR was linked to higher mortality 
(P<0.05).In addition, after ex vivo incubation of monocytes extracted from the non-
surgical infected group with LPS, the monocytes from the surviving patients 





2-5-6 Toll-like receptors (TLRs)  
 
The innate immune system is the first line of defence against invasion by 
microorganisms. Monocytes-macrophages, granulocytes and dendritic cells possess 
surface receptors that recognise bacteria, viruses and fungi, triggering the initial 
cascade of the immune response 134. There are at least ten TLR receptors, that are 
activated selectively by different pathogen associated molecular patterns (PAMPs) ; 
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TLR-2 (gram positive bacteria and fungi), TLR-4(gram negative bacteria and some 
viruses), TLR-5( flagellae of legionella pneumophilia). 
Binding of LPS to TLR-4 activates the transcription factors nuclear factor-κB and 
activator protein 1. A missense mutation has been described (Asp299Gly and 
Thr399lle)affecting  TLR-4 .Arbour et al 135 found in 83 patients that individuals  
homozygous or heterozygous for the two mutations (n:10) were hyporesponsive to 
inhaled LPS in comparison to volunteers with the wild variant. This was the first 
evidence that allelic variation of TLR-4 in humans may affect the immune response 
to endotoxin and opened the avenue for many other investigations. A further 
investigation by the same authors in a case control study of 91 patients with septic 
shock found that the possession of the Asp299Gly mutant was associated with a 
higher incidence of septic shock and gram negative infections , although there were 
no significant differences in disease severity (SAPS-2), multiorgan dysfunction (OSF 
score) or mortality 136. Contrary to this positive finding a British study including 1047 
patients with microbiologically proven meningococcal disease failed to show any 
difference between patients who survived and those who died (n:86) in terms of  
possession of the 299 variant (OR:1.55; 95% CI, 0.70-3.44).These investigators 
highlight the need to investigate TLR-2 and other TLR-4 co-factors in order to have a 
better understanding of the roles of TLR in innate immunity 137. Furthermore , 
Shalhub et al 138in a group of trauma patients (n:598) 25% of whom developed 
severe sepsis or septic shock used haplotype tagging to demonstrate  that the TLR-4 
299 variant was linked to a common haplotype  associated with a decreased risk of 
complicated sepsis (OR:0.2). 
The TLR-2 Arg753 variant has been found to be responsible for hypo- 
responsiveness to bacterial challenge in vitro and was more common in patients 
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suffering from septic shock induced by staphylococcal infection (9% versus 3% in a 
healthy control group)139. However, the fact that only 2 out of 22 patients presenting 
with gram positive septic shock were carriers of the mutation seriously limits the 
validity of this finding. 
Mal (Ser180 leu,TIRAPrs8177374) is a polymorphism in a protein involved in   of 
LPS signalling that is located downstream of Toll-like receptors  2 and 4. This 
polymorphism is more common in the European population and seems to have 
spread in West-Eurasia under evolutionary pressure. Using an in vivo model in 
healthy volunteers it was found that carriers of this variation inTIRAP/Mal produced 
more proinflammatory cytokines when exposed to LPS. The authors hypothesised 
that this polymorphism may have a protective effect in sepsis140. Furthermore, two 
SNPs have been described that differentially influence susceptibility to sepsis. 
TIRAP/Mal SNP re7932766 has been associated with an increased risk of meningeal 
tuberculosis in Asian patients141 whereas TIRAP/Mal SNP (Ser180 leuco TIRAP 
rs8177374) has been shown to have a protective effect in pneumococcal 
pneumonia142 A further study investigated the possession of TLR4 (299 SNP) and 
TIRAP/Mal (Ser 180 leu) in three groups of patients; 375 complicated surgical 
patients, 159 patients with ventilator associated pneumonia(VAP) and 415 patients 
after uncomplicated cardiac surgery. In the surgical group homozygotes for the 
TIRAP/Mal polymorphism were at an increased risk of sepsis (OR:7.3) while the 
possession of both SNPs (TIRAP/Mal and TR-4 299) was associated with an odds 
ratio of 5.5 for sepsis risk. In the group of patients with pneumonia the combination 
of TLR-4 and TIRAP/Mal SNPs was not associated with lower levels of cytokines 
whereas cytokine levels were lower in patients who were carriers of only one SNP. In 
patients after cardiac surgery no differences were found between any genotype 
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combination and cytokine levels (TNF-alpha, IL-6, IL-10, IL-8).This study suggests 
that lower cytokine levels are associated with an increased risk of developing sepsis 
after surgical interventions143. These findings contradict the observations made by 
Ferweda et al140, whose results suggest a negative interaction between TLR-4 and 
TIRAP/Mal SNPs and plasma cytokine levels . 
 
 
2-5-7 Mannose-Binding lectin 
 
Mannose-binding lectin (MBL)is an opsonic that binds to carbohydrates on the 
surface of micro-organism, promoting bacterial elimination through activation of the 
complement system. MBL plays an important role in innate immune defence112. 
The MBL gene has point mutations within the exon 1 at codon 52, 54 or 57 (variants 
B,C and D) while the wild allele is called A144.  
Individuals homozygous for any of the mutations have been found to have  lower 
plasma levels of MBL(normal >1000 μg/l) and present with recurrent, unusual  
severe infections throughout life145. 
The presence of MBL polymorphisms has been associated with lower plasma levels 
of MBL before chemotherapy in children (n:100) and adults(n;54) suffering from 
haematological malignancies and with a more prolonged median duration of febrile 
neutropenic episodes146, 147.Furthermore, in a group of 266 children , the proportion 
of patients presenting with meningococcal meningitis was higher in the group with 
mutations than in healthy controls (OR:6.5)148.  
Gordon et at144 in a multicentre study including 174 patients with severe sepsis or 
septic shock confirmed that MBL allelic variants are more frequent in patients with 
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sepsis and that lower plasma levels of MBL (<1000 μg/l ) are associated with higher 
mortality. However these investigators failed to corroborate the hypothesis that in 
patients with MBL mutations (A/O or O/O) the level of MBL was different between 




2-5-8 Cell wall recognition molecules: BPI, LPB and CD14 
 
Permeability increasing protein (BPI) is a protein present in the granules of 
neutrophils. It binds to the lipid A portion of LPS and inhibits LPS induced responses, 
BPI is cytotoxic for Gram-negative bacteria and promotes phagocytosis. Three 
polymorphisms have been identified with an incidence of >1%; (G545>C) Tag is a 
silent mutation, BPI (A645 >G)216 corresponds to a lys216 amino acid exchange for 
Glutamine and BPI Pstl (T for C) intron 5. 
Lipopolysaccharide binding protein (LBP) is a plasma protein produced by the liver in 
increased amounts during the acute phase response .LBP binds to LPS and jointly 
with CD14(LPS –receptor found on the cell surface of macrophages and monocytes) 
induces macrophage activation. Two polymorphic nucleotide exchanges of LBP have 
been investigated (Cys98 to Gly) and (Leu436 to pro)112. 
CD14 is a glycoprotein expressed on the cell surface of macrophages, monocytes 
and polymorphonuclear leukocytes. It is a co-receptor for LPS, peptidoglycan and 
lipoteichoic acid. CD14 is also present in a soluble form that mediates the activation 
of cells that do not express the CD14 receptor, such as endothelial and epithelial 
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cells. A polymorphism within the promoter region that consists of an exchange of C 
to T at position -159 has been described. Individuals who carry the T allele have 
higher levels of CD14s 149. 
A case control study of 345 patients aged 0-19 years old presenting with SIRS 
,severe sepsis or septic shock investigated the presence of two BPI polymorphisms 
BPI (G45>C ) Taq and BPI (A645>G)216. These investigators found a  significant 
difference  in the presence of BPI Taq and sepsis in all groups  (SIRS ;OR:2.07, 
severe sepsis;OR:1.59 and MODS;OR:3.04).Interestingly, all the non survivors(14 
patients;4.1%) were homozygous for the SNP Tag (GG)150 . 
Contrary to this finding, a similar study of 204 adult septic cases with a higher overall 
mortality than the previous study (47%) found no difference in the possession the 
BPI genotype between patients and controls, although further analysis revealed that 
male patients who were carriers of the minor allele of LBP Gly98 were at higher risk 
of sepsis, The protective effect of female hormones (post-pubertal) might help to 
explain the differences between findings in adults and children. On the other hand 
one could speculate that the significant difference in mortality (4% versus 47%) 
between the two studies at least in part, may explain the discrepancy in findings.151 
Gibot et al 152 investigated the influence of CD14 polymorphisms on sepsis 
susceptibility and mortality. These investigators studied just 90 patients with septic 
shock; individuals homozygous for C-159T had an increased risk of death (OR:5.30). 
However, a German case control study of 204 patients with severe sepsis failed to 
corroborate this finding 153 .One of the limitations of these studies is the lack of 
quantification of CD14 .In addition CD14 expression levels (ex vivo measured by 
flow cytometry in monocytes) has not been found to differ in patients with severe 
sepsis or septic shock in comparison with healthy volunteers154.  
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2-5-9 Immunoglobulin Receptors 
 
Fc receptors for immunoglobulins (IgG, IgA and IgM) facilitate the process of 
phagocytosis and play an essential role in the host response to invading 
microorganisms. 
There are three principal FcRs for IgG (Fcγ receptors Ia, IIA, IIIa and IIIb). Three 
classes of polymorphisms have been described. FcγRIIa is expressed by 
granulocytes and mononuclear phagocytes, a single point mutation has been 
reported in exon 4 at amino acid 131; H(histidine) to R (arginine).  Neutrophils 
homozygous or heterozygous for this mutation showed reduced phagocytic activity. 
Another mutation in FcγRIIIa at aminoacid 158 Fenylalanine (F) for Valine (V) affects 
the binding of FcγRIIIa to its effectors; IgG1, IgG3 and IgG4. Two variants of 
FcγRIIIb carry 4 substitutions (FcRIIIb-NA1 and FcγRIIIb-NA2). 
Although Neisseria menigitidis nasopharyngeal colonization is frequent and has 
been reported in up to 10% of the population, the incidence of invasive Meningoccal 
disease (MD) is only approximately 1-3 cases /100.000 person a year. Airway 
colonization elicits the production of specific antibodies (IgG, IgA and IgM) that 
protect individuals from invasive infection. Consequently, several investigators have 
examined the role of Fcγ receptor polymorphisms in predisposition to invasive MD. 
In children (n:98) an association was found between carriers of RIIaR131 and the 
incidence of meningococcal disease (OR:2.9) as well as  the development of severe 
disease (OR:4.8)155. In addition, Van der Pol et al 156studied 50 survivors of MD and 
183 first degree relatives of survivors and non survivors; they confirmed the 
observation that RIIaR131 was more common in patients with meningitis than in 239 
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healthy control subjects. In addition the frequency of the FcγRIIa/IIIa/IIIb combination 
RR-FF-NA2/2 was nearly 3 fold higher in relatives of patients than in controls 
(0R:2.6). 
 
2-5-10 Heat shock proteins 
 
The heat shock protein 70 (HSP70) family of proteins have an immunomodulatory 
role. Synthesis of heat shock proteins is stimulated by infection and cellular stress 
(heat, ischaemia/reperfusion and inflammation). They exert several cytoprotective 
effects including stabilization and repair of denatured protein structures. In addition, 
HSP70 gene expression exerts an anti- inflammatory effect by inhibiting the 
translocation of NF-κβ into the nucleus. Surprisingly secreted in the extracellular 
space HSP70 acts as a pro-inflammatory cytokine, increasing the production of TNF 
and IL-6157-159. Furthermore, HSP70 is, in evolutionary terms, part of an ancient 
mechanism of cellular preservation, believed to be present in all living organisms 
(bacteria, plants, animals and humans beings). Interestingly, all eukaryotic 
organisms exhibit a remarkable aminoacid sequence similarity (60% to 78%) for 
HSP70. Located in chromosome 6 within the major histocompatibility complex, a 
highly polymorphic area involved with antigen recognition. it is not surprising that 
HSP70 allelic variants have been the focus of several studies investigating sepsis 
susceptibility in humans. Three polymorphisms of HSP70 genes have been identified 
HSPA1A, HSPA1B and HSPA1L. In a prospective cohort of 434 patients presenting 
with Community Acquired Pneumonia (204 black patients and 139 white patients) 
the possession of the genotype HSP701- B1267 AA was associated with a trend 
toward higher mortality (p=0.06) and in the group of patients with septic shock (30 
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patients , mortality: 40%) the HSP701-B1267  AA genotype was found to increase 
significantly the mortality risk (OR: 3.5)160. However striking these results are, 
HSP70-B1267 A is a silent mutation and unlikely to be biologically responsible for  
the observed difference in septic shock mortality. Investigators from the same group 
studied genetic variants in the promoter region of HSPA1A and HSPA1B in 100 
healthy individuals and measured m-RNA production (HSPA1A and HSPA1B) using 
PCR in stimulated monocytes (E.coli LPS) collected from 36 selected individuals. 
Two SNPs HSPA1A-27G>C and HSPA1A-372A>C were found to be in linkage 
disequilibrium with HSPA1B1267A>G but this variant was not linked to increased m-
RNA production. Interestingly, another variant HSPA1B-179C>T, also in linkage 
disequilibrium with the others, was associated with an increase in HSPA1A and 
HSPA1B’s m-RNA synthesis 158. Further research into the functional role of the 
haplotype HSPA1B1267A>G: HSPA1B-179 was performed using an ex vivo 
experiment with peripheral blood monocytes (PBMC) isolated from 31 healthy 
volunteers. After stimulation (killed streptococcus pneumonia and E.coli bacteria) 
individuals with the haplotype HSPA1B-179:HSPA1B267 A had decreased 
expression of HSP-70 of m-RNA and protein, as well as more elevated levels of m-
RNA for TNF. These findings suggest that polymorphisms of HSP70 may have an 
impact on the phenotypic variation observed in patients presenting with severe 
sepsis and septic shock 157. 
 
2-5-11 Plasminogen activator inhibitor-1 
 
Plasminogen activator inhibitor (PAI) is an acute phase reactant synthesised by the 
liver, endothelial cells and platelets. PAI reacts with plasminogen activators as well 
62 | P a g e  
 
as with protein C. Reduced fibrinolytic activity has been associated with coronary 
disease. The polymorphism (4G/4G) in the PAI-1 promoter has been associated with 
reduced PAI-1activity and an increased risk of myocardial infarction in young 
patients (OR 2.15) 161. 
Microvascular thrombosis is frequently found in septic patients who develop 
multiorgan failure and PAI-1 activity has been associated with poor outcome both in 
sepsis and severe trauma112, 162. Consequently, several authors have investigated a 
possible link between carriers of PAI-1 polymorphism and outcome in sepsis. 
Coagulopathy is a common feature in meningococcal disease the pathogenesis of 
which is considered to be in part the result of an imbalance between pro-coagulant 
and anticoagulant activity. In a group of 133 children with meningococcal sepsis the 
4G/4G genotype was associated with higher PAI-1 activity and a higher mortality 
(OR: 2.0)163. Furthermore, Westendorp et al164 examined 50 patients who survived 
meningococcal infection, together with 183 first degree relatives and 131 controls. 
Amongst the 50 patients who survived carriers of the 4G/4G genotype had an 
increased risk of developing septic shock (OR: 4.8). Moreover the 4G/4G genotype 
was more common in first degree relatives of patients who presented with severe 
disease. Based on these observations the authors calculated that patients whose 
relatives were carriers of the 4G/4G allele have a higher risk of developing septic 
shock (OR: 5.9). However important these findings are, meningococcal disease has 
a very distinctive presentation and is usually associated with disseminated 
intravascular coagulation. Consequently, these results may not be applicable to 
patients presenting with severe sepsis or septic shock caused by other micro-
organisms. A more recent study including 319 patients (74% had sepsis, 19% had 
severe sepsis and 7% had septic shock) with documented gram negative 
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bacteraemia (powered >80% to detect a 1.5 fold increase of relative risk of death for 
the heterozygous forms) failed to corroborate any correlation between mortality and 




2-5-12 Protein C 
 
 Sepsis triggers an imbalance between procoagulant and fibrinolytic pathways .LPS 
induced up-regulation of tissue factor in endothelial cells activates coagulation 
Endotoxin exposure can precipitate thrombosis in the micro circulation that may lead 
to areas of hypoperfusion, tissue necrosis and ultimately may be partially responsible 
for the development of multiple organ dysfunction166. The Protein C pathway is one 
of the major regulators of the responses observed in sepsis. During activation of the 
coagulation cascade thrombin reacts with thrombomodulin to form a complex that 
transforms protein C to activated protein C(a-PC).  Activated Protein C (a-PC) exerts 
anti-thrombotic, profibrinolytic, anti-inflammatory and anti-apoptotic activities, as well 
as stabilising the endothelial barrier167 . In sepsis protein C deficiency is common 
(>85%) and plasma levels correlate inversely with outcome, independently of the 
infecting micro-organisms168 . 
Two haplotypes in the promoter region of protein C have been described (-1641 A/G 
and -1654 C/T).-1641G/-1654C and are associated with decreased plasma levels of 
protein C and an increased risk of thrombotic events 169. 
In a case control study of 288 children presenting with meningococcal infection, 
patients younger than one year old who carried the genotype CG-CG had a higher 
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risk of developing severe sepsis (3.43). However the positive association between 
allele CG and sepsis severity was only present in patients younger than 2 years old. 
In addition  plasma levels of protein C were not measured to confirm the functional 
role of these variants 170. 
Furthermore, In 240 Asian patients Chen et al 171 found that the haplotype -1641A/-
1654 C was associated with fatal outcome in patients suffering from severe 
sepsis(OR:1.74). Interestingly, the C allele of protein C 673(  in linkage 
disequilibrium with the haplotype A/C) was also found to be linked to higher mortality 
in a group of patients of East Asian ancestry living in the USA 172. In a prospective 
candidate gene association study including just 62 Caucasian patients only the 
genotype -1641A was associated with decreased 28 day survival and more renal , 
neurological and hepatic dysfunction, as well as higher plasma levels of IL-6169. 
 The haplotype -1641 G/-1654C is associated with lower levels of Protein C and this 
haplotype has been associated with worse outcome in severe sepsis. These 
conflicting findings and the lack of measurement of plasma levels of Protein C or 
other surrogates of the coagulation pathway (fibrinogen or dimer D) in any of the 4 
studies described above, unfortunately fails to advance our understanding of the 
functional role of genetic variants in of protein C. They also fail to answer the 





2-5-13 Angiotensin-converting enzyme (ACE)  
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Angiotensin I converting enzyme plays a key role in blood pressure control 
generating angiotensin II (AT)-II from (AT)-1a potent vasopressor. In addition, ACE 
degrades bradykinin, a vasodilator peptide involved in inflammatory responses. The 
ACE gene has a restriction fragment length polymorphism consisting of the presence 
(insertion I) or absence (deletion D) of a repeat sequence in intron16. In 35 healthy 
volunteers those who carried the DD genotype had a mean increase in plasma levels 
of angiotensin II of 75% and 39% in T-lymphocytes173. ACE activity may be involved 
in the pathogenesis of ARDS through mechanisms involved in the control of vascular 
tone and permeability as well as fibroblastic activity174. In addition, one British group 
found that the DD genotype was associated with susceptibility to ARDS 174. 
 Due to the widespread actions of ACE, several investigators have explored the 
association of I/D polymorphism with sepsis. In a case control study of 212 patients 
with severe sepsis Villar et al175 failed to find a link between ACE polymorphisms and 














Mendel’s conclusion that allelic variants are inherited independently and unchanged 
was based on the study of discrete traits encoded by single genes with definitive, 
easily recognised phenotypic effects. Mendelian genetic cannot, however explain 
complex and quantitative traits 57.   
In 1932 Haldane introduced the concept that genes “accelerate or retard “ other 
genes or groups of genes and that the activity of genes can also be affected by 
environmental factors176. The question as to how multiple genes communicate 
between themselves and respond to environmental factors to shape phenotypic 
variation remains to be answered. Improved understanding of this intricate process 
will be invaluable to advance our understanding of the pathogenesis of  complex and 
multi-factorial diseases 177. 
The availability of low-cost high throughput technologies for genotyping hundreds of 
thousands of genes have made genome wide association studies (GWAS) possible. 
However, the biological meaning of genetic signals associated with very high levels 
of significance remains unclear60  These findings have prompted the application of 
new methodologies  aiming to elucidate  how DNA  polymorphisms can affect 
phenotypic variation. The development of microarrays in the mid 1990’s made it 
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possible to perform genome wide expression arrays, treating transcript abundance 






2-6-2 Gene-expression in sepsis: 
 
The host response to sepsis involves the interaction of multiple mechanisms related 
to the innate and adaptative immune systems. Cytokine based studies have been at 
the centre of research into the pathogenesis of sepsis. The conventional view of the 
inflammatory process has been that pro-inflammatory mechanisms predominate 
initially, whilst later inflammatory pathways are responsible for controlling 
inflammation and re- establishing homeostasis. However, the lack of success of trials 
using interventions aimed at pro-inflammatory mediators,  the considerable variability 
of cytokine plasma levels observed in  patients with sepsis and the increase body of 
evidence suggesting that immune stimulation and downregulation occurs 
simultaneously  has stimulated investigators to use genomic studies to discover 
other mechanisms/pathways that might contribute to the pathogenesis of sepsis179. 
Response to endotoxin 
Several investigators have administered endotoxin to healthy human subjects in 
order to define gene expression profiles in sepsis. Gene expression was determined 
in whole blood using a global gene expression array of >44.000 probe sets by 
Calvano et al17. After administration of endotoxin to 4 individuals (there were 4 
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controls) 3714 genes showed a change in signal intensity, more than half (1857) 
being down-regulated. A small number of probe sets showed up-regulation by 2 
hours and the remaining genes were induced at 4-9 hours. Expression of all genes 
returned to baseline by 24 hours. Network analysis (Ingenuity  Pathways analysis) of 
the main interactomes revealed an initial up-regulation of pro-inflammatory cytokines 
and chemokines (TNF, IL1A, IL1B,IL8,CXCL10) followed by increased expression of 
several members of the nuclear factor/relA transcription factor complex (NFKB1, 
NFKB2, RELA and RELB).  4-6 hours after endotoxin injection a number of 
transcription factors involved in the innate immune response were over-expressed 
(STAT genes), c-AMP–response element binding protein (CREB) as well as genes 
that limit the inflammatory response (IL1RAP, IL1R2, IL10 and TNFRSF1A). In 
addition, the authors identified suppression at the transcription level of regions 
associated with mitochondrial energy production and protein synthesis.  
Another study investigating gene expression profiles after administration of 
endotoxins to healthy volunteers (8 individuals compared to 4 controls) showed a 
similar pattern in whole blood and in mononuclear cells. The peak change in 
mononuclear gene expression occurred 6 hours after endotoxin administration (439 
genes up-regulated and 428 down-regulated). Endotoxin administration up-regulated 
genes associated with pathogen recognition and immune response (complement 
receptors, bactericidal/permeability-increasing protein BPI and leukocyte 
immunoglobulin receptors), chemokines (IL1RA, IL17R, IL15R, CCR2, 
CCR1,CCR7), microbicidal oxidase and oxidative stress genes and S100 
calgranulins. The main down-regulated genes were T and B cell associated (CD48, 
CD43, CD7, CD3E, CD3D,CD4,CD3Z,CD3G ,TNFRSF7), major histocompatibilty 
complex class 2, apoptosis (caspase 8, Fas-induced apoptosis) and Natural Killer 
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inhibitory receptors (KIR2DL3,KIR3DL1), the latter binds human leukocyte antigen 
(HLA) class 1 180 . 
Interestingly, both studies of changes in gene expression after endotoxin challenge 
revealed a widespread response of the transcriptome involving very diverse genes 
that returned to baseline by 24 hours. 
Gene expression profiles to diagnose and predict sepsis 
Using a microarray containing 340 genes implicated in inflammation Prucha et al 181 
identified in  8 patients with severe sepsis (compare to a group of 4 patients who 
underwent spinal surgery), a gene profile that included 50 genes (19 up-regulated 
and 31 down-regulated) with a positive predictive value of 98% for the diagnosis of 
sepsis. 
Since then, several investigators have used peripheral blood leukocyte transcription 
profiles for the diagnosis of sepsis or infectious complications in critically ill patients. 
Using a global gene expression array (56, 613 probes sets) Cobb et al182 found that 
a panel of 1837 genes could predict the onset of  VAP in a group of 158 blunt trauma 
patients however with low (57%) sensitivity  and specificity (69%). More importantly 
the transcript model was associated with 90% negative predictive value for 
pneumonia. Amongst the genes associated with pneumonia several are implicated in 
the host response to infection: NAIP activates caspase-1 and leads to IL-1B 
secretion and apoptosis, CEACAM8 regulates recruitment of adhesion to endothelial 
cells and α-Defensins are antimicrobial peptides stored in neutrophil granules. 
Using a genome wide microarray containing 54.613 probes, Johnson et al 183, 184 
identified a unique gene expression profile in patients 0 to 48 hours before the 
development of clinical sepsis that differed from the profile seen in non-infected 
patients (45 patients with non-infectious SIRS and 45 before development of infected 
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SIRS). Of the 459 genes differentially expressed in those who developed sepsis, 65 
were down regulated and 394 up regulated .Pathways analysis using  recognised 
annotations  (KEGG and Biocarta) identified 10 inflammatory pathways implicated in 
sepsis that could be separated  into 4 domains: 1-Innate Immunity :characterized by 
the up-regulation of TLR-2, TLR-4 and TLR-5 as well as the MAPK and IRAK 
pathways , this last being implicated in the activation of NF-κβ leading to cytokine 
production.2-Cytokine receptor up-regulation of the IL-1 receptor family and the IL-22 
receptor pathways with involvement of SOCS3. The latter decreases pro-
inflammatory signalling and inhibits the expression of MHC II molecules. 3-T cell 
differentiation (dependent on the STAT signalling pathways) and evidence of 
upregulation of caspase –dependent and independent pro-apoptotic activity, as well 
as anti-apoptotic mechanisms. 4- protein synthesis regulation. 
Tang et al185 have also explored the use of global expression signatures in the 
diagnosis of sepsis. Gene- expression profiling was performed in neutrophils 
obtained from 44 patients with retrospectively confirmed sepsis “training set” and 50 
prospectively enrolled patients with suspected sepsis “validation set”. A set of 50 
genes (35 genes up-regulated and 15 down-regulated) were associated with a 
predictive accuracy for sepsis of 91% and 88% for the training and validation sets 
respectively. Hierarchical clustering of the group of genes comprising the signature 
profile revealed 3 groupings. 1-The inflammatory cluster was, perhaps surprisingly, 
down-regulated. The reduction in the expression of genes implicated in systemic 
inflammation suggests that infection inhibits the neutrophil associated inflammatory 
response. 2- genes implicated in immune regulation were predominantly repressed. 
3- Genes involved in mitochondrial function such as oxidative phosphorylation and 
ATP synthesis were downregulated. Inhibition of mitochondrial activity is considered 
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to be a physiological adaptation to ensure cell survival by reducing oxygen 
consumption186.  
A similar study by the same investigators aimed at identifying gene signatures 
implicated in sepsis in circulating peripheral blood mononuclear cells (PBMC) rather 
than neutrophils. A similar pattern of sepsis-related immunosuppression was seen. 
Seventy patients were recruited in whom the diagnosis of sepsis or SIRS was 
established at the end of the patient’s hospital stay (35 “training set “and “35 
validation set”). A molecular signature of sepsis that included 138 genes was 
identified (105 up-regulated and 33 down-regulated) with a predictive accuracy 91% 
and 80 % in the training and validation sets, respectively. Interestingly, there was no 
difference in the genes differentially expressed in relation to the causative micro-
organism (gram positive or negative sepsis). These findings suggest that the host 
response to bacterial infection is non-specific.   Hierarchical clustering of the genes 
comprising the signature profile revealed three groups. 1-Pro-apoptotic genes were 
up-regulated, for example CARD12 (caspase recruitment domain family). 
Furthermore, anti-apoptotic genes such as BCL2 were down-regulated. 2-Genes 
associated with the activation of lymphocytes were upregulated. 3 and 4- These 
clusters  consisted of genes implicated in the inflammatory and immune response 
the expression of which was reduced187.  
It must be recognised that the sepsis related –immunosuppression described above 
is based on evidence obtained from peripheral blood immune cells, and may not be 
a reflection of the activity of monocytes and neutrophils resident in other organs 188. 
Gene expression profiles over time and in relation to outcome 
In order to study leukocyte gene expression profiling during recovery of septic shock 
Payen et al 189 measured gene expression in leukocytes (monocytes, immature 
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neutrophils and lymphocytes) obtained from 17 septic shock patients (14 survivors 3 
deaths) at  0,1,7 and 28 days using a microarray containing genes implicated in the 
inflammatory process (340 genes) . Hierarchical clustering showed that decreased 
expression over time of S100A8 and S100A12 was associated with survival 
(Friedman test, p=0.001). S100A8 and S100A12 m-RNA encode calcium binding 
proteins (calgranulins). S100A8 is a pro-inflammatory protein concentrated in 
granulocytic granules and is secreted by immune cells in response to inflammation 
and LPS administration. In addition, S100 proteins are responsible for a 
prothrombotic response in endothelial cells. Another relevant finding of this study is 
that CD74 (a major histocompatibility complex (MHC) class II associated protein) 
was down-regulated during the initial stages of sepsis compared to later in the 
evolution of the disease. This observation is in accordance with previous evidence 
showing reduced HLA-DR expression during early sepsis 190, 191.  
Another transcriptional analysis of peripheral blood cells collected from 38 patients 
(25 survivors and 13 non survivors) presenting with septic shock corroborated the 
decrease in expression of  HLA-DR  in all patients, but showed that this 
downregulation was more pronounced in non-survivors as measured by means of 
flow cytometry of monocytes. Employing an array that interrogated 14.500 genes 
these authors identified a group of 28 up-regulated genes whose expression 
discriminated between survivors and non-survivors with a sensitivity of 100% and a 
specificity of 86%. Survival was associated with the restoration of immune function. 
In survivors there was an increased expression of genes implicated in the 
modulation of T cell activity; Toll like receptor signalling pathways, chemokine 
CX3CR1 (known to play an important role in lymphocytic cytotoxicity) and IL-2RB 
(involved in T cell proliferation and activation)192. 
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One of the limitations of the studies described above is that the investigators have 
used arrays containing a limited number of genes. Wong et al 193 used a global 
microarray that interrogated the whole genome (54, 681gene probes) and described 
genome level expression profiles in 42 children presenting with septic shock (33 
survivors and 9 non-survivors). Cluster analysis of the genes most differentially 
expressed in non-survivors versus survivors revealed a list of 34 genes that were up-
regulated and 27 genes that were down-regulated. Interestingly two isoforms of 
metallothionein (MT) showed increased expression in non-survivors.MT are 
intracellular binding proteins that are capable of binding zinc avidly. Conversely, the 
authors demonstrated a reduction in the plasma levels of zinc in non-survivors. Zinc 
metabolism has been associated with immunity; furthermore MT null mice were 
protected (in comparison with wild-type controls) against the lethal effects of TNF 
administration 194. 
 Wong et al 195, 196 showed the utility of pre-defined genome wide expression sub-
classes. Using K means clustering analysis of leukocytes obtained from patients with 
septic shock (98 derivation group and 82 validation group), the authors were able to 
identify 3 expression mosaics; A, B and C (each containing 100 genes) .Visual 
inspection by clinicians of the graphic composite mosaic for the sub-classes A, B and 
C in comparison with a computer generated classification resulted in a high level of 
agreement between the allocation to subclasses. The odds ratio for mortality for 
subclass A vs subclass B was 1.5 and vs subclass C 2.2. Analysis of the biologically 
relevant genes for each subclass, revealed that the majority of the genes that 
corresponded to adaptive immunity and glucocorticoid receptor signalling are 
repressed in subclass A in comparison with subclasses B and C.  
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These exciting advances may have profound implications for the future management 
of patients with sepsis and several experts are formulating the following question: Is 
genomic profiling on the threshold of becoming a diagnostic/treatment tool in the 
care of critically ill patients? It is probably too early, to give a definitive answer to this 
question. However, it is likely that an increasing understanding of genomics will 
become a necessary aspect of the training of future clinicians. 
 
 
2-6-3 Gene expression studies in cardiovascular surgery: 
 
Very few of studies have investigated changes in gene expression in response to 
cardiac surgery (see Table 1). Analysis of genome-wide expression among a group 
of 42 patients undergoing CPB revealed that the differential expression of gene 
pathways involved in the inflammatory response was associated with an increased 
risk, and greater severity of neurocognitive decline (42). This study clearly illustrates 
the potential power of this approach but did not define the role of genetic diversity in 
modulating the individual patient responses. 
All of these studies analysed gene expression in peripheral blood leukocytes in small 
numbers of patients, and only Ramlawi and colleages interrogated the whole 
genome (>40.000 probes). In two of the studies the first sample was obtained after, 
rather than before induction of anaesthesia (i.e. no “baseline” sample) and the period 
of investigation did not exceed 6 hours after surgery, with the exception of 8 patients 
in the study by Tomic and colleages in whom samples were obtained 24 hrs after 
surgery (19). Finally the lack of genotyping in these studies means that the role of 
DNA sequence variation in modulating gene expression, and consequently individual 
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patient responses, could not be ascertained. Nevertheless, all three studies clearly 
demonstrate that genes involved in cell adhesion, regulation of inflammation and 
apoptosis are the most differentially expressed after cardiac surgery and CPB. 
These findings enrich and challenge our traditional understanding of the stress 
response to surgery that has been based on literature focussing on the 
determination of plasma levels of selected inflammatory cytokines at various time-
points after surgery.  
There remains a need to more precisely define sequential patterns of global gene 
expression following cardiac surgery and to understand the mechanisms by which 
DNA sequence variation modulate disease severity. At the same time important 
advances in molecular biology have opened several doors to advancing our 
understanding. High throughput genotyping, for example has facilitated new 
approaches to investigating individual genetic variability and to elucidating how DNA 
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Table 1 
Studies investigating gene expression in response to cardiac 
surgery 
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2-6-4 Sequential gene expression profiles following elective cardiac 
surgery involving cardiopulmonary bypass (CPB) 
 
There is increasing evidence that changes in leukocyte activation are an important 
cause of organ dysfunction after cardiac surgery 34, but the key molecular pathways 
involved are not well understood. In this context gene expression profiling using 
genome-wide microarrays of mRNA transcribed from leukocytes has the potential to 
shed light on the complex pathophysiological mechanisms, regulatory functions and 
gene to gene interactions that are involved in the response of leucocytes to cardiac 
surgery and CPB.  
I set out to define these biological pathways at the level of gene expression by 
sequential analysis of transcription before and after surgery using global expression 
microarray profiling. I analysed gene expression in circulating peripheral blood 
leukocytes, collected with a leukodepletion filter system that can be used at the 










2-6-5 Methods: Experimental details and design of the investigation 
 
1.  Patients were recruited at St Bartholomew’s Hospital. Following written informed 
consent, adult patients presenting for first time, elective open cardiac surgery for 
coronary artery bypass grafting (CABG), valve replacement or repair requiring CPB 
were recruited. Exclusion criteria included:  lack of capacity for informed consent, 
immunocompromised (HIV positive, neutropenic or regular therapy with 
immunosuppressive drugs including steroids), emergency operation, malignancy and 
pregnancy.  
Approval for this study was obtained from the East London and the City Ethics 
Committee. 
2. The anaesthetic technique was standardised. Patients were premedicated with an 
oral benzodiazepine (temazepam) on the morning of surgery. Anaesthesia was 
induced with fentanyl and thiopentone, muscle relaxation was achieved with 
rocuronium or vecuronium. Following tracheal intubation, anaesthesia was 
maintained with isoflurane and fentanyl before CPB and with a continuous infusion of 
propofol during and after CPB. Patients were mechanically ventilated with oxygen 
enriched air. Anticoagulation was achieved with heparin sodium (initial bolus 3mg/kg) 
and supplemented as necessary to maintain an activated clotting time more than 480 
s during CPB. Moderate hypothermia 32-34⁰C was achieved using a heat exchanger 
in the bypass circuit. Non pulsatile flow was maintained at 2.3 to 2.6 l/min per square 
metre.  Glyceryl trinitrate, metaraminol and phentolamine were titrated against blood 
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pressure as required. At the end of surgery, heparin was antagonized with protamine 
to return the activated clotting time to baseline. Patients were returned to the 
intensive care unit (ICU) for postoperative care. 
3. A comprehensive clinical report form (CRF) was completed for each enrolled 
subject that included differential white cell count, indices of postoperative organ 
dysfunction and infectious complications. Date of hospital discharge and 28 day 
mortality was recorded.  
4- Samples were obtained before induction of anaesthesia, after aortic cross-clamp 
release, on admission to intensive care, on the first postoperative day and on day 
three following surgery. 8 ml of whole blood was collected at each time point and 
after centrifugation at 1600 G at 4C for 10 minutes, plasma and buffy coat was 
collected. 
6 ml of whole blood was drawn into a Vacutainer through a leukoLOCK filter that 
captures leukocytes as illustrated in the Figure 2-2 below. The filter was flushed with 
phosphate buffered saline (PBS) (2.5ml) to eliminate red blood cells and RNA later 
(2.5ml) solution to stabilize the RNA. Filters and plasma, together with the buffy coat 
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Figure 2-2: LeukoLOCK capture filter – 6ml sample of blood is passed through a 
LeukoLOCK filter, which captures the total leukocyte population 
 
 
5. RNA and DNA extraction and processing were carried out by me at the Wellcome 
Trust Centre for Human Genetics (WTCHG) in Oxford under the supervision of Dr 
Julian Knight. 
RNA was prepared using the LeukoLOCK ™ Total RNA Isolation Kit (Ambion); 
proteinase k was used to degrade cellular proteins and bead capture was used to 
bind the RNA during washing and subsequent Turbo DNase treatment. 
 RNA concentration was measured by the absorbance of 260nm wavelength light 
employing a NanoDrop 1000A spectrometer figure 2-3, using aliquots of 1ul of 
purified RNA . The calculation of concentration was based on the Beer-Lambert law: 
A=E*B*C (A:absorbance, E:wavelength dependent molar absorptive coefficient 
,C:analyte concentration, B:path length). The ratio of absorbance at 260nm and 
280nm is used as a measure of RNA purity (an index >2 is indicative of pure RNA). 
 RNA integrity (RIN) was assessed using the Agilent 2100 bionalyser 
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Figure 2-3: NanoDrop 1000 – A measurement. Features displayed: 
Sample ID 
Concentration: based on absorbance at 260 nm 
A-260: absorbance at 260 nm 















Figure 2- 4. An algorithm is used to analyse the entire electrophoretic trace of the 
RNA sample, including the presence or absence of degradation products (range 0-
10; higher values >7RIN indicate intact RNA). The ratio of ribosomal RNA bands 18S 







5-Gene expression profiles were generated for samples taken at baseline, 
immediately postoperatively and 24 hours after surgery by hybridisation of RNA to 
Illumina Bead array (HumanHT-12 ). This arrays targets more than 25,440 annotated 
genes with more than 48,000 probes  
6-Data analysis was carried out using GeneSpring v 11.05(Agilent technologies, 
Santa Clara US) using the illumina workflow analysis.  Our experimental set up 
aimed to detect differentially expressed genes before and 24 hours after cardiac 
surgery. The main covariate used for the analysis of differentially expressed gene 
was sampling time; before and after 24 cardiac surgery 
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Normalization was achieved by dividing each measurement by the 70th percentile of 
all measurements in the array. Quality control involved unsupervised analysis and 
Filtering by flag values and samples.  In addition to the analysis of individual genes, 
an analysis was performed based on a pre-selected group of gene sets  that are 
involved in common biological processes : Pathways and Gene Ontology  were 
performed to obtain more information at the functional level and for  hypothesis 
generation . 
  I used Gene Spring© to generate networks and regulatory pathways based on the 
information contained in the literature (Medline) and accurate databases BIND 
(Biomolecular interaction network) and MINT (molecular interaction). In order to 
identify significant interactions between differentially expressed entities, we filtered 
genes according to categories of binding, metabolism, protein modification and 
regulation. Finally the entities without direct connections were removed before 
generating the figures displayed in the results section. 
7-Statistical analysis was carried out by selecting the genes that displayed a P-value 
of <0.05 corrected by false discovery rate (FDR) using Benjamini Hochberg 
correction. FDR is one way to conceptualise the rate of type 1 errors in null 
hypothesis testing when multiple testing. This is achieved in Benjamini Hochberg by 
the ratio of the hypothesis at a significant level by the number of entities tested. The 
output of this analysis was filtered by fold expression. Thus, lists of genes 
differentially expressed at least twofold (q <0.05 after correction for multiple testing) 
were generated for each time-point. 
 Power calculations are shown in Figure 3-4. This demonstrates that 60 individuals 
is the minimum number required to detect a 1.5-fold difference in expression with a 
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false discovery rate of 0.01 while 135 patients would allow detection of such 







Figure 3-4: Power calculation. The lower bound of power to detect a 1.5-fold difference in 
expression with a false discovery rate of 0.01 was calculated for 60 or 135 unrelated 
individuals. A classical t-test approach was used, incorporating the minor allele frequency 
and unequal sample sizes in each genotype group, as a result of allele frequency. The 
population variance (SD 0.424) was calculated based on published datasets199. (Power 
calculations were performed by Dr Jennifer Taylor, Bioinformatics and Statistical Genetics 


















































 The median age of the subjects was 69 years (range 43-81).Total number of 
subjects; 63 .CPB time ; 108(97-119).Aortic clamp time 87(75-99).See table 1. Post-
operative complications were : Atrial Fibrillation 16 patients (25%),  infection 6 
patients (9.5%) ,respiratory failure requiring invasive or non-invasive respiratory 
support 5 patients (7%),confusion 2 patients (3.1%).The median lenght of stay(LOS) 
in hospital was  5 days (3-16) of which a median of 1 day(1-4) was spent in ITU . 
Of the 95 genes differentially regulated 24 hours after cardiac surgery 80 were found 
to be up-regulated and 15 were down-regulated (table 2 and 3). A heat map 
generated using hierarchical clustering is shown to illustrate these changes in gene 
expression (GeneSpring) Figure 2-5.  
We grouped  the 80  up-regulated genes into functional groups according to the 
information available through literature searches (Medline, Online Mendelian 
Inheritance in Man database) 1-Regulation of apoptosis(TLR5, IL4R, MAPK14, 
ZDHHC19, ATP9A, DYSF, PLSCR1), 2-Mitochondrial function (TPSO, HK3, PGS1, 
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PFKFB3) 3-  Adhesion molecules (CD177, RETN, ANNEXIN3,ILR4,VNN1) 4-
Epigenetics (HISTPH2BB, CDK5RAP2, TDRD9),5-
Microcirculation(ARG1,METTL7B, CD163,HP), 6-Glucose 
metabolism(GYL1,UGCG,MGAM,OPLAH,SC37A3),7-Leukocyte receptors 
(LILRA5,LILRA6,FCGR1B,IL18RAP,IL18R1),8-Complement (CR1,C1QB) and 9-
Estrogen receptor(GPER)Table 2, Figure 2-6 and 2-7. 
Of the 15 down-regulated genes, two are interferon induced proteins (IFIT1 and 
IFIT44L), both being implicated in the clearance of pathogens as part of the innate 
immune response. Other down-regulated genes were associated with leukocyte 
trafficking and chemotaxis (GPR56, CCR3). The majority of down-regulated genes  
(7 out of 16) are implicated in the activation of T lymphocytes (CD4 , CD8 ,γδ) and 
Natural Killer cells (EOMOS, GNLY, FGFBP2, GZMK,FCER1A,PRSS33) Table 3, 




















    
 









DEMOGRAPHICS   
Age 69 (43-81) 
Sex (M/F) 47/16 
PROCEDURES   
CABG 38 
Valv repl/repair 14 
Combined 11 
COMORBIDITIES   





OPERATIVE DATA   
CPT time 108 (97-119) 
Cross Clamp time 87 (75-99) 
N patients req RBC 20 
Deaths                                    0 
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Table 2: Significant by up-regulated genes after cardiac surgery 
(>2-fold change, q<0.05) 
Gene Symbol Corrected p-value Definition     
C19orf59 5.72415E-16 Homo sapiens chromosome 19 open reading frame 59    
RETN 5.72415E-16 Homo sapiens resistin (RETN), mRNA.    
TLR5 1.84444E-15 Homo sapiens toll-like receptor 5 (TLR5), mRNA.    
TSPO 1.84444E-15 Homo sapiens translocator protein (18kDa) (TSPO), transcript variant   
LILRA5 5.81439E-15 Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A  
IL4R 6.00336E-15 Homo sapiens interleukin 4 receptor (IL4R), transcript variant    
ANXA3 1.59058E-14 Homo sapiens annexin A3 (ANXA3), mRNA.    
HP 2.15181E-14 Homo sapiens haptoglobin (HP), mRNA.    
HK3 2.18525E-14 Homo sapiens hexokinase 3 (white cell) (HK3) 
C5orf32 2.21979E-14 Homo sapiens chromosome 5 open reading frame 32    
LILRA5 2.21979E-14 Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A  
PGS1 3.18618E-14 Homo sapiens phosphatidylglycerophosphate synthase 1    
GYG1 4.9167E-14 Homo sapiens glycogenin 1 (GYG1), mRNA.    
ZDHHC19 5.33388E-14 Homo sapiens zinc finger, DHHC-type containing 19    
LILRA6 5.4222E-14 Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A  
UPP1 2.23105E-13 Homo sapiens uridine phosphorylase 1 (UPP1), transcript 
variant  
  
ALPL 3.60899E-13 Homo sapiens alkaline phosphatase, liver/bone/kidney (ALPL)  
DYSF 3.80787E-13 Homo sapiens dysferlin, limb girdle muscular dystrophy 2B   
LMNB1 4.24313E-13 Homo sapiens lamin B1 (LMNB1), mRNA.    
PFKFB3 4.45655E-13 Homo sapiens 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase   
MAPK14 7.03465E-13 Homo sapiens mitogen-activated protein kinase 14 (MAPK14)  
RGL4 7.45685E-13 Homo sapiens ral guanine nucleotide dissociation stimulator   
METTL7B 7.96494E-13 Homo sapiens methyltransferase like 7B (METTL7B)    
PLSCR1 9.72622E-13 Homo sapiens phospholipid scramblase 1 (PLSCR1)    
CR1 1.05145E-12 Homo sapiens complement component (3b/4b) receptor 1  
CD177 1.11551E-12 Homo sapiens CD177 molecule (CD177), mRNA.    
S100A12 1.18023E-12 Homo sapiens S100 calcium binding protein A12 
(S100A12), mRNA. 
   
CYP1B1 1.19942E-12 Homo sapiens cytochrome P450, family 1, subfamily B, polypeptide 1 
(CYP1B1), mRNA. 
 
GADD45A 1.3174E-12 Homo sapiens growth arrest and DNA-damage-inducible.   
UGCG 1.42211E-12 Homo sapiens UDP-glucose ceramide glucosyltransferase    
GPER 1.90687E-12 Homo sapiens G protein-coupled estrogen receptor 1 (GPER)  
SOCS3 2.0375E-12 Homo sapiens suppressor of cytokine signaling 3     
ATP9A 3.7798E-12 Homo sapiens ATPase, class II, type 9A (ATP9A), 
mRNA. 
   
HIST1H2BD 3.85193E-12 Homo sapiens histone cluster 1, H2bd (HIST1H2BD)   
CDK5RAP2 4.04209E-12 Homo sapiens CDK5 regulatory subunit associated protein 2 (CDK5RAP2) 
LOC648984 4.04209E-12 PREDICTED Homo sapiens similar to Baculoviral IAP repeat. 
PFKFB3 4.29083E-12 Homo sapiens 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase   
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CR1 4.81582E-12 Homo sapiens complement component (3b/4b) receptor 1 
MGAM 5.08185E-12 Homo sapiens maltase-glucoamylase (alpha-glucosidase)    
TDRD9 5.3819E-12 Homo sapiens tudor domain containing 9 (TDRD9)    
OPLAH 5.53517E-12 Homo sapiens 5-oxoprolinase (ATP-hydrolysing)     
MMP9 5.85406E-12 Homo sapiens matrix metallopeptidase 9  
GPER 7.73973E-12 Homo sapiens G protein-coupled estrogen receptor 1 (GPER)  
F5 1.44309E-11 Homo sapiens coagulation factor V (proaccelerin, labile 
factor)  
  
CD177 1.60141E-11 Homo sapiens CD177 molecule (CD177), mRNA.    
TDRD9 1.6578E-11 Homo sapiens tudor domain containing 9 (TDRD9),     
GADD45A 1.68232E-11 Homo sapiens growth arrest and DNA-damage-inducible, 
alpha  
  
PPARG 1.73218E-11 Homo sapiens peroxisome proliferator-activated receptor gamma (PPARG) 
CA4 1.76482E-11 Homo sapiens carbonic anhydrase IV (CA4), mRNA.    
LOC100170939 2.19151E-11 Homo sapiens glucuronidase, (LOC100170939)   
CST7 2.28599E-11 Homo sapiens cystatin F (leukocystatin) (CST7), 
mRNA. 
   
C1QB 3.54476E-11 Homo sapiens complement component 1, q subcomponent, B chain   
FCGR1B 3.67399E-11 Homo sapiens Fc fragment of IgG, high affinity Ib, receptor (CD64) (FCGR1B) 
LOC153561 3.72328E-11 Homo sapiens hypothetical protein LOC153561     
LOC642103 4.40724E-11 PREDICTED: Homo sapiens similar to Maltase-glucoamylase, 
intestinal ( 
 
IRAK3 6.97223E-11 Homo sapiens interleukin-1 receptor-associated kinase 3 
(IRAK3) 
  
CES1 1.16432E-10 Homo sapiens carboxylesterase 1 (monocyte/macrophage serine esterase 
1)  
FCAR 1.58255E-10 Homo sapiens Fc fragment of IgA, receptor for (FCAR), 
transcript  
  
CDK5RAP2 1.89858E-10 Homo sapiens CDK5 regulatory subunit associated protein 2 (CDK5RAP2) 
PGLYRP1 1.90602E-10 Homo sapiens peptidoglycan recognition protein 1 (PGLYRP1)   
RNASE2 2.0339E-10 Homo sapiens ribonuclease, RNase A family, 2  
OSM 2.09299E-10 Homo sapiens oncostatin M (OSM), mRNA.    
GPR84 2.22834E-10 Homo sapiens G protein-coupled receptor 84 
(GPR84), mRNA. 
   
LOC728519 2.24904E-10 PREDICTED: Homo sapiens similar to Baculoviral IAP repeat-containing 
protein 1 (Neuronal apoptosis inhibitory protein) (LOC728519), mRNA. 
FCAR 5.06518E-10 Homo sapiens Fc fragment of IgA, receptor for (FCAR), 
transcript variant 10, mRNA. 
  
SLC37A3 7.11227E-10 Homo sapiens solute carrier family 37 (glycerol-3-phosphate transporter), 
member 3 (SLC37A3), transcript variant 2, mRNA. 
MERTK 1.26984E-09 Homo sapiens c-mer proto-oncogene tyrosine kinase 
(MERTK), mRNA. 
  
LOC100130904 2.02304E-09 PREDICTED: Homo sapiens misc_RNA 
(LOC100130904), miscRNA. 
   
VNN1 4.08378E-09 Homo sapiens vanin 1 (VNN1), mRNA.    
ORM1 6.0905E-09 Homo sapiens orosomucoid 1 (ORM1), mRNA.    
ARG1 6.19529E-09 Homo sapiens arginase, liver (ARG1), mRNA.    
IL18RAP 7.67715E-09 Homo sapiens interleukin 18 receptor accessory protein 
(IL18RAP), mRNA. 
  
CCR3 1.15839E-08 Homo sapiens chemokine (C-C motif) receptor 3 (CCR3), transcript 
variant 2, mRNA. 
 
FCGR1B 1.22552E-08 Homo sapiens Fc fragment of IgG, high affinity Ib, receptor (CD64) 
(FCGR1B), transcript variant 1, mRNA. 
CLEC4D 1.99724E-08 Homo sapiens C-type lectin domain family 4, member D 
(CLEC4D), mRNA. 
  
HPGD 3.45641E-08 Homo sapiens hydroxyprostaglandin dehydrogenase 15-
(NAD) (HPGD), mRNA. 
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PFKFB2 3.03439E-07 Homo sapiens 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 
(PFKFB2), transcript variant 2, mRNA. 
CD163 5.67315E-07 Homo sapiens CD163 molecule (CD163), transcript 
variant 2, mRNA. 
   
CD163 5.71855E-07 Homo sapiens CD163 molecule (CD163), transcript 
variant 2, mRNA. 
   
IL18R1 1.82709E-06 Homo sapiens interleukin 18 receptor 1 (IL18R1), 
mRNA. 








Table 3: Significant downregulated genes after cardiac   
surgery (< 2 fold change, q<0.05) 
 
Gene Symbol Corrected p-value Definition       
GPR56 2.50E-13 Homo sapiens G protein-coupled receptor 56 (GPR56), 
transcript variant 2, mRNA. 
  
S1PR5 4.00E-13 Homo sapiens sphingosine-1-phosphate receptor 5 
(S1PR5), mRNA. 
   
GPR56 9.70E-13 Homo sapiens G protein-coupled receptor 56 (GPR56), 
transcript variant 3, mRNA. 
  
EOMES 3.30E-12 Homo sapiens eomesodermin homolog (Xenopus laevis) 
(EOMES), mRNA. 
  
GNLY 9.00E-12 Homo sapiens granulysin (GNLY), transcript variant 
519, mRNA. 
   
FGFBP2 1.20E-11 Homo sapiens fibroblast growth factor binding protein 2 
(FGFBP2), mRNA. 
  
GNLY 2.30E-10 Homo sapiens granulysin (GNLY), transcript variant 
NKG5, mRNA. 
   
GZMK 2.70E-10 Homo sapiens granzyme K (granzyme 3; tryptase II) 
(GZMK), mRNA. 
   
PRSS33 5.10E-10 Homo sapiens protease, serine, 33 (PRSS33), 
mRNA. 
    
FCER1A 7.10E-10 Homo sapiens Fc fragment of IgE, high affinity I, receptor for; 
alpha polypeptide (FCER1A), mRNA. 
 
GZMH 3.00E-09 Homo sapiens granzyme H (cathepsin G-like 2, protein h-
CCPX) (GZMH), mRNA. 
  
CCR3 1.10E-08 Homo sapiens chemokine (C-C motif) receptor 3 (CCR3), 
transcript variant 2, mRNA. 
  
CLC 2.80E-08 Homo sapiens Charcot-Leyden crystal protein (CLC), 
mRNA. 
   
IFIT1 2.40E-07 Homo sapiens interferon-induced protein with tetratricopeptide 
repeats 1 (IFIT1), transcript variant 2, mRNA. 
IFI44L 1.16E-05 Homo sapiens interferon-induced protein 44-like 
(IFI44L), mRNA. 
   


























Figure 2-5: Hierarchical clustering of gene expression matrices; We observe 
a graphical representation of the normalized signal intensity where the 
individuals’ values contained in the matrix are represented in colours. Gene 
expression experiments produced large amount of data. One of the 
methods to summarize unsupervised data to extract information from the 
biological process investigated is to build a gene expression matrix. 
Hierarchical clustering was performed using GeneSpring X10.5. Each row 
represents a single gene and each column represents an individual. Left: 
Baseline measurements Right: 24 hours after cardiac surgery. Red: 
Indicates over-expression of genes and blue under-expression of genes. 
The branches of the dendrogram represent the degree of closeness of 
genes 
We can observe that the  sampling time (before and 24 hour after surgery) 
is clear determinant of the gene expression investigated. 
 















Figure 2-6:Volcano plot: Y axis shows statistical significance (log10 (p-value). 
X axis shows fold change (log2 fold change) .On the right hand side (red squares) are 
displayed the genes that are significantly up-regulated. On the left hand side (red squares) 
are displayed the genes that are significantly down-regulated. Centre (gray squares) are 












Figure 2-7: Graphical representations of genes that are differentially up or down 
regulated by 2-fold change. Up-regulated genes are red, down-regulated genes. We 
observed that most differentially expressed genes after cardiac surgery are 
upregulated. Multiple and complex interactions link MAPK14, PPARG and MMP9.  
Interactions are shown: blue square = binding, light blue diamond = metabolism, 
purple square = regulation, red square = expression, pink = protein modification, ± 












To further explore the functional relevance of the genes that are differentially 24 
hours over-expressed after cardiac surgery and the associated pathways, I 
employed gene ontology (GO) and pathways analysis using GeneSpring. GO is a 
controlled vocabulary that describes gene products’ properties. There are three 
groups: 1- Cellular component (structural part of a cell); 2- Molecular function 
(activity of a cell product); 3- Biological process (molecular process involved). 
Enrichment p value is calculated for each GO term. The closer the p value to zero 
indicates the less likelihood that the genes of your interest fell into any category, just 
by chance. 
The GO analysis demonstrated that the domains Molecular Function (42%) and 
Biological Process (57%) contain GO terms satisfying a corrected p value <0.05. 
Those terms, significantly enriched, correspond to molecular functions implicated in 
molecular, signal transducer activity and receptor activity (immunoglobulin receptor 
activity). Within the biological process branch the main GO terms are associated with 
the innate immune response and response to stimulus (defence, stress, wounding 
and inflammatory responses). 
 
 






 Figure 2-8: GO analysis. GO accession is the numerical identifier and GO term 



















Network and regulator analysis 
The biological association network analysis (BAN) was used to generate a diagram 
of all the differentially expressed genes arranged by groups of nodes with different 
interactions. Finally, genes are coloured according to expression levels (red for over-
expressed and blue for under-expressed) Figure 2-9.   
 The BAN revealed several nodes with high density inter-connectivity 24 hours after 
cardiac surgery. The DNA damage inducible/repair genes GADD45A and PPARG 
molecular pathway that represses the transcription activity of multiple inflammatory 
genes are prominent in the nuclei.  
In the cytosol, the key gene nodes are MAPK14 (cytokine-suppressive anti-
inflammatory drug-binding protein 2), which is activated by TLR5 and OSM (tyrosine 
phosphorylation of STAT 1 protein). In addition, we found key regulators of glucose 
metabolism to be important; RETN (known to increase the resistance to insulin), and 
PFKFB3 and PFKFB2 (phosphofructo-2-kinase/fructose-2,6-biphophatse 2 and 3). 
Furthermore RETN acts to suppress the activity of SOC3 and PPARG. 
At the plasma membrane, the main network node gene is MMP9 (matrix 
metalloproteinase), the key connection for which is MAPK14. Other gene 
connections are with receptors for immunoglobulins FRCGR1B and FRCGR1A 
(CD64 Fc fragment of IgG), CR1(complement receptor 3b/4b), IL4R(regulator of IgE 
production) and IL18R1(interleukin 18 receptor). 




Figure 2-9: Biological network analysis of differentially expressed genes (p >0.05 after 
multiple comparison correction), by setting advance filters, we selected genes that 
present a direct level of interaction (binding, regulation expression or metabolism); 
blue square = binding, light blue diamond = metabolism, purple square = regulation, 
red square = expression, pink = protein modification, ± stimulation or inhibition.  
Genes are shaped and colour coded. The level of expression was added; red for over-
expression and blue for under-expression (see entities and relations diagram). 









Previous gene expression studies have found that genes related to cell signalling, 
immune response cell adhesion and apoptosis were significantly altered by cardiac 
surgery using cardiopulmonary bypass34, 200. This study of changes in global gene 
expression in response to uncomplicated cardiac surgery and CPB confirms the 
importance of similar groups of genes, but further analysis of the host response to 
cardiac surgery and its regulation reveals a novel and more complete picture of the 
biological mechanisms involved. 
Using global gene expression arrays, I found that the key biological pathways 
involved in the host response to cardiac surgery include those related to the 
regulation of apoptosis, mitochondrial biogenesis and immune responses. Genes 
involved in epigenetic regulation seem to be important. The majority of significantly 
down-regulated genes are likely to contribute to the immune compromise known to 
occur in response to cardiac surgery and CPB 14. Network analysis revealed PPARγ, 
MAPK14 and MMP9 as key regulators of the innate immune response in this setting. 
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 The host response to cardiac surgery is triggered by a number of distinct events, 
including the initiation of  CPB( during which blood is exposed to foreign material) 
ischaemia/reperfusion of vital organs such as the heart and lungs, the re-warming 
period and surgical tissue injury 2. The interplay of all these factors triggers a host 
response that involves activation of innate immune pathways, a systemic 
inflammatory response and immune compromise that can predispose to infectious 
complications and organ failures14. The ability to successfully regulate the 
propagation and resolution of this host response is now considered to be one of the 
principal determinants of individual patient outcome following cardiac surgery15, 16 
and involves an orchestrated pattern of changes in gene expression that is designed 
to protect the host and promote recovery17. The principal cause of death in patients 
undergoing cardiac surgery is sepsis and MODS3. 
 
Several studies in which  immune cells obtained from patients after cardiac surgery 
have been exposed to mitogens 201 or LPS 14 have found evidence of an impaired  
immune response, suggesting that  immune paresis  may be an important feature of 
the response to CPB. Apoptosis may contribute to this immune dysfunction by 
inducing T cell anergy, whilst uptake of apoptotic cells by macrophages and dendritic 
cells has been shown to induce immune tolerance 202 203, 204.  Indeed, post-mortem 
examination of patients with sepsis and MODS has revealed histological evidence of 
extensive immune cell apoptosis 205, 206 Moreover, the severity of circulating 
lymphocyte apoptosis has been associated with poor outcomes and intestinal tissue 
samples taken from patients after road traffic accidents have shown severe 
reversible epithelial and lymphocyte apoptosis207.  Interesting,  evidence suggest that 
sepsis may induce an state of immunosuppression characterised by apoptosis of 
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immune cells  lymphoid cell loss , and decreased capacity of T cells to fight and 
eliminate pathogens208 . Moreover  agents currently being investigated for the 
treatment  of  sepsis related immune suppression (IL-7, IL-15 and Granulocyte 
macrophage colony-stimulating factor) enhance T-cell activity and decreased sepsis 
induced apoptosis209 
 
In addition, cellular stress caused by ischaemia /reperfusion and tissue damage are 
known triggers of biological pathways that can induce mitochondrial dysfunction and 
thereby lead to cellular death.    
 I observed down-regulation of genes involved in leucocyte activation ( T cell 
cytotoxity and tissue damage) and up-regulation of those involved in mitochondrial 
function and regulation of apoptosis. These findings suggest that these pathways 
may play a key role in the evolution of the response to cardiac surgery and may be 
important in determining whether patients regain immune homeostasis and recover 
uneventfully or “immune dysfunction” supervenes, increasing the susceptibility of 
patients to nosocomial infections and/or MODS.  
Up-regulation of cell surface markers that function to facilitate adhesion and tissue 
invasion have been documented using flow cytometry14 and RNA hybridisation34 in 
post cardiac surgery patients. We also found up-regulation of T cell receptors gene 
expression that was more pronounced immediately after surgery (CD3D, CD36, 
CD8, CD2) .This up-regulation of T cell receptors has been previously considered as 
evidence of “priming” of immune cells that will then be readily available to invade 
peripheral tissue in the event of  a secondary insult  (hypotension, infection or re-
operation) , perhaps thereby triggering   the cascade of events that can lead to 
MODS or death14, 34. 
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BAN analysis indicated that MAPK14, and its interaction with T cell receptors and 
GADD45 is an important regulator of the host response to cardiac surgery.  These 
genes form part of the alternative MAPK14 activation pathway in T cells. Activation 
of MAPK14 is triggered by environmental stress, pro-inflammatory cytokines and 
TNF. MAPK14 plays a crucial role in pro-inflammatory signalling cascades and is 
considered an attractive molecular target for novel treatments for inflammatory 
diseases.  GADD45 is a cellular stress response gene, that in the presence of 
antigen receptor T cell activation, represses the activity of MAPK14, probably acting 
as a negative feedback mechanism of the immune response210, 211.  
As well as MAPK14, I also identified PPARγ  and MMP9 as important biological 
network regulators during the host response to cardiac surgery and CPB. Singer et 
al212 have  shown that up-regulation of PPARγC1(a key factor in maintenance of 
mitochondrial biogenesis) was   associated with survival in a group of sixteen 
critically ill patients presenting with sepsis and MODS. PPARγ binds to PPARγC1 
and intensifies its biological activity. Moreover, MAPK14 is a known activator of 
PPARγ213, 214. In addition, a recent association has been demonstrated between the 
activity of MMP8 (which normally up-regulates MMP9) and sepsis survival  in 
children215. We could speculate that the response of survivors to sepsis may mirror 
the response to uncomplicated major surgery.  
Traditionally the response to cardiac surgery has been described as an acute, 
predominantly  pro-inflammatory reaction, characterized by  increased  plasma levels 
of pro-inflammatory cytokines (TNF-alpha, Interleukin 6 and Interleukin 8), to some 
extent counterbalanced by  a parallel  antinflammatory response aimed at controlling  
and curtailing the inflammatory  process 216 . Increased levels of some pro-
inflammatory  cytokines have been correlated with increased morbidity217, whilst 
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other investigators have shown that a higher ratio of IL10/TNFa is predictive of an 
uncomplicated postoperative course 216.  
Interestingly, using a global gene expression array none of the genes encoding 
cytokines traditionally associated with the inflammatory host response to surgery 
(TNFα, IL-1, IL-4, IL-6, IL8 and IL-10) were significantly differentially expressed 
24hrs after cardiac surgery. Moreover, there was no evidence of a sequential pro-
inflammatory response followed by an anti-inflammatory phase. These  findings are 
in agreement with a recent systematic review of genome-wide expression profiling in  
human sepsis179.  There are two possible explanations for these observations. 
Firstly, considerable variability in plasma cytokine levels has been reported after 
cardiac surgery 31 and in sepsis179. Secondly, changes in gene expression in 
circulating leucocytes may not reflect those in local tissue resident leukocytes218 or 
other cells/organs. 
Given the well-recognised limitations of sepsis studies based on  measurement of 
plasma levels cytokine a number  of investigators have attempted to use genome-
wide transcriptional studies in order to characterise  signatures gene expression 
profiles of sepsis.(principal published investigations have been reviewed in detail in  
chapter 2). In these studies, most investigators nearly exclusively report   the genes 
and pathways up-regulated or down regulated in the septic group 183, 219..  
Consequently the transcription profile of patients presenting with “sterile SIRS ” 
reported to be as high as 70% patients with SIRS in ITU is not explored in detail220. 
Moreover the list of genes differentially regulated in this group is generally not 
reported181, 184. 
A systematic review of gene-expression profiling in 12 cohorts of 784 individuals 
diagnosed with sepsis showed that activation of genes associated with the host  
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response  were  variable and in consistent . Moreover there was no evidence  at the 
transcriptional level  of a biphasic response to sepsis (a pro-inflammatory response 
followed by an anti- inflammatory reaction) 179.     These investigators also found that 
the activation of pattern recognition receptors such as Toll receptors and CD14 
jointly with the activation of pathways that included mitogen activated protein kinase 
(MAPK), janus kinase (JAK) and activator of transcription protein (STAT) was 
common in most of the studies reviewed.  Recently Maslove et al221 used 
hierarchical clustering of gene expression profiles from neutrophils taken from 126 
patients with SIRS and infection to identify two subtypes of  gene expression 
patterns . One was associated with significantly more differential expression of 
genes linked to the inflammatory response and Toll receptor signalling pathway. In 
addition different expression signatures were identified according to the 
pharmacological agents that patients had received (e.g vasopressin, norepinephrine 
or Protein C). These findings may in part explain the   intermittent findings of many of 
these studies. 
The objective of the study reported in this chapter  was characterize in detail  of the 
gene expression profile of the host response to major surgery.   Interestingly my 
results showed that the  genes and signalling pathways activated after cardiac 
















One of the limitations of our investigation is that we analysed RNA extracted from a 
mixed population of peripheral blood leucocytes. Nevertheless, the separation of 
white cells into different  cellular subsets, particularly when collecting a large number 
of samples in an acute clinical environment is  technically challenging and the 
process of separation may in itself stimulate changes in gene expression, as well as 
inducing RNA degradation187.  
One of the potential confounders in our study is the lack of mathematical corrections 
for differential cell counts. To our knowledge, no preceding studies to our 
investigation into gene expression in cardiac surgery employed statistical corrections 
of cell counts 34, 197, 200. Different statistical strategies to deal with difficulties arising 
from investigations in peripheral blood cells and gene expressions signatures have 
been developed over last decade219, 222, 223 . We acknowledge that differential cell 
counts and cell-type specific gene expression should be considered in future 
studies224 . Nevertheless, we still hope that our description of the global leukocytes 
transcriptome after cardiac surgery can contribute to shed some light into the 
complex pathophysiology of the host response to cardiac surgery 
 Interestingly, Tang et al187, 225, 226 demonstrated that genetic signatures obtained 
from PBMC or neutrophils provide similar diagnostic power in sepsis. 
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Another limitation of the present study is the lack of tissue sampling or information at 





Functional genomics has the potential to identify key biological pathways and genetic 
modulators involved in the propagation and resolution of the host response to injury. 
I believe that the investigation of the normal host response to low risk cardiac 
surgery is an essential first step in achieving these objectives. To our knowledge this 
study is the largest cohort of adult patients undergoing cardiac surgery in whom 
global gene expression profiling (>48000 genes) has been undertaken.  
The pathogenesis of host response to cardiac surgery and CPB is complex, not 
completed understood and deserves further investigation 
It involves the simulation activation of genes linked to a pro- inflammatory and anti-
inflammatory response. 
The regulation of apoptosis is one of the key biological pathways  
We have shown that genes associated with mitochondrial biogenesis are relevant.  
Furthermore, the observed down regulation of genes related to leukocyte 
trafficking/chemotaxis and activation of lymphocytes and NK cells, as well as 
interferon induced proteins, is likely to contribute to the immune compromise that 
follows cardiac surgery. Network analysis revealed PPARγ, MAPK14 and MMP9 as 
key regulators of the innate immune response in these patients. 
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These findings will provide a valuable comparator group for functional genomics 
studies in sepsis, and will be informative in the study of other groups of patients 









Most of the genetic association studies investigating disease traits have identified 
SNPs that are in non-coding regions. The current challenge is to understand how 
these genetic variants exert an effect. It is increasingly recognised that these SNPs 
regulate gene activity at the transcription level227. Investigating the genetic 
determinants that affect gene expression can help to understand how genetic 
variability acts at the functional level228, 229. 
One type of variant that influences gene expression is called expression quantitative 
trait loci (eQTL). eQTLs are regions of DNA sequence variants that influence the 
expression level of one or more genes. To carry out an eQTL analysis two types of 
data are analysed. First, each individual of the population investigated is genotyped 
(using SNPs microarrays). Second, the expression of each gene is measured using 
RNA microarrays. Statistical analysis determines which genetic variants are linked to 
a significant different level of expression within two populations or within one 
population (before and after experimental exposure to a stimuli). In other words 
108 | P a g e  
 
eQTL can provide a link between genetic variants in a particular chromosomic region 
and the biological process they affect228. 
If eQTLs are located within 1Mb of the genes they influence, they are called “cis 
eQTLs”. If they affect genes located at a longer distance they are called “trans    
eQTLs”229. Cis-acting SNPs can act to change transcription of local genes, post-
transcriptional, by affecting message stability or affecting the targets for messenger 
RNA processing or decay. Trans-polymorphism can act on different genes most 
commonly with transcription factors or more indirectly by altering the transcription of 
a number of genes activated by an environmental factor (e.g. diet, endotoxins). 
In 2003 Schadt et al230 reported analysis of 56 individuals from four CEPH (Centre 
d’Etude du Polymorphisme Humain) reference families (CEPH/Utah pedigrees). 
These investigations showed that 29% of the differentially expressed genes had a 
genetic detectable component. These were the first genome-wide eQTLs carried out 
in humans. The high level of genes whose gene expression had a hereditable 
component stimulated investigators to see eQTL as a useful tool to interrogate the 
genome in order to unravel genetic networks that underlie the pathogenesis of 
disease and/or new therapeutic targets. 
The capacity of eQTLs for identifying statistics associations between regions of the 
genome and expression of genes has opened a new road map where hits detected  
in genome-wide studies are enriched for eQTL and vice versa. 
One example of this approach is Moffat et al231 who investigated the influence of 
genetic variants on the risk of asthma: after characterising 317,000 SNPs in DNA 
obtained from 994 patients with childhood onset asthma they identified several 
explanatory genes on chromosome 17q21 (p <10-12). This finding was then 
independently replicated in two cohorts of British (3,301) and German (2,301) 
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patients232. Gene expression analysis in EBS transformed lymphoblastoids cells 
showed that within or near the 206kb region on chromosome 17 q21 one SNP 
(rs7216389) was significantly (p <10 −22) associated with the transcript of the gene 
ORDMDL3; ORMDL3 encodes transmembrane proteins. Barret et al233 performed a 
meta-analysis of three studies of patients with inflammatory bowel disease (3,230 
cases and 4,829 controls) and confirmed 11 previously reported loci including 
replication of the well-recognised association: with NOD2234 and IBD5235, as well as 
discovering 21 new loci. Some of these markers are found on chromosome 5. 
Interestingly an eQTL showed that one of the implicated SNPs (rs4495224) 
increased the expression of PTGER4 (prostaglandin E receptor) in transformed 
lymphoblastoid cells. Given knockout mice for EP4 develop ulcerative colitis after 
dextran sodium sulphate treatment this gene is a clear candidate for further 
investigation236. Barret’s meta-analysis adds additional information in relation to the 
functional aspect of the IBD5 region; eQTL analysis associates this region with the 
expression of ORMDL3 (lod 20), establishing a novel link between the 
pathophysiology of asthma231 and Crohn’s disease233. 
It is becoming increasingly clear that variability on gene expression is not only 
determined by DNA variation but affected by individual characteristics such as sex, 
age and clinical setting. There is a need to fill an important gap that links 
pathophysiology of diseases with human regulatory variants. One remarkable 
example is Musunuru et al’s study237: high plasma levels of low-density lipoprotein 
cholesterol (LDL-C) are associated with an increased risk of myocardial infarction 
(MI). 
GWAs for plasma lipoproteins traits have identified a number of SNPs associated 
with plasma levels of LDL-C. These SNPs lie on chromosome 1p13. Europeans who 
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are homozygous for the major alleles of these SNPs have a 40% increased risk of 
MI. A common SNP at the 1p13 locus (rs12740374) located in the 3’ untranslated 
region of a gene alters a predicted binding site for a transcriptor factor, the minor 
allele creating the site and the major allele disrupting it. The minor allele (associated 
with a decreased risk of myocardial infarction) increases the expression of sortilin 
(SORT1), preferentially expressed in the liver. Over-expression studies in mouse 
liver subsequently showed that the minor allele results in over-expression of SORT1 
and high levels of sortilin are associated with lower levels of LDL-C.  
Nevertheless of significant advance, eQTL studies still pose a significant challenge. 
The abundance of transcript is a quantitative phenotype in which thousands of traits 
allow a very rich depiction of the biological landscape of the process interrogated. 
However, the number of traits to be analysed has become a formidable statistical 
and interpretative challenge. 
Unless a study has a large number of individuals only e-QTLs with the largest effect 
can be detected. In addition, more than two eQTLs are needed to explain one trait 
(due to the limited size effect of one individual eQTL on genetic variation).  Trans e-
QTLs need to cover markers over the whole genome increasing the number of 
comparisons consequently increasing the risk of false-positive results. To overcome 
this problem, a more stringent threshold should be applied to reach the same level of 
significance. Cis-eQTL by affecting local transcription have better resolution and are 
less statistically cumbersome. 
Studies based on transformed cell lines have the advantage that only one type of cell 
is investigated (mostly lymphoblastoids cell lines) increasing the reproducibility and 
power of the studies. However, cell manipulation for immortalisation and prolonged 
culture may introduce artefacts into the observed gene expression patterns, perhaps 
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caused by epigenetic changes and consequently may alter cellular phenotypes. As a 
result, findings obtained from such studies may not accurately reflect the in vivo 
changes induced by the disease processes being investigated178, 238.   
Furthermore, regulatory DNA elements (e.g. enhancers, promoters, silencers or 
insulators) can be cell context specific and dependent on the cell type239 and cellular 
activation240. 
 To advance our understanding of how genetic variability affects the way patients 
responded to cardiac surgery we performed an eQTL analysis in our cohort of 




For this eQTL study samples obtained before induction of anaesthesia and on day 




DNA was purified from buffy coat and isolated using a QiAcube machine (Qiagen™). 
Picogreen quantification and normalisation of the DNA concentration was carried 
out. Genotyping of the 63 samples was performed in the High Throughput Genomics 
facilities at the WTCHG on Illumina Infinium Human OmniExpressed-12v1 beadchips 
using the Infinium HD Ultra protocol.  These beadchips capture a large proportion of 
variability by screening samples for ~400.000 single nucleotides polymorphisms 
(SNP). A MAF ≥ 5% was used to minimise the risk of type 1 error (false positive) and 
type 2 error (false negative). 
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We use Plink toolset 241  for the analysis of genotypes data. 
Given the large number of SNPs included in the analysis, even a low genotype error 
rate can result in a high level of false negative and false positive associations. 
Quality control assessment of the data was assessed prior to statistical analysis. We 
carried out the following procedures to identify and remove poorly genotyped 
markers or individuals242. 
1. Sample mix up and plating; 2 patients were removed. 
2. Low quality of DNA, missing genotypes were determined (threshold 0.05 %); 
6 patients removed 
3. Plates effects were evaluated using Principal Component Analysis.  
4. Population stratification. Identification of individual with discordant ancestry 
were identified using multidimensional scaling (MDS) based on 1000 
genomes population ancestry 243; 6 patients removed. 
5. Identification of duplicates was carried out by genetic distribution metric to 
identified related to samples duplicates (DST); 3 patients removed. 
6. Call rate: markers with call rate of less than 95% were removed. 
7. Deviation from Hardy Weinberg Equilibrium (HWE) was  assessed . 
 
This quality control process resulted in the removal of 17 subjects out 63.  This 
resulted in a group of 46 patients consisting of 35 males and 11 females with a 
median age of 69 (41-97) years.  
 
 3-2-2 Data analysis 
As explained in the introduction, the goal of an eQTL analysis is to identify SNPs that 
affect the expression levels of known genes. To achieve this computationally 
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demanding task we used R package Matrix eQTL244, that tests associations between 
each SNP and transcripts using an ANOVA model. Matrix eQTL is able to compute 
38.4 billion operations per second. We performed a cis regulatory gene analysis at 
this stage, testing genes –SNP pairs within 1 million base pairs of each other. After 
analysis of each SNP, Matrix calculates the FDR (≤0.05) only for the genes that 
passed the standard accepted threshold of established significance (10e-6; this cut-
off has been selected as per Matrix software 244 and was supervised by Dr Peter 
Humburg, statistician at the Wellcome Trust for Human Genetics, Oxford University). 
The calculations are based on Benjamini Hochberg algorithms.  
We included major principal components (PCs) of the gene expression data as 
covariates in the eQTL analysis. Mapping an increasing number of cis eQTL allowed 
us to detect the maximum number of probes that had cis eQTLs. No others clinical 
covariates were analysed.  
To check for results errors in our eQTLs results due to unaccounted covariates, 
population stratification, plate effects or model misspecification. We built a quantile-
quantile (Q-Q) plot. Matrix eQTL Q-Q plots graphic the distribution of p-values, even 
in those below the significance threshold p-value 
 http://www.bios.unc.edu/research/genomic_software/Matrix_eQTL/runit.html. 
Figure 3-1. 
Specific SNPs associated with cardiac surgery were analysed using RegulomeDB245. 
This online database gathers annotated high-throughput data from the ENCODE 
Project consortium and other sources. By intersecting eQTL associated regions with 
RegulomeDB we looked for evidence to support the functional role of our findings. 
To assist with the interpretation of results RegulomeDB results are grouped 
according to a score that ranges from 1a to 6 according to the evidence available 
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regarding how confident it is possible to establish that a variant lies in a functional 
location. Variants that are known eQTL for genes and have been associated with 
expression belong to Category 1; on the other hand, eQTL SNPs not associated with 
functional annotation are Category 6. 
We used the National Institute of Health (NIH) online catalogue of SNPs-trait 
associations from published genome-wide association studies in order to identify 
already reported underlying functionality at the trait/disease-associated loci 
http://www.genome.gov/gwastudies246. 
eQTLs obtained were further analysed to identify networks, bio functions and 
canonical pathways of interest using Ingenuity Pathway Analysis (IPA, Ingenuity 
Systems; http://www.ingenuity.com). We adjusted the software to detect, direct and 
indirect relationships of variants enriched for s only observed in humans. This 
software develops networks and functions from target genes. In addition, we used 
IPA-Tox – a tool within IPA that provides a toxic genomic analysis based on peer-
reviewed toxicological databases http://www.ingenuity.com/library/pdf/tox. IPA-Tox 
identifies a subset of genes which are activated by a biological insult or a 
pharmacological compound. This toxic-genomics data-set  may help to predict 
potential cellular damage or biochemical alterations that may occurs in host  after 
exposure to a chemical or biological trigger . By linking our results to specific sets of 
toxicological data, we aimed to identify a subset of genes that might be predictive of 
organ damage. We downloaded our eQTLs results into the Genotype-Tissue 
Expression (GTEx) browser (database of eQTL detected in multiple tissues) 
http://www.gtexportal.org/home/ . No matching references were found. 
 
 






Figure 3-1: Q-Q plot for all p-values 
 
 
3- 3   Results 
 We found 659 cis eQTLs associated with elective cardiac surgery and CPB (Table 
3-1). 
We found that a group of our enriched eQTLs had high RegulomeDB scores (1a to 
1d) (Table 3-2). 
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According to the information available in RegulomeDB and other online databases 
(OMIN, ENCODE) we classify them according to their cellular function in two groups: 
cis eQTLs involved in the immune process and cis eQTLs involved in cellular activity 
and senescence. 
 
Immune response-related eQTLs 
RS11663049 main motif are the transcriptor factors NF- kappa B and E2F-1:DP-2.   
NF-κB belongs to a family of transcription factors that have a primordial role in 
inflammation and the innate immune response.  RS12145700 motif is USF. 
Degradation of USF has been associated with suppression of the immune host 
response. RS693235 acts on the transcription factor RREB1 that acts as an HLA-6 
promoter247. RS4766497 main motif is NF-Y major histocompatibility class II 
promoter248. RS3768324 motifs are the transcription factors FL-1 and GABPA, ELK1 
and SAP-1A248.  GAPB activates genes related to apoptosis (BCL2). RS226503 
main motif is the transcriptor factor OLF-1. OLF-1 is involved in the regulation of pre-
B and early B cell lines. RS1362126 main motif is IKAROS, a zinc finger transcriptor 
factor. The main gene affected by this SNP is HLA–A (major histocompatibility 
complex, class 1). RS226503 main motif is the transcriptor factor OLF-1. OLF-1 is 
involved in the regulation of pre-B and early B cell lines. RS4766497 main motif is 
NF-Y major histocompatibility class II promoter248. RS1362126 main motif is IKAROS 
a zinc finger transcriptor factor. The main gene affected by this SNP is HLA–A (major 
histocompatibility complex, class 1). RS540 main motif is FOXP1 and TBP. FOXP1 
is the transcription factor that plays a critical role in monocyte differentiation and 
macrophage function.  
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Cellular and senescence related eQTLs 
RS3007030 main motif is POU5F1 involved in reprogramming pluripotency stem 
cells247. RS1025196 acts on the transcription factors FREAC-3, OCT-1, FOXA2. 
FREAC induce the expression of stress response and apoptosis genes. 
RS3754109 acts on the transcription factors SIX-1, SIX-2, SIX-4249. Overactivity of 
SIX-1 is associated with breast cancer invasiveness.  
RS13230744 main motif is MTF-1, a metal-regulatory transcription factor that is 
involved in heavy metal detoxification and free radical scavenging. RS540 main motif 
is FOXP1 and TBP. FOXP1 is the transcription factor that plays a critical role in 
monocyte differentiation and macrophage function.  
RS9630856 main motif are ERR and RORA. ERR plays a role in the regulation of 
cellular energy. RS6102 main motif is NANOG, a homeobox transcription factor that 
is involved in cellular differentiation. RS575 main motif are zinc finger protein 
transcription factors ZIC1, ZIC2, ZIC3. These transcription factors exert their 
modulatory effect in the vicinity of any sequence to which a protein domain binds.  
RS4668936 main motif is the zinc finger ZBT3. The gene affected by this SNP is 
putative RNA helicase that by altering RNA can influence translation, initiation and 





















Table 3-1: Cis regulated SNPs (independent) and genes, before surgery, 24 
hours after surgery. We found 659 cis eQTLs after cardiac surgery (P > 1+06) out of 
the 758 present before surgery. It is remarkable the significantly changes of eQTLs 
pre-and post-cardiac surgery. We could hypothesise that the reason to explain the 
change observed is that before elective low risk cardiac surgery patients are clinically 
stable and no receiving any acute medical intervention. On the contrary, cardiac 
surgery and CPB is characterised by a massive induction of cytokines1, activation of 
coagulation and haematopoietic cells2, 3. Furthermore, cardiac surgery is associated 
with the highest incidence of post-operative morbidity of any elective surgical 
procedure 7 
 



















After R Matrix analysis, a list of the top regulatory 20 SNPs 24 hours after surgery 
according their level of significance are shown in Table 3-3. Most of the genes listed 
are involved in processes activated as a result of insults that trigger the host innate 
immune responses and some regulate responses to viral infection through the action 
of interferon. OAS1, APOBEC3B and ClEC4C are involved in the proliferation of 
immune cells through the activation of complement. 
C4BPA codes for the C4B-binding protein (C4BP) that takes part in the 
coagulation/fibrinolysis cascade (It acts by inhibiting the activated protein C pathway.        
See Appendix 2 for further analysis of SNPs associated with cardiac surgery.    
We tested the most significant SNPs against the level of gene expression measured 
by probe signal intensity. Correlation between genotype and expression level are 
indicated by each boxplot. The level of significance is due to the population minor 
allele frequency of each SNP Figure 3-2. To explore the possibility that genes near 
BLM may be functionally relevant we used a LocusZoom. This web-based software 
displays the area of genome surrounding BLM and gives an indication of the extent 
of linkage disequilibrium, recombination patterns and the position of other genes in 
the region Figure 3-3. 
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We interrogated the RegulomeDB database in order to explore the current 
knowledge associated with the most significant cis eQTLs in relation with the p-value 
(Matrix eQTL FDR <0.05). The RegulomeDB score for the top ten cis eQTLs ranges 




1. Cis eQTLs involving the immune response 
RS10774671, rs2660, rs4767030 cis eQTL for OAS1 (SNPs rs3177979 and 
rs474189 did not have available evidence in RegulomeID database). The OAS1 
gene is a key component of the innate immune response to viruses.  
RS4766497 regulates gene GPN3 and acts on the transcriptor factor NF-Y. 
The CCAAT box is a widespread element found in promoters and enhancers. NF-Y 
is a heterodimer binding factor that binds with CCAAT in major histocompatibility 
(MHC) class 2 promoters. 
This gene affects the action of ATP2A2, an ATPase located in the sarcoplasmic 
reticula of muscle cells involved in the pumping outside the cytosol CA (2+). 
Mutations of this gene have been associated with Darier syndrome, characterised by 
keratosis follicularis. 
RS11687089 cis eQTL of ADCY3 allelic variants of ADCY3 have been found to be 
associated with inflammatory diseases (ulcerative colitis and Crohn’s disease)250, 251.  
 
2. Cis eQTLs involved in cell division and senescence 
RS933489 cis eQTL of PAQR6. This gene regulates the activity of KIAA0907, an 
oncogene associated with lung tumorogenesis252, 253. 
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RS4767030 cis regulation of gene BLM. Stavropoulos et al254 found that BLM 





Table 3-3: Top enriched eQTLs, SNPs ordered 
according to P-values 
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Figure 3-2: Allelic expression of top enriched eQTL:  BLM, OAS1, NFXL1, GPN3, PAQR6 
and ADCY3. X axis represents expression signal for each gene; p-value <0.0001. GPN3 P-
value 0.19. 







RS39480 is associated with the expression of BLM P 3.06 E-08. This plot shows 
association p values on the –log 10 scale on the vertical axis and the 
chromosome position (Chr 15) on the horizontal axis. We show BLM and the 
gene names and size of the flanking region.  RS389480 is displayed by a blue 
diamond. Each circle represents an SNP with the colour indicating linkage 




























Table 3.3. Matrix eQTL. List of SNPs only 24 hours after cardiac 
surgery. SNPs are ordered as per p-values. 





3-5 Pathways present only 24 hours after cardiac surgery 
 Matrix eQTL results were submitted to the Ingenuity Pathway Analysis program 
(IPA, see Methods). We found canonical pathways associated with our results  
Figure 3-3. See Appendix 3 for further analysis. We detected that the top ten 
enriched pathways had several eQTLs in common. We constructed three subgroups 
that share four cis eQTLs. 
Figure 3-4: Pathways enriched for cis eQTL – 659 only present 24 hours after 
cardiac surgery. The Y axis shows the –log (p value threshold is <0.05) for the 
enrichment of each pathway. The p value is calculated using a right tailed Fisher 
exact test by considering: 1. The number of focus genes that participate in the 
process; 2. The total number of genes that are known to be associated with that 
process in the selected pathway reference set. The enrichment p value indicates the 
likelihood that the genes detected fell into a pathway category, just by chance. 
First group: Jak/Stat signalling, IL-2 signalling, IL-3 signalling, IL-15 signalling, FLT3 
signalling. Figure 3-4 
127 | P a g e  
 
Second group: IL-3 signalling, RANK and GM-CSF signalling and T cells receptor is 
signalling. Figure 3-5 
Third group: GAP junction signalling, leptin signalling in obesity, melanocyte 
development signalling. Figure 3-6 
PI3K (RS 51330 p 2.4 E-06), Mek1/2 (RS 12611262 p 4.5 E-07), ERK1/2 (RS 
12373078 p1.5 E-06) are present in all pathways groups. Other genes that showed 
enriched eQTLs are AKT (RS 10787735 p1.5 E-09), RAS (RS 10993 p 4.4 E-06), 
STAT6 (RS 4559 p1.2 E-06), AC (RS 9964798 p 6.5 E-10).   
The first group of pathways. Figure 3-5 
 The activation of granulocyte-macrophage colony-stimulating factor (GM-CSF) 
activates three cascades255: 
1. A small GTP binding protein (RAS) triggers the activation of mitogen activated 
protein kinases (MAPK) including MEK1/2 and ERK1/2, resulting in an increase in 
cell survival, proliferation and cell differentiation.  
2. JAK/STAT signalling.   
3. Activation of PIK3 and AKT.  
 2 and 3 cascades lead to an increase of cellular survival and cell proliferation. 
 
 
The second group of pathways. Figure 3-6 
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The second group of pathways are activated by the action of interleukins, GMF-CSF 
and interferon after engaging on their respective membranous receptor through two 
cascades:  
1. The activity nucleotide exchange factor (m SOS), RAS and the mitogen-activate 
kinases (MAPK) ERK ½ and MEK1/2 trigger the activation of NF-κB, CEBP and JUN 
(having a proliferative and haematopoietic effect).  
2. JAK/STAT signalling pathway that activates the nuclear transcription of pro-
inflammatory genes (IL-6 induce) and BCLXL (gene that regulates cellular 
proliferation)256. 
 The third group of pathways. Figure 3-7 
The third group integrates different intracellular mechanisms activated by leptins. 
Leptin levels increase after acute inflammation. Leptin acts via transmembrane 
receptors that are similar to other cytokines (IL-2, IL-3, IL-4 and GM-CSF).  Binding 
to its receptors results in the activation of inflammatory signalling pathways via 
JAK/STAT or phosphorylation (PI3K).  Leptin as well as other cytokines, growth 
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3-5 Toxic genomic analysis 
To complement our analysis we submitted the results obtained by matrix-eQTL to 
IPA toxico-genomic database in order to explore the presence of potential genetic 
biomarkers. We identified three functional areas which enriched genes for eQTLs. 
 
A: Clinical chemistry and haematology 
Increased level of Alkaline Phosphatase; MAPK3 (RS 12373078, p 1.5 E- 
06). Increased level of haematocrit: JMJD6 (RS 8067445, p 5.3 E 08) and increased 
levels of red blood cells: EIF2AK1(RS 4724770, p 3.2 E-06) 
 
B: Nephrotoxicity 
132 | P a g e  
 
Genes expressed in renal tubular cells: PLEKHA1 (RS 12765679, p 3.3 E-06), TRIM 
27 (RS 2015436, p 4.5 E-08), genes involved in the physiopathology of the immune 
response in renal failure: GSTT1 (RS 6734622, p 3.2 E-07), TNFRSF1A (RS 




Genes that control immune and inflammatory responses: STAT6 (RS 4559, p 1.2 E-
06), TNFRF1A (RS 795580, p 2.01 E-06), PP3R1 (RS 6734622, p 3.2 E-07).  Other 
genes in this group are linked to thyroid function: DIO3 (RS 17100339, 5.73 E-07) 








In this eQTL study we focused on answering two questions: 
1. Which are the most relevant regulatory SNPs involved in the host response to 
elective cardiac surgery in a population of European ancestry? 
2. What is the clinical relevance of the regulatory SNPs detected? 
In this study we identified 569 SNPs (10.E-06) that are significantly associated with 
the cis regulation of 218 genes, 24 hours after cardiac surgery. 
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Detailed analysis of the top SNPs using different online databases and catalogues 
revealed a complex picture. Other investigators have found that genes linked to the 
immune response, apoptosis and coagulation cascades are involved in the host 
response to cardiac surgery. In this context, we confirmed that many of the SNPs 
significantly associated with the response to cardiac surgery are linked to genes 
involved with the same biological processes. Interestingly, we detected SNPs 
affecting the regulation of genes not conventionally associated with the host 
response to cardiac surgery such as telomere activity, epigenetic modifications, cell 
programming and mitochondrial function. Interpretation of these findings and 
moreover their clinical relevance remains elusive. 
 Unsurprisingly the pathways associated most strongly with the post-operative 
response to surgery, at least in a mixed population of leukocytes, are related to the 
innate immune response and inflammation. 
We found that many genes up-regulated in response to surgery have eQTL (MMP9, 
MAPK14 and PPARƳ).  
Analysis of the top ten pathways associated with the host response 24 hours after 
cardiac surgery reveals that all pathways share three genes (ERK 1/2, MEK 1/2 and 
PIK3).  ERK and MEK have been linked with the pathogenesis of infections caused 
by Yersinia Pestis and Bacillus Anthracis respectively. The concept that multiple 
genes located in different loci as part of a functionally linked common pathway, has 
proved successful in identifying genes involved in tumorigenesis or tumour 
progression in pancreatic, brain cancer and metabolic disease such as obesity-
related traits257-260.  Interestingly tox functions linked our dataset with clinical 
biochemistry and genes previously associated with cardiotoxity and nephrotoxity 
(see Appendix 4). 
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We evaluated the potential for mapping by comparing the top SNPs for BLM gene 
(rs389480) by performing a relation association plot. The differential LD pattern 
(r2=0.6-0.8) may prove useful to identify and prioritise SNPs for functional evaluation 
see Figure 3-2. 
This study demonstrates the feasibility of carrying out functional molecular studies in 
the context of critical illness and major surgery. Furthermore, it contributes to our 
understanding of the host response to acute physiological challenges. However, 
there are inevitably a number of limitations. One resides in the technology being 
used since the current resolution of eQTLs limits their ability to detect all regulatory 
variants229. Interpretation of the results of this study should be viewed cautiously in 
view of the small sample investigated and consequently the low statistical power to 
detect eQTLs for threshold MAF of 5% 261. However, we hope that by employing a 
rigorous process of selection and following a stringent quality control analysis we 
have guaranteed a homogenous population within the limitations of a clinical study. 
Another challenge to be overcome is how to extrapolate findings resulting from the 
analysis of cells harvested from one specific tissue (in this case circulating 
leukocytes).  Gene regulation is complex and tissue specific229. Cells from different 
tissues share common ancestral features, but later developmental cell variation can 
have significant functional effects229. Gene expression comparisons between human 
osteoblast (Hobs) and lymphoblastoid cell lines (LCLs) showed that genes 
associated with cell survival and cellular metabolism such as protein ubiquitination, 
glucocortocoid receptor signalling, PI3/AKT signalling, oxidative phosphorylation and 
purine/pyrimidine metabolism are commonly expressed in both cell types, 
constituting 43% of the total genes expressed. A large number of genes are not only 
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expressed in both cells but they seem to be regulated by the same SNPs acting 
independently in different tissues.  
The potential value of studying tissue specific functional diversity has been 
demonstrated by the characterisation of a brain specific splicing factor called Nova2. 
The activation of Nova 2 induces the synthesis of different isoforms of proteins 
affecting brain synapses. In Nova 2 knockout mice splicing changes represent 6.6% 
of the total splicing in relation to immune cells.  Interestingly Nova-regulated RNA 
levels are the same in knockout mice as in the wild type, suggesting that NOVA acts 
mainly by affecting the quality of synapses regulation262. 
The above examples illustrate the necessity not only of studying genetic diversity by 
analysing the different allelic variants involved but complementing these findings with 
proteome and metabolomics analysis.  
 
3-7 Conclusions 
This is to our knowledge the first study of expression quantitative trait loci (eQTL) in 
the context of cardiac surgery.  Our aim was to reveal how the function of the 
genome interrogated through the use of whole genome expression array is affected 
by DNA sequence variation. 
 We were able to identify some of the key SNPs, genes and pathways involved in the 
host response to cardiac surgery and CPB. As well as the expected predominance of 
genes/pathways associated with inflammation and innate immune responses, 
pathways previously implicated in cancer pathogenesis were also identified. 
Associated network functions showed a predominance of processes involved in cell 
to cell signalling, cellular integrity and DNA repair. Top disease and biological 
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function associated with the gene variant detected are predominantly related to 
disorders of the gastrointestinal, haematological and renal systems. 
Hence, we believe the results of this study may serve as a platform from which to 
develop a wider understanding of the biological processes involved in the host 
response to cardiac surgery, allowing the identification of potential biomarkers of 
organ damage and finally facilitating the development of novel therapeutic 
approaches. 
  




Context of the research, final remarks and added value:  
 
Adults require cardiac surgery using CPB relieve life-threatening coronary disease 
and for treatment of severe valvular heart disease. Surgery and CBP trigger a 
systemic inflammatory response22,2, the severity of which is an important determinant 
of outcome9.  
Genetics variants have been associated with the host response to surgery and the 
development of complications. However, candidates’ gene associated studies are 
frequently inconsistent and failure in replicating their results is common63, 64, 71, 72, 80. 
Several investigators have attempted to explain the functional role of the association 
detected, many times without exploring the role that genetic diversity plays in 
modulating the host response to cardiac surgery 34, 197, 198. 
This investigation tried to fill a need to complement genotyping with functional 
analysis to understand the mechanisms by which genetic variation affects host 
responses to cardiac surgery. 
This is to our knowledge the first study to investigate regulatory eQTLs variants in 
the context of cardiac surgery. 
We first investigated the transcriptome response of 63 Caucasian patients 
undergoing elective cardiac surgery requiring CPB. The anaesthetic technique was 
standardised. We obtained whole blood samples before and 24 hours after surgery 
for RNA and DNA isolation. 
Traditionally the host response to cardiac surgery has been described as an 
inflammatory response characterised by increased plasma levels of proinflammatory 
cytokines2. We found a transcriptome response that showed a different response 
pattern. 
We identified 90 genes that were differentially expressed 24 hours after cardiac 
surgery (FC >2, FDR <0.05), with 80 upregulated and 15 downregulated. The 
upregulated genes are majority related to immune response including T receptors 
and downregulation of T cells and natural killers. Gene ontology enriched terms (p 
<0.05) after cardiac surgery corresponded to the immune response and response to 
stimulus (defence, stress and inflammatory pathways). Network analysis suggests a 
complex interaction between key mediators of the immune response (MMPK14, 
PPARγ and MMP9). 
We then identified 659 cis-acting eQTLs (FDR <0.05) that significantly enriched for 
canonical pathways, IL-3, JAK/Stat signalling and GM-CSF signalling that are 
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involved cell proliferation, survival and differentiation. In addition, Leptin signalling 
pathways (most commonly known for its role in feeding/satiety behaviour) that is 
linked to the inflammation response mediated via activation of JAK/STAT or PIK3. 
One of the principal limitations of this study is the small sample size; findings should 
be taken with caution. However, results obtained by our work are currently being 
used by colleagues at the Wellcome Trust for Human Genetics as a “control group” 
for the investigation of the host response of patients to sepsis. Provision acceptance: 
Blue 201608-1685C.R1 “Shared and distinct aspects of the sepsis transcriptomic 
response to faecal peritonitis and pneumonia” – American Journal of Respiratory and 




























 Gene expression study 
 
1-1 Genes significantly upregulated 24 hours after cardiac surgery 
(>2fold change ,p-value <0.05) 
 
RETN: Resistin (corrected p :5.72 E-16) is a signaling molecule traditonaly known for 
increasing the resistance to insulin in peripheral tissues that, has been implicated in 
the pathophysiology of type 2 diabetes and obesity.However more recent 
investigations have linked resistin with inflammation .Expressed in circulating 
monocytesresistin up-regulates adhesion molecules , chemokines and down 
regulates TRAF3 (tumor necrosis factor receptor associated factor-3).High plasma 
levels of resistin have been associated with an  increased risk of heart failure in a 
population with documented coronary disease(N:980 OR : 2.06) 263 . 
TLR5:  (corrected p:1.8 E-15) Toll-like receptor 5 belongs to a family of genes (TLR1 
to TLR10) associated with molecular pattern  recognition.  Flagellin,  present in 
Gram-negative and Gram-possitive bacteria lead to  activation of TLR5  triggering  
NF-κB  and TNFα production. Interesting TLR5 signaling induce anti-inflammatory 
and anti-apoptotic as well as antimicrobial molecules including NOD2/CARD15 
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(genetic polymophisms of these genes have been associated with Crohn’s disease) 
264 . 
TSPO:  (corrected p value 1.84 E-15)Translocator protein 18-kd is located in the 
outer mitochondrial membrane and is part of the mitochondrial transition pore 
(MPTP).TPSO mitochondrial tranport  activity is dependant on its interation with Heat 
Shock Proteins (mainly HSP 70).The best known function of TSPO is the transport of 
cholesterol through mitochondrial membranes which is one of the key steps in 
steroidogenesis.TPSO  has a particular  role regulating the opening of the MPTP and 
has been implicated in apoptosis  necrotic cell death and cellular proliferation. 
Expressed in  immune cells  TPSO is up-regulated by inflammation and plays a role 
in immune regulation 265 266 . 
LILRA5 : (corrected p 5.8 E-15) called  leukocyte immunoglobulin-like receptors 9 is  
expressed by  natural killer cells where it  inhibits cytotoxic responses against cells 
expressing major histocompatibility complex (MHC) on the surface of moncytes 
LILRA5 induce the liberation of cytokines:IL1B,Tκalpha and IL6.LIRA5 acts as an 
immunological regulator that influence modify the host response determing its major 
components at the cellular or humoral level 267 . 
IL4R: Interleukin 4 receptor regulates the productin of Ig-E Polymophisms of IL4-R 
have been associated with atopy and slow progression of HIV as discussed 
previously. More interesting theIL4/IL4R SYSTEM has been associated with the 
Tyrosine kinase Syk Activated in PMN is involved in phagocytosis,increase 
neutrhophil adhesion capacity and delay apoptosis 268 . 
ANNEXIN A3: (corrected p 1.5 E-14) is a of calcium-dependent phospholipid binding 
protein.ANXA3 is better known as  a tissue marker of prostatic cancer and reduced 
expression of this protein has been associated with a bad prognosis in such cases269 
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. ANXA3 has beeen implicated in neutrophil degranulation , leukocyte trafficking and 
lymphocyte migration 270. 
HP: (corrected p 2.1 E-14) secreted by the endoplasmic reticulum the main function 
of haptoglobin main  is to bind haemoglobin,  forming the complex HP-HB that is 
subsequently removed from the circulation by monocytes and macrophages, thereby 
preventing the oxidative harm associated with free haemoglobin.In addition, free  
haemoglobin reduces intravascular nitric oxide (NO) bioavailability and may 
contribute to microcirculatory dysfunction after cardiac  or major vascular 
surgery.Interestently haemolysis increases the levels of arginase 1 converting L-
arginine (substrate of NO) to ornthine , in that way reducing the production of new 
NO271, 272.  
HK3: (corrected p 2.1 E-14)HK3 belong to the family of  hexokinases. These  are 
glycolytic enzymes that are implicated in the first step of glucose metabolism .They 
function as a link between mitchondrial ATP synthesis and glucose metabolism.In 
addition hexokinases are known to be overexpressed in malignant tumours .Recent 
evidence from cell  culture experiments  has suggested that HK2 could be a key 
regulator of apoptosis via changes in mithocondrial function 273 . 
PGS1 (corrected p 3.1 E-14) phosphatidylglycerophosphate synthetase function is 
the biosynthesis of anionic phospholipids and cardiolipin has  been decribed in the 
mithocondria and in the endoplasmic reticulum. In a hamster model investigators  
transfecting cells with a defective PGS1 gene induced a reduction in the synthesis of 
phospholipid in additon to mitochondrial morphological and functional abnormalities 
274 . 
GYG1: (corrected p 4.9 E-14) Glycogenin is involved in  the synthesis from glucose. 
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ZDHHC19:  (corrected p 5.33 E-14) zinc finger DHHC-type containing 19 belongto 
the family of  finger proteins, These  are involved in multiple mechanisms including 
regulation of apoptosis, lipid binding,DNA recognition and RNA packaging.ZDHHC19 
has been found to be one of the 15 genes most significantly upregulated(corrected p 
<0.001) after infection with mycobacterium bovis  in cattle 275 . 
LILRA6: (corrected p value 5.4 E-14) belongs to a group of leukocyte receptors 
expressed in monocytes and granulocytes and known to exhibit a high degree of 
polymorphism.  Upregulated LILRA6 receptors act  to inhibit NF-κB and  dendritc 
cells, inducing anergy and immunosupression 276 277.  
UPP1:  (corrected p value 2.23 E-13) Uridine phosphorylase 1 catalyses the 
phosphorylation of thymidine or deoxyribose to ribose or deoxyribose increased  
expression off UPP1has been found in several type of tumoural cells, expression of 
UPP1 is controlled by oncogenes,and tumor supressant genes .UPP1 expression is  
increased by inflammatory cyokines :TNFα a IL-1 and Interferon δ 278. 
ALPL: (corrected p 3.6 E-13) Alkaline phosphates are membrane glycoproteins that 
hydrolyse monophosphate esters .There are 4 well decribed alkaline phosphatases 
:intestinal , placental , placental-like and liver/bone/kidney In addition ALPL has been 
found to be expressed in  B lymphocytes . In children with recurrent tonsilitis it has 
been postulated that B lymphocytes of diseased tonsils are less able to responde to 
bacterial antigens . Interesting, levels of alkaline phosphate are a marker of  B cell 
capacity of proliferation upon antigen stimulation and can be used as a marker of 
organ immune competence in children with tonsilitis279  . 
DYSF : (corrected p 3.8 E-13) this encode a skeletal muscle protein that plays a role 
in calcium-mediated membrane fusion events. Several mutations of this gene have 
been implicated in mucular dystrophies and myopathies.The endoplamic 
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reticulum(ER) is a quality sensor of cytoplasmic  protein , aberrant proteins has been 
are extracted and by the ER –associated degradation(ERAD) system of 
authophagy/lysosome. Dysferin plays a role in the vesicular membrane that is 
subsequently degraded by the ubiquinin/proteasome ERAD system. Dysferin mutant 
(L1341P) is not properly degraded trigering ER stress cell death pathway through c-
Jun N-terminal kinase (JNK) and caspase -12 280 . 
S1PR5: (corrected p 4.0 E -14) Lysosphingolipid sphingosine 1- phosphate  (S1P)is 
expressed in mature CD56 human NK cells.Natural killer (NK ) cells are a 
subpopulation of lymphocytes involved anti-tumour survillance and constitute part of 
the innate immune response to viruses , bacteria and parasites . Emigration of 
Natural killers cells from Lymph nodes and bone marrow is stimulated by the 
expression of S1PR5 probably promoted by  T-bet ( containing trancription factor 
required for Th1 cell development)281.Investigators have shown in mice that S1PR5 
is responsible  for NK cell trafficking in inflammatory situations ;interestenting this 
mechanism of migration is independent of chemokines 282  . 
LMNB1: (corrected p 4.2 E -13) ,Lamins are a major component of the nuclear 
lamina which covers the nuclei of eukaryotic cells .Lamina B is present in T cells , in 
a member of the interphase nuclear lamina family and  plays a role in mantaining the  
shape and mechanical integrity of the nucleus . A mutacion of lamina B causes the 
Pelger-Huet anomalycharactherized  by abnormal nuclear shape and chromatin 
abnormalities in granulocytes 283.In addition, Malhas et al284 demostrated using  an in 
vitro model that lamin B1 negative cells have high levels of  reactive oxygen species 
(ROS) and are more suceptible to oxidative  stress. 
PFKFB3: (corrected p 4.45 E-13) 6-Phosphofructo-2-kinase/fructose-2,6-
bisphosphatase 3 regulates the concentration of fructose 2-6-biphosphate and is a 
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key activator of the glucolysis.In astrocytes, PFKFB3 facilitates the maintenance of 
mitochondrial  membrane potential by increasing the production of glucolytically-
generated ATP, thereby  preventing apoptotic cell death 285. 
MAPK14: (corrected p 7.03 E-13) , mitogen-activated protein kinase 14 catalyzes 
the phosphorylation of serines and threonines and is activated in response to cellular 
stress and LPS stimulation .MAPK14 expression is rapidly increased after treatment 
with IL-1,  lipopolysaccharide (LPS) and heat shock stress.The JNK/c-Jun pathway 
regulates cell proliferation and cell death, MAPK14 in haematopoeitic cells seems to 
supress JNK kinases.In addition,MAPK14 modulates the expression of inflammatory 
cytokines TNF-alpha, IL-6 and IL12 . Inhibitors of MAPK14 are being developped to 
treat chronic inflammatory conditions211, 286. 
RGL4 :(corrected p 7.4 E-13) Ral guanine nucleotide dissociation stimulator-like 4 
initially identified like as oncongene and is expressed in human T-cell malignacies 287  
METTL7B:( corrected p 7.9 E-13) Methyltranferase like b7. Grape seed 
proanthocyanidins (GSPE) contained  in grapes and wine have been reported to 
promote health  by  acting as anti-oxidant, antimicrobial and neuroprotective 
agents.Grape and wine exert  a cardiprotective effect through increasing HDL, 
decreasing the level of endothelial oxidation and promoting 
vasorelaxation.Interestently, METTL7B has been found as one of the putative genes 
differentially upregulated  in rats fed with a high fat diet (HFD) when compared with 
rats fed with HFD+GPSE 288 . 
PLSCR1: (corrected p value9.72 E-13)  Phospholipid Scramblases  are  activated by 
an increase in the  intracellular Ca++ concentration caused by  of cellular injury or 
apoptosis.  Their function  is to alter the normal structure of the plasma membrane 
by increasing the  expossure of  phosphatidylserine (PS) .This action not only 
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facilitates the phagocytosis  of damaged  cells by circulating macrophages but 
triggers the activation of the blood coagulation cascade.In addition , PLSCR1 
integrate the family of genes stimulated by Interferon that require JAK/STAT 
signalling and which bilogical functions are antiviral, immunomodulatory and anti-
proliferative 289. 
CR1: (corrected p 1.05 E-12) complement component receptor 1is expressed in 
eosinophils, monocytes , macrophages ,B-lymphocytes,CD4 T cells and dendritic 
cells. It binds the C3b/C4b opsonized immune complex that is engulfed by 
macrophages and other phagocytes. Polymorphisms of CR1 have been associated 
to SLE  and other autoimmune disoders, as well as to suceptibility to  malaria  and 
disease progression in HIV patients.Cytokines(TNF-alpha, TNF-B, IL-4,IFN-G ) 
increase  plasma levels of CR1while IL-4 and IL-10 supress CR1 expression. In SLE 
immune complexes  reduce the level of CR1.Interestenting, recombinant s-CR1 is 
being investigated as a novel treatment in autoimmune and inflammatory 
disorders290. 
CD177: (corrected p 1.11 E-12) glycoprotein expressed on the suface of neutrophils. 
After neutrophil activation CD177 is translocated from secretory vesicles and specific 
granules to the plasma membrane .Up-regulated by bacterial infections . The main 
function of CD177  is to facilitate adhesion of neutrophils to  the endothelialium 291. 
 
Other  genes significantly upregulated 24 hours after Cardiac Surgery: 
S100A12: (corrected p 1.18 E-12) this calgranulin related protein is abundant in 
neutrophils and infiltrating granulocytes ,after engaging with its receptor RAGE on 
endothelial, phagocytes or lymphocytes trigger activation. 
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CYP1B1: (corrected p 1.19 E -12) ; cytochrome P450, subfamily 1, CYP1B1 belong 
to the P450 cytochrome family (reposible for phase 1 oxidation).However , Cyp1b1 is 
not expressed in the liver,  but is expressed by most tumour cells and on monocytes 
.It is considered a target for antigen-specific cytotoxic T-cells 292 . 
GADD45A: (corrected p 1.31 E-12), DNA damage–inducible gene . Induced by 
enviromental stress GADD45A activates MAPK14.In addition ,GADD45 is a negative 
regulator of T cell proliferation.Studies in animal models have shown that lack of 
GADD45 is associated increase vulnerability to autoimmune disorders. 
UGCG: (corrected p 1.4 E-12), UDP-glucose ceramide glucosyltransferase catalyses 
the first step in the synthesis of glycosphingholipids which are a component of 
plasma membrane  
GPER: (corrected p 1.9 E-12), G protein–coupled estrogen receptor.Estrogens are 
known to have an anti-atherogenic effect on blood vessels and to exert a protective 
effect against vascular injury. The GPER gene is expressed in B and T cells and in 
peripheral monocytes and  plays a role in the adaptative immune response 293 . 
SOCS3: (corrected p 2.03 E-12) ,supressor of cytokine signaling 3, predominantely 
expressed by T-helper acts as a negative regulator of cytokines(JAK/STAT3 
pathway) 
ATP9A: (corrected p 3.77 E-12), ATP ase ,class 2.In eukaryotic  plasma mebranes 
contain different lipids  such as phosphodylserine(PS) and 
phosphatidylethanolamine distritributed in an asymetric structure.Exposure of PS on  
the outer side of the membranes as occurs durig cytokinesis lead to apoptosis and 
blood coagullation. ATPases are located in different areas of the cells ,their function 
is to  translocate phospholipids .ATP9A has been recently found   distributed 
thoroghout the cytoplasm as well as in Golgi-like structures in Hella 294 . 
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HIST1H2BD: (corrected p 3.8 E-12), histone gene cluster family member B,histones 
are reponsible for the nucleosome structure and epigenetic regulation 
CDK5RAP2: (corrected p 4.02 E-12), regulatory subunit–associated protein.This 
gene encodes a protein that form the form pericentriolar matrix scaffold. 
MGAM: (corrected p 5.08 E-12), maltase-glucoamylase ,codes for an enzyme 
invoved in the breakdown of sugar. 
TDRD9: (corrected p 5.38 E-12), tudor domain containing 9, is a key factor in the 
biogenesis of chromatoid bodies which  are thought  to regulate translation  and RNA 
decay 295 . 
OPLAH: (corrected p 5.5 E-12), 5-@oxoprolinase(ATP-HYDRLYZING);catalyzes the 
hydrolysis  of pyroglutamate to L-gutamate and ATP to ADP. 
MMP9: (corrected p 5.3 E-12), matrix metalloproteinase 9,is a type IV collagenase  
belonging  to the group of zinc metalloproteinases that degrade extracellular 
collagen.Neuthrophils, macrophages and dendritic cells secrete MMP9 in variable 
amounts .It has been show that MMP9 controls trafficking of inflammatory cells and 
T-cells  in response to allergens .Several MMP9 SNPs have been associated with an 
increased incidence of asthma and COPD296. 
F5: (corrected p 1.4 E-11), factor V leiden, is a key protein in the coagulation 
pathway and is a cofactor for the conversion of prothrombin to thrombin by factor Xa. 
PPARG: (corrected p 1.73 E-11), peroxime proliferator-activated receptor-gamma 
acts as a nuclear co-repressor of NF-κB. 
CA4: (corrected p 1.76 E-11), carbonic anhydrase IV,belongs to a family of zinc 
metalloenzymes that catalyse the hydration of CO2 to HC03 . Located in the plasma 
membrane this gene is up-regulated by metabolic acidosis.  
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CST7: (corrected p 2.2 E-11) ,cystatin 7  secreted by TH1, TH2 and natural killer 
cells is an immune regulator  by inhibiting cysteine proteases 
C1QB: (corrected p 3.54 E -11),complement componen 1, the complement sytem is 
has more than 20 plasma proteins that contribute to the clearance of microbes by 
binding opsonins and anaphylotoxins .C1QB is produced by macrophages and 
dendritic cells and  contributes to the clearance of apoptotic cells . C1 QB plays a 
key role in  the pathogenesis of  SLE and its production is increased by IFNγ. 
FCGR1B:( corrected p 3.6 E-11), Fc Fragment of IgG ,high affinity Ib is encoded by 
three genes  that share over 98% of sequence homology located within chromosme 
1. 
IRAK3: (corrected p 6.9 E-11), interleukin 1 receptor –associated kinase 3,IRAK is 
induced after TLR stimulation and negatively regulates TLR signalling, playing a key 
role centre of  the innate immune self-regulation. 
CES1: (corrected p E -10) ,carboxylesterase 1monocyte esterase is implicated in the 
metabolism of multiple drugs .In addition, deficiency of CES1 is associated with 
impaired lytic monocyte activity297 . 
FCAR: (corrected p 1.58 E-10) , Fc fragment of IgA, is present in 
monocytes,neutrophils,macrphages and eosinophils and mediates phagocytosis , 
antibody dependant cytotoxicity and stimulates od release of inflammatory mediators 
PGLYRP1: (corrected p1.9 E-10), peptidoglycan recognition protein1, PGLYRP1 
binds peptidoglycan and gram positive  bacteria resulting in membrane 
depolarization and inhibition of  DNA and RNA synthesis, leading  to bacterial death. 
RNASE2:(corrected p 1.9 E-10) ,eosinophil-derived neurotoxin(EDN), encodes an 
eosinophil granule protein. The RNASE2 gene has been found to be upregulated in 
peripheral blood mononuclear cells taken from patients presenting with inflammatory 
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bowel disease and rheumathoid arthritis 298 . In addition ,EDN is a chemotatic 
antimicrobial protein that acts on dendritic cells 299 . 
OSM: (corrected p 2.03 E-10), OSM is ubiquous in many tissues , It has been 
identidfied as an effector of cell death induced by tyrosine kinase (trk) in the nervous 
system  300 . 
GPR84: (corrected p 2.2 E -10) ,G protein–coupled receptor 84, plays a role in cell-
cell  communication 
SLC37A3: (corrected p 7.11 E-10), belongs to a family of 4 genes that act as 
transmembrane sugar transport. 
MERTK: (corrected p 1.2 E-10), a tyrosine kinase protooncogene, expressed in 
blood monocytes acts as a feedback inhibitor of TLR and cytokine triggered 
inflammatory responses. 
VNN1: (corrected p 4.08 E -09) , vanin 1  facilitate adhesion of peripheral 
lymphocytes. 
ORM1: (corrected p 6.09 E -09) ,orosomucoid 1, alpha 1 acid glycoprotein 
ARG1: (corrected p 6.19 E -09), arginase 1 induction has been found to lead to T 
cell dysfunction and nitric oxide production thereby  increasing the suceptibility to 
infections 301  
IL18RAP: (corrected p 7.67 E -09),interleukin 18 receptor accesory ptrotein, is 
expressed in peripheral blood leukocytes .Coexpression of IL18RAP and IL18R1 are 
required for NF-κB and JNK activation. 
FCGR1B: (corrected p 1.2 E -08), high affinity receptor for Immunoglobulin G. 
CLEC4D: (corrected p 1.99 E -08) ,C-type lectin domain family 4,expressed on the 
surface of macrophages are implicated in microbial recognitiona and cell interaction 
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HPGD: (corrected p 3.4 E-08), hydroxyprostaglandin dehydrogenase  is the main 
enzyme involved in prostagladin degradation. 
PFKFB2: (corrected p 3.03 E-07), fructose2-6 bisphospate controls glycolysis in all 
eukaryotic cells 
CD163: (corrected p 5.71 E-07), macrophage antigen that mediates endocytosis of 
haptoglobin –hemoglobin complexes 
IL18R1: (corrected p 1.8 E -06), IL-18 receptor activates NF-κB. 
 
 
1-2 Genes significally downregulated 24 hours after cardiac surgery  
(>2 fold change, p-value < 0.05). 
 
 
GPR56 trancript variant 2 and 3 (p; 2.5 E-13 and 9.7 E- 13 ): GPR56 belongs to the 
family of G protein –coupled receptors (GPRs) that exhibit  several transmembrane 
domains(LNB-7TM) and are  found in a wide range of tissue. Preferentially 
expressed in neuronal progenitor cells  allelic variant of this GPR56  have been 
associated with polymicrogytia .Downregulation  of GPR56 has been show to reduce 
tumor progression and metastasis in melanoma cell lines.Interestently LNB-7TM 
protein has been reported to play a role in cell-cell or matrix cell adhesion and 
leukocyte trafficking 302, 303. 
EOMOS (p; 3.34 E -12) belongs to the T-box  family of transcription factors . Eomes 
regulate the expression of a group of cells involved in Type 1 immunity. Eomes 
expressed in CD8+ T cells might regulate cytotoxic actions of these cells.  
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Itlekofer et al304 demostrated in an experimental model of Eomes knockout mice 
infected with lymphocytic choriomeningitis virus (LCMV) that CD8 cells collected 
from infected mice had a reduced cytotoxic capacity and  a significantly reduced  
IFN-γ expression.Not only might this  lead to a reduction in the clearance of viruses 
but in addition, the authors made the striking observationthat 1 week after infection 
EOMOS knockout mice started  to lose weight and  developed extensive mutliorgan 
dysfunction. Postmorten histology revealed generalized neuthrophil infiltration and 
anatomical destruction of several organs. 
GNLY trancription variants 519 and NKG5 (corrected p;9.0 E-12 and p; 2.35 E-
10)This gene encodes for granulysin(saposin-like  protein ) that is present in the 
cytotoxic granules of T and Natural killer cells. Granulosyn exerts an antimicrobial 
effect against intracellular pathogens such as Listeria monocytogenes and 
Mycobacterium tuberculosis.In addition, GNLY expression  has been recently found 
to increase after acute myocardial infartion (6 fold) and GNLY lymphocytes, probably 
attracted by chemokines and interleukins, lead to apoptotic  rather than necrotic cell 
death at the site of infarction305 
FGFBP2 (corrected p; 1.2 E -11) killer –specific secretory protein, Ksp37. In 
peripheral blood Ksp37 is secreted by Th1-type CD4  , CD8 , γδ and CD16 NK cells. 
Ksp37 is commonly expressed in cytotoxic lymphocytes .Ogawa et al 306 studying 
patients with infectious mononucleosis  suggest that plasma levels of Ksp37 may be 
of clinical value for  monitoring cytotoxic lymphocytic activity . 
GZMK granzyme H and K (corrected p;2.75 E-10 and 3.05 E-9) are serine proteases  
found in the granules of cytotoxic T lymphocytes and natural killer (NK). They exert a 
significant role against tumours, viruses and transplant tissue.Granzyme K(GrK) has 
been implicated in caspase-independent apoptosis,  characterized by mitochondrial 
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damage  an increase in intracellular reactive oxygen species (ROS) and  single 
stranded DNA .Using PBMCs isolated from patients with multiple sclerosis Jiang et 
al 307demostrated that GrK plays a role in the immunorgulation of the immune 
response including immune memory. 
FCER1A (P corrected;5.18 E-10)Immunoglobulin E receptor, high-affinity, of mast 
cells. This Ig E receptor allow allergens to stimulate mast cells triggering  
inflammatory and hypersensitivy responses (type 1 and 2), that charactherise allergic 
reactions as well as asthma and hay fever.High affinity IgE receptors are expressed 
in mast and basophil cells. Investigators have shown in a rodent  model that the 
inhibition of FCER1A by a chimeric protein (GE2) reduced mast cell 
degranulation/recruitment 308. 
PRSS33: (corrected p ; 5.18 E -10) (EOS) Protease serine 33 has been detected in 
many tissues including leucocytes and macrophages.Photeases belong to a family of 
proteins that are implicated in polypeptides post-translation .Protease serine 33 has 
a role in macrophage-related functions . The definitve role of PRSS33 and the stimuli 
that release EOS has not been fully elucidated  309. 
CLC: (corrected p; 2.85 E -8) Charcot-Leyden crystal protein or Galectin are 
hexagonal bipyramodal crystals found in secretions and tissues in relation to  allergic 
conditions or parasitic infections 310.CLC/galectin-10 belongs to the lectin family 
.Galectin10 is considered a marker of eosinophil activity  .In addition 8 SNPs in  the 
promoter region of CLC are associated with an increased risk of allergic rhinitis(OR 
of minor alleles 5.9-7.8) 311. 
CCR3 or CKR3: (corrected p; 1.15 E-8)Chemokine ,CC motif ,receptor . 
Chemokines are characterised according to their aminoacid sequences CC(cyteine-
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cysteine) or CXC(cysteine-X-cysteine) . Included among the CC family are MIP-1-
alpha, Rantes, ,MCP3 and eotaxin.  
There are three CC receptors  CKR1/CKR2/CKR3, the latter being this last is 
expressed in eosinophils, T helper lymphocytes , basophils and mast cells. CCR3 
can be constitutively expressed or temporarily induced by specific cytokines.The 
activation of CCR3 leads to the  degranulation of eosinophils that result in the 
release of reactive oxygen species and cytotoxic molecules at  sites of 
inflammation.In basophils, CCR3 activation results in the liberation of histamine and 
leukotrienes 312 . 
IFIT1: (corrected p;2.4 E-7) Interferon-induced protein with tetratricopeptide repeats 
1is considered to be a mediator of negative-feedback regulation of virus-triggered 
induction of type I IFNs . Another function has been recently attribuited to IFIT, 
similar to the leucitine –rich repeat that confer pattern recognition to the Toll- like 
receptors,IFIT tetratricopeptide repeats have nucleic acid-binding ability.It is  this 
capacity that confers  the ability of IFIT to clear pathogens ,playing a key role in the 
interferon induced innate immune nextwork 313. 
IFIT44L (corrected p: 1.16 E-05) Interferon-induced protein 44-like gene encodes a 
protein that has antiviral activity against hepatitis C.In addition other functions of 
interferon induced protein have been revealed recently. C-reactive protein (CRP) is 
an acute phase protein  the levels of which rise in acute and chronic inflammation, as 
well as in bacterial, viral and fungal infection .CRP presents in two forms (m) CRP on 
the cell membrane of activated platelets and (p) CRP in the plasma. Deposition of 
(m)-CRP has been proposed  as a link between CRP and   inflammation.Interferon-
responsive genes are up-regulated by (m)CRPand  are to be innvolved in   
the pathophysiology of localized inflammation e.g artherosclerosis 314. 
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nt 2 and 3 (p; 2.5 E-13 and 9.7 E- 13 ): GPR56 belongs to the family of G protein –
coupled receptors (GPRs) that exhibit  several transmembrane domains(LNB-7TM) 
and are  found in a wide range of tissue. Preferentially expressed in neuronal 
progenitor cells  allelic variant of this GPR56  have been associated with 
polymicrogytia .Downregulation  of GPR56 has been show to reduce tumor 
progression and metastasis in melanoma cell lines.Interestently LNB-7TM protein 
has been reported to play a role in cell-cell or matrix cell adhesion and leukocyte 
trafficking 302, 303. 
EOMOS (p; 3.34 E -12) belongs to the T-box  family of transcription factors . Eomes 
regulate the expression of a group of cells involved in Type 1 immunity. Eomes 
expressed in CD8+ T cells might regulate cytotoxic actions of these cells.  
Itlekofer et al304 demostrated in an experimental model of Eomes knockout mice 
infected with lymphocytic choriomeningitis virus (LCMV) that CD8 cells collected 
from infected mice had a reduced cytotoxic capacity and  a significantly reduced  
IFN-γ expression.Not only might this  lead to a reduction in the clearance of viruses 
but in addition, the authors made the striking observationthat 1 week after infection 
EOMOS knockout mice started  to lose weight and  developed extensive mutliorgan 
dysfunction. Postmorten hisstology revealed generalized neuthrophil infiltration and 
anatomical destruction of several organs. 
GNLY trancription variants 519 and NKG5 (corrected p;9.0 E-12 and p; 2.35 E-
10)This gene encodes for granulysin(saposin-like  protein ) that is present in the 
cytotoxic granules of T and Natural killer cells. Granulosyn exerts an antimicrobial 
effect against intracellular pathogens such as Listeria monocytogenes and 
Mycobacterium tuberculosis.In addition, GNLY expression  has been recently found 
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to increase after acute myocardial infartion (6 fold) and GNLY lymphocytes, probably 
attracted by chemokines and interleukins, lead to apoptotic  rather than necrotic cell 
death at the site of infarction305 
FGFBP2 (corrected p; 1.2 E -11) killer –specific secretory protein, Ksp37. In 
peripheral blood Ksp37 is secreted by Th1-type CD4  , CD8 , γδ and CD16 NK cells. 
Ksp37 is commonly expressed in cytotoxic lymphocytes .Ogawa et al 306 studying 
patients with infectious mononucleosis  suggest that plasma levels of Ksp37 may be 
of clinical value for  monitoring cytotoxic lymphocytic activity . 
GZMK granzyme H and K (corrected p;2.75 E-10 and 3.05 E-9) are serine proteases  
found in the granules of cytotoxic T lymphocytes and natural killer (NK). They exert a 
significant role against tumours, viruses and transplant tissue.Granzyme K(GrK) has 
been implicated in caspase-independent apoptosis,  characterized by mitochondrial 
damage  an increase in intracellular reactive oxygen species (ROS) and  single 
stranded DNA .Using PBMCs isolated from patients with multiple sclerosis Jiang et 
al 307demostrated that GrK plays a role in the immunorgulation of the immune 
response including immune memory. 
FCER1A (P corrected;5.18 E-10)Immunoglobulin E receptor, high-affinity, of mast 
cells. This Ig E receptor allow allergens to stimulate mast cells triggering  
inflammatory and hypersensitivy responses (type 1 and 2), that charactherise allergic 
reactions as well as asthma and hay fever.High affinity IgE receptors are expressed 
in mast and basophil cells. Investigators have shown in a rodent  model that the 
inhibition of FCER1A by a chimeric protein (GE2) reduced mast cell 
degranulation/recruitment 308. 
PRSS33: (corrected p ; 5.18 E -10) (EOS) Protease serine 33 has been detected in 
many tissues including leucocytes and macrophages.Photeases belong to a family of 
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proteins that are implicated in polypeptides post-translation .Protease serine 33 has 
a role in macrophage-related functions . The definitve role of PRSS33 and the stimuli 
that release EOS has not been fully elucidated  309. 
CLC: (corrected p; 2.85 E -8) Charcot-Leyden crystal protein or Galectin are 
hexagonal bipyramodal crystals found in secretions and tissues in relation to  allergic 
conditions or parasitic infections 310.CLC/galectin-10 belongs to the lectin family 
.Galectin10 is considered a marker of eosinophil activity  .In addition 8 SNPs in  the 
promoter region of CLC are associated with an increased risk of allergic rhinitis(OR 
of minor alleles 5.9-7.8) 311. 
CCR3 or CKR3: (corrected p; 1.15 E-8)Chemokine ,CC motif ,receptor . 
Chemokines are characterised according to their aminoacid sequences CC(cyteine-
cysteine) or CXC(cysteine-X-cysteine) . Included among the CC family are MIP-1-
alpha, Rantes, ,MCP3 and eotaxin.  
There are three CC receptors  CKR1/CKR2/CKR3, the latter being this last is 
expressed in eosinophils, T helper lymphocytes , basophils and mast cells. CCR3 
can be constitutively expressed or temporarily induced by specific cytokines.The 
activation of CCR3 leads to the  degranulation of eosinophils that result in the 
release of reactive oxygen species and cytotoxic molecules at  sites of 
inflammation.In basophils, CCR3 activation results in the liberation of histamine and 
leukotrienes 312 . 
IFIT1: (corrected p;2.4 E-7) Interferon-induced protein with tetratricopeptide repeats 
1is considered to be a mediator of negative-feedback regulation of virus-triggered 
induction of type I IFNs . Another function has been recently attribuited to IFIT, 
similar to the leucitine –rich repeat that confer pattern recognition to the Toll- like 
receptors,IFIT tetratricopeptide repeats have nucleic acid-binding ability.It is  this 
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capacity that confers  the ability of IFIT to clear pathogens ,playing a key role in the 
interferon induced innate immune nextwork 313. 
IFIT44L (corrected p: 1.16 E-05) Interferon-induced protein 44-like gene encodes a 
protein that has antiviral activity against hepatitis C.In addition other functions of 
interferon induced protein have been revealed recently. C-reactive protein (CRP) is 
an acute phase protein  the levels of which rise in acute and chronic inflammation, as 
well as in bacterial, viral and fungal infection .CRP presents in two forms (m) CRP on 
the cell membrane of activated platelets and (p) CRP in the plasma. Deposition of 
(m)-CRP has been proposed  as a link between CRP and   inflammation.Interferon-
responsive genes are up-regulated by (m)CRPand  are to be innvolved in   




 Further analysis of SNPs associated with cardiac surgery 
2-1 We explore all the SNPs using RegulomeDB. The top SNPs according to 
RegulomeDB scoring scheme are shown in the table 3 below. 





RS 11663049 regulates two motifs (short sequence of DNA) the transcriptions 
factors NF-κB and E2F-1: DP-2 . 2 An eQTL has found SNPs of this gene to be 
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associated with heart disease susceptibility249.  Protein binding between this SNP 
and NF-κB has been documented by the investigators of the ENCODE project. 
NF-κB belongs to a family of transcription factors that have a primordial role in 
inflammation and the innate immune response.   Activation of NF-κB can be 
mediated through Toll –like receptors(TLR), Interleukin-1, tumor necrosis factor 
(TNFα), Lipopolysacchrides (LPS) and Lymphotoxin B-receptor. In addition activation 
occurs through IKK after genotoxic stress (this has been called the atypical activation 
pathway). 
 NF-κB regulates the activity of thousands of genes.  The most recognised effect of 
this transduction factor is a proinflammatory response characterized by the activation 
of cytokines such as TNFα, IL-1,IL-6 and IL-8 as well as  up-regulation of adhesion 
molecules that facilitate the migration  of leukocytes to inflammatory sites. 
Furthermore, NF-κB and STAT3 (another key inflammatory transcription factor) 
regulate other genes, and have a synergistic   anti-apoptotic action. This relationship 
between inflammation and apoptosis is increasingly the subject of investigations that 
seek to clarify not only aspects of the inflammatory host responses but the potential 
link between the pathogenesis of cancer and inflammation . Experimental 
compounds that target NF-kappa B are being developed as potential therapies315. 
RS 3768324 cis regulated motifs are the transcription factors FL-1 and GABPA, 
ELK1 and SAP-1A248. FLI1 is a proto-oncogene present in haematopoietic and 
endothelial cells. GABPA; intervene in the regulation of mitochondrial enzymes. 
ELK1; activates genes involved in gene differentiation. 
This SNPs is NDUFS5; the multi-subunit NADH; ubiquinone oxireductase is the first 
enzyme complex in the electron transport chain of the mitochondria. 
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Yu et al 316have confirmed the binding of rs3768324 to GABPA in mice cells. These 
authors have found that GABPA is not only essential for the maintenance and 
differentiation of lymphopoiesis stem/progenitors’ cells but it actions regulating 
different genes. GAPB activates genes related to apoptosis (BCL2), as well as 
transcritption factors essential for cells survival (Zfx, Etv6) and cell renewal (Foxo3) . 
GABPA exerts direct/indirect regulation of genes involved in DNA repair (ATM), 
telomere maintenance (TERF2) and epigenetics modifications; including DNA 
methylation (DNMT1) and Histone acetylation (ep300, MYST4). 
RS12145700 regulates the motif USF. Degradation of USF has been associated with 
suppression of the immune host response. 
RS 693235 cis regulate the transcription factor RREB1that acts as an HLA-6 
promoter. The gene whose expression is cis regulated by this SNPs is splicing factor 
1 SF1; a zinc protein that regulates cellular RNA metabolism247. 
RS4766497regulates the  motif  NF-Y major histocompatibility class II promoter248. 
The gene affected by this SNP ID ATP2A2 this ATPase acts as a slow Ca 
transporting system. A mutation of ATP2A2 has been found to contribute to the 
abnormal transport of intracellular Ca and has been associated with hypertension. 
RS3007030 regulates the motif POU5F1 involved in reprogramming pluripotent stem 
cells.247. 
RS1025196 regulates the   transcriptions factors FREAC-3, OCT-1, FOXA2. FREAC 
to induce the expression of stress response and apoptosis genes. OCT-1 interacts 
with immunoglobin heavy chain promoters. Mutations of FOXA2 have been involved 
in cholestatic and pancreatic disease and alterations in insulin production. The gene 
affected by this SNP is SERPINB10 that expresses a serine protease inhibitor that 
regulates proteases during haematopoiesis. 
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RS3754109 regulates the transcription factors SIX-1, SIX-2, SIX-4 249. Overactivity of 
SIX-1 is associated breast with cancer invasiveness. SIX2 and 4 have been 
described as being involved in the development of the eye. This SNP affects the 
expression of TTF2 a transcriptor termination factor that participates in the control of 
t lymphocytes gene expression by acting on the transcription elongation. 
RS 226503 regulates the transcription factor OLF-1. OLF-1 is involved in the 
regulation of pre B and early B cell lines. This gene affects the gene FLJ20639 that 
forms a complex with heat shock protein 90 that is involved in protein folding317. 
RS 1362126 regulates the motif named IKAROS, a zinc finger transcriptor factor. 
The main gene affected by this SNP is HLA –A (Major histocompatibility complex, 
class 1). MHC class1 plays a crucial role in the antigen presentation and initiation of 
T cell mediated immune responses 
RS 13230744 regulates the motif is MTF-1, a metal-regulatory transcription factor 
that is involved in heavy metal detoxification and free radical scavenging. The gene 
affected by this SNP is GATS, a glycine N-acyl transferase. That transfers acyl 
groups in the mitochondria. The   functions of this gene have been mainly described 
in the liver where lt has been shown to be downregulated in hepatitis. 
RS 540 regulates the motif FOXP1 and TBP. FOXP1 is a transcription factor that 
plays a critical role in monocyte differentiation and macrophage function. TBP is a 
DNA-binding subunit involved in the expression of protein-encoding genes. The gene 
regulated by this SNP is MRPL28; a component of the large subunit of the 
mitochondrial ribosome encoded in the nuclear genome. 
RS 9630856 regulates the motif ERR and RORA. ERR plays a role in the regulation 
of cellular energy. RORA is a member of the steroid hormone receptor present in 
peripheral leukocytes. The gene affected by this SNP is SERPINB10. 
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RS 6102 regulates the motif NANOG, a homeobox transcription factor that is 
involved in cellular differentiation. 
RS 575 regulates the motifs are zinger finger protein transcription factors ZIC1, 
ZIC2, ZIC3. These transcription factors exert their modulatory effect in the vicinity of 
any sequence to which a protein domain binds. The gene affected by this SNP is 
SARS2  a mitochondrial seryl-t RNA synthetase 2 , which provide serine 
aminocetylation to mitochondrial T-RNA . Mutations of this gene have been 
associated with alterations in the mitochondrial translation system that lead to 
derangements in the synthesis of mitochondrial proteins and cellular energy supply 
RS 4668936 regulates the motif zinc finger ZBT3.The gene affected by this SNP is a 
putative RNA helicase that by altering RNA can influence translation, initiation and 
splicing. 
RS 160404 regulates the motif EWSR1-FLI, a putative tumour suppressor. The gene 
affected by this SNP is CTNNAI, a cadherin associated protein that plays a role in 
cell cycle regulation. 
RS 2949170 regulates the motifs MAFB, transcription factors that contribute to 
differentiation and function of, monocyte and macrophages. Another transcription 
factor influenced by this SNP is V-ETS, an oncogene that is involved in the 
regulation of telomerase activity. The gene affected by this SNP is ZFAND2A, a 
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Appendix 3 
3-1 Network analysis 
 
Analysis of associated network functions showed that the top five eQTLs relate to 
cell signalling, cell to cell communication and different aspects of cellular integrity 
including DNA replication, recombination and repair. 
Table 3-1 see below shows the top networks and the number of genes from our 















3-2 Top disease and biofunctions 
 Top diseases and bio functions associated with each gene are  divided  into three 
groups .Table 3-2. 
A: Diseases and disorders B: Molecular and cellular functions C: Physiological 













A. Diseases and disorders 
Most genes that belong to this group are linked to gastrointestinal and hepatic 
diseases.  Within this group genes associated with inflammatory disorders have 
been found to be associated with an increased susceptibility to inflammatory bowel 
disease. 
 Some of the most relevant genes form this category. 
ADK: adenosine kinase. This gene plays a role in the inflammatory process. 
Mutations of this gene have been associated with liver dysfunction 318. 
GAA: glucoside alpha is a liposomal enzyme involved in the degradation of glycogen 
within cellular vacuoles. Mutations of this gene have been associated with glycogen 
storage diseases. 
LGALS9: lectin, galactoside-binding soluble 9 is derived from T cells and is a potent 
chemo-attractant 319. 
PPP3R1: protein phosphatase s regulatory subunit B . This gene increases 
tumorogenesis, potentially by acting through senescence associated mechanisms 
320. 
ROGDI: encodes a leucine zipper protein expressed in many cell including 
mononuclear cells. This gene is involved in intracellular transport and cells 
division321. 
APC: encodes a protein associated with tumour suppression and cell adhesion322 . 
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NOD2: nucleotide-binding oligomerization domain protein 2. NOD expression 
activates NFKB  . NOD activation in Crohn’s disease has been associated with the 
inability of the bowel to clear pathogens 323. 
STAT6: signal transducer and activator of transcription 6. STAT6 is involved in the 
physiological action of leptin. This gene mediates immune signalling in response to 
cytokines and to viral infection at the level of the endoplasmic reticulum (chen et al 
2011). STAT6 activity has been implicated in the pathogenesis of non-atopic 
asthma324. 
TNFRSF1A: tumour necrosis factor receptor superfamily.TNFRSF1A polymorphisms 
have been associated with coronary artery disease325 and multiple sclerosis 326 . 
IRF5: Interferon regulatory factor 5 is a regulator of Interferon activity. 
Polymorphisms of these genes have been linked with the pathogenesis of 
inflammatory bowel disorders, rheumathoid arthritis and primary biliary cirrhosis327. 
CLEC2B:  C-type lectin domain family 2 member B. This gene is a myeloid specific 
activating receptor that binds NKp80 on natural killer (NK) cell, acting as a cross 
talking molecule between myeloid cells and NK cells328 . 
C3AR1: complement 3a receptor-1 present in neutrophils. Activation of this gene is 
implicated in the pathogenesis of inflammatory disease through de-granulation, 
smooth muscle contraction, arachidonic acid metabolism and cytokine release 329 
B. Molecular and cellular functions.  
This category includes genes that play roles in intracellular signalling, cell to cell 
communication and development.  Genes idenfied by eQTL that belong to this group 
include  APC, C3AR1, IRF5, LGALS9, STAT6 and TNFRSF1A. Other genes that 
take part in this group are described below. 
167 | P a g e  
 
BCR: breakpoint cluster region.This gene encodes a phophodiesterase associated 
with serine/threonine kinase. BCR is involved in translocation 9,22 known as the 
Philadelphia chromosome. BCR is involved in the regulation of RAC mediated 
superoxide production by the NADPH-oxidase system in leukocytes. BCR null mice 
exposed to endotoxin develop severe septic shock and injury in diverse organs 
caused by enhanced neutrophil activity 330. 
JMJD6: jumonji domain-containing protein 6. JMJD6 is a phosphatydil serine 
receptor that enables B and T cells to recognize and engulf apopototic cells in a 
phosphatidylserine-serine dependant manner. 
MAP2K2: mitogen-activated protein kinase 2. MAP2K2 activates ERK, JNK, p38 and 
the NFKappa B signalling pathway 331. 
PLEKHA1: pleckstrin homology domain containing protein family A. PLEKHA1 
interacts with phosphodylisitol 3, 4 biphosphate. Polymorphisms in the critical region 
10q 26 are associated with a 5 fold increase in susceptibility to  age-related 
maculopathy 332. 
RALBP1: associated EPS domain –containing protein 2. RALBP1 plays a role in 
receptor mediated endocytosis. 
RASGRP4: ras guanyl nucleotide releasing protein 4. RASGRP4 encodes 
transduction signals through RAS; a superfamily of small GTP binding proteins. 
SEMA4A: semaphoring 4 A. SEMA4A is a member of a group of soluble and 
transmembrane proteins that enhance priming of antigen-specific T cells. 
Polymorphisms of this  gene have been associated with an increased susceptibility 
to retinitis pigmentosa and cone-rod dystrophy333 . 
SNAI3: snail drosophila homolog zinc finger protein. 
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LGALS2: lectin galactose-binding signalling, galactin 2. Polymorphisms of LGALS2 
have been associated with an increased susceptibility to myocardial infarction. 
GSTT1: gluthatione s-tranferase theta-1.  GSTT1 acts as a transferase of potential 
toxins. 
CEP152: centrosome protein that act as a major micro-tube organizer centre that 
influences cell shape, polarity and motility. 
CIB1: calcium and integrin binding protein. CIB1 takes part in the adhesion process 
between megakaryocytes. CIB1 activity has been linked to cardiac hypertrophy in 
response to pressure overload 334. 
RALBP1: associated EPS domain-containing protein 2. It intervenes in receptor 
mediated endocytosis335. 
CTNNA1: catenin alpha 1. CTNNA1 integrate the adhesion complex, This gene acts 
as a convector that anchors the e-cadherin to cytoskeletal actin bundles. 
 
C. Physiological system development and function. 
Genes involved in these functions are: APC, BCR, C3AR1, IRF5, LGALS9, MAPK2, 
MAPK3, PLEKA1, RALBP1, RASGRP4, SNAI3, MAPK3, CIB1, BLM, SARS2 
already described above. In addition, EIF2AK1 is a major kinase that is activated by 
heme deficiency and other stimuli to promote haematopoiesis. 
 
 
3-3 Canonical pathways 
Table 3-3: Top 5 pathways 24hours after surgery 
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IL-3 signaling pathway: IL-3 is produced by activated T cells in response to 
mitogens or antigens. IL-3 receptor recruits JAK2 tyrosine kinase, resulting in the 
activation of multiple STATs (STAT1, STAT3, STAT5 and STAT6). Furthermore, IL-3 
activates signal transduction proteins such as RAS and PIK3. These activate  ERK, 
P38 and JNK. IL-3 receptor activation mediates the activity of the BCL2 family that 
promotes cell survival. Interestingly, the IL-3 pathway regulates the glycolytic cycle 
and in BAF cells has been found to decrease glucose uptake and lead to lactate 
production. 
IL- 12 signaling and production in macrophages:  IL -12 is a pro-inflammatory 
cytokine produced by macrophages or activated T cells.  IL-12 signaling induces the 
synthesis of interferon gamma (IFN-γ) that promotes the differention of T helper 
cells. In addition, IL-12 stimulates the production of nitric oxide that facilitates 
bacterial clearance. Moreover, IL12p40 or IL1-1280 monomers induce the production 
of tumour necrosis factor through the activation of the mitogen activated protein 
kinase (MAPK) and NF kappa B.  At the same time IFN-Kβ up-regulates the 
production of IL-12p40 that in turn is inhibited by two nuclear receptors;  peroxime 
proliferator activator receptor gamma (PPARγ) and retinoid X receptor (RXR) 336. 
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IL-15 signaling: IL- 15 signaling is mediated through a transmembrane heterodimer 
receptor complex (that contains some subunits shared by IL-2) . IL-15 stimulates 
JAK/STAT and NF-κB that act on NK cells and T cells to control proliferation, survival 
and enhance phagocytosis, thereby, playing an important role in the host 
inflammatory responses. 
Role of Pattern recognition receptors (PRRs) in recognition of bacteria and 
viruses: PRRs participate in the innate immune response, recognizing bacterial cell-
wall components, such as peptidoglycan and lipopolysaccharide. 
PRRs are divided into three groups: 1-Toll like receptors (TLRs) activate pro-
inflammatory pathways through TRAF6 and Myd88 adaptors and NF-κB.  
 2- Extracellular PRRs:  take part in the process of phagocytosis and apoptosis 
triggered by the exposure of immune cells to the surface of virus and bacteria. 3- 
Cytoplasmic PRRs: These comprise several mediators of pro-inflammatory cytokines 
(NODs, NALPs and PKRs). 
Endometrial Cancer Signalling: The most common histological form of endometrial 
cancer is adenoncarcionoma. They exist in two forms, type 1 (oestrogen and 
progesterone related) and Type 2 (unrelated to hormonal stimuli), those lacking or 
having scarce oestrogen and progesterone. 
Type 1 carcinomas are associated with alteration of the PTENK-Ras genes and type 










4-1 Tox-Integrated Pathways Analysis 
This analysis is based on an integrated literature review of toxicological lists and 
toxicological functions . This method is mainly used in the pharmacological industry 
to evaluate potential toxicity of new pharmacological compounds. However, by virtue 
of examination of annotated pathways and  gene to gene interactions integrated with 
clinical chemistry databases,  this type of analysis has the potential to contribute to 
the identification possible biomarkers,  generate hypothesise  and  link genes to the 
pathogenesis of specific  organ injuries,  such as  liver cholestasis,  kidney injury or 
cardiac damage. 
Top Toxonomics List: 
 
PPAR signalling:  
This pathway involves a family of peroxime proliferator-activated receptors that act 
as transcriptional regulators linked to genes that regulate the plasma levels of lipids. 
In addition, PPARs are involved in fatty acid metabolism, peroxisome proliferation, 
colon and hepatocarcinoma. PPAR activity is inhibited by TNF and IL-1 through 
activated NFKB and ERK , this last in response to growth factors. 
NRF2-mediated oxidative stress response: 
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Severe oxidative stress activated by the accumulation of peroxides and free radicals 
can activate apoptosis and necrosis. The main molecular agent of the antioxidant 
response is the nuclear factor-erythroid 2-related factor 2 (Nrf2). Nrf2 circulates in an 
inactive form in the cytosol, being activated upon responses to cellular stress by  
protein kinase C and MAPK. Nrf2 travels to the nucleus and subsequently binds to 
antioxidant response elements (ARE). This process results in the activation of 
detoxifying and antioxidant enzymes such as gluthatione S-transferase, cytochrome 
P450, NADPH, quinone oxireductase , heme oxygenase and superoxide dismutase. 
Xenobiotic Metabolism Signaling: 
Xenobiotics include endogens or foreign compounds that have the particularity of 
activate cellular stress responses leading to cellular apoptosis and necrosis. This 
category includes a group of metabolizing enzymes or XME that by chemical 
transforming xenobiotic compounds facilitate their elimination, thereby minimizing or 
preventing cellular damage. They are divided into three groups Phase 1 enzymes 
(CYP, ALDH, FMO) introduce a polar moiety into the xenobiotics. Phase 2 enzymes 
(UGT, GST, SULT) by means of conjugation with diverse hydrophilic compounds 
(glucuronic acid, sulphate). Phase 3 enzymes (MDR, OATP2 and MPR) facilitate the 
transport of xenobiotics to the extracellular space. In addition, there are constitutive 
XME (CAR, PRX, AHR) enzymes. These defence molecules are normally inactive 
until stimulated by cellular stress mediated by MAPK activation of NRF2 and MAF. 
Interestingly, the activation of these enzymes is potentiated by their own substrates 













Figure 4-1 : Top tox pathways enriched for cis eQTL of the 218 genes only present  
24 hours after cardiac surgery. The Y axis show the –log (pvalue) for the enrichment 
of each pathway. The ratio is calculated from the number of genes in the dataset 















Top toxicogenomic functions: Figure 4-1 
Clinical chemistry and Haematology: 
Increased Level of Alkaline: 
 MAPK3: is a mitogen-activated protein kinase that regulates ERK and JNK in 
addition, to NF-κB exerting anti-apoptotic actions, after being cleaved by caspases, 
however MAPK3 can have an anti-apoptotic effect. 
Increased level of haematocrit: 
 JMJD6 is a histone arginine demethylase that requires the presence of Fe (++), 2 
oxoglutamate and ascorbate. Interestingly, the fact that hypoxia induced factor (HIF) 
hydroxylase acts as a sensor of tissue hypoxia in virtue of its substrates or cofactors 
raises the possibility that demethylation could be regulated by metabolic or 
environmental changes 337. 
 
Increased levels of red blood cells:  
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EIF2AK1: this gene is activated by  heme deficiency in reticulocytes  and its activity 
is triggered by nitric oxide as part of the coordination and regulation of the innate 
immune response by this molecule338 . 
 
Nephrotoxity: 
SARS2: mutations in the Seryl-t RNA gene result in decreased aminoacetylation, 
affecting the synthesis of mitochondrial proteins and energy supply. In children 
polymorphisms of this gene are linked with an un-characterized multystemic 
mitochondrial cytopathy that leads to renal failure339. 
AGA: Deficiency of the enzyme Glucosylaparaginase leads to the accumulation of 
aspartylglucosamine within lysosomes.  Mutations of apartylglucosamidase are 
associated with aspartylglycosamanuria 340.  
GSTT1: This is a calmodulin regulated protein phosphate also called calcineurin B. 
Inhibition of calcineurin/nuclear factor of activated T cells is associated with 
nephrotoxicity in transplanted kidneys. The pathogenesis of this process is unclear 
but  is perhaps linked  to the calcineurin inhibitor induced fibrogenic activity of NOX2 
, in association with other  genetic factors predisposing to renal failure341. 
TNFRSF1A: TNF and TNFRSF1A mediate activation of β, C-Jun NH2 terminal 
kinase and mitogen activated kinase family (MAPKK) and death domain. TNFRSF1A 
is a receptor involved in the pathogenesis of glomerulonephritis and a negative 
correlation between the TNFR1 m-RNA and creatinine has been found 24 and 48 
after burns injury342. 
PLEKHA1: in a recent GWAS investigating the associating between the possession 
of certain single nucleotide polymorphism in a population of European ancestry and 
glomerular filtration rate.  PLEKHA1, a gene expressed in renal tubular cells was 
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significantly associated with renal impairment. Moreover an eQTL showed cis 
regulation of PLEKHA1 was associated with expression of this gene in blood and 
lymphocytes 343. 
Trim27: This molecule integrates a group of RET finger proteins which activate 
several intracellular pathways such as Ras, extracellular signed regulated kinase, 
p38 mitogen activated protein kinase and the c-Jun N-terminal kinase pathway. In 
addition, RET induces GZPF1, a protein expressed in tubular cells of adult kidneys. 
Tubular expression of GZPF1 correlates inversely with creatinine levels in a number 
of chronic inflammatory kidney disorders as well to acute tubular necrosis. GZPF1 is 




CTNNA1: cadherin-associated alpha. Desmosomes at the intercellular junction 
include molecules of the cadherin family. Polymorphisms of these genes are 
suspected as being involved in the pathogenesis of certain arrhythmias 345. 
DIO3: deiodinase iodothyronine type 3 catalyses the conversion of T4 to T3 and to 
inactive metabolites. Heart failure is associated with T3 signalling disturbances. In 
rodents, re-expression of D3 has been found in pathological ventricular hypertrophy. 
Interestingly, whilst hypoxia induces D3 signalling 346. 
STAT6: This molecule is a transducer and transcriptor induced by IL-13 and whose 
effectors are P and E selectin. The activation of STAT6 is considered as evidence of 
the inflammatory character of the atherosclerotic process that leads to coronary 
disease 347, 348. 
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TNFRF1A: TNF and TNF receptors activate signalling pathways that control 
inflammatory, immune and stress responses, in addition to host defence and 
apoptosis. In a group of 28 elderly patients suffering from heart failure, TNFRF1A 
was one of 22 genes differentially expressed in peripheral mononuclear cells 
(PBMC) in comparison with age matched healthy controls. Interestingly, differentially 
expressed genes linked with inflammation were still present in the recovery phase349 
. 
PPP3R1: Protein phosphate 3 is a calcineurin. Calcineurins are implicated in the 
pathogenesis of  myocardial remodelling after infarction350. 
JMJD6:This gene  acts as a phosphatidylserine receptor (PSR) that when 
transfected into B and T lymphocytes,  enable them to detect and phagocytose 
apoptotic cells .In rodents, PSRs have been identified as one of the key molecules in 
the pathogenesis of cardiac development and congenital heart malformations 351. 
CRELD1: This gene encodes a matricellular protein considered a putative cell 
adhesion molecule. Allelic variants of this gene have been linked to atrioventricular 
septal defect 352. 
  




Table 4-1: Top toxicogenomic functions. The right hand side of the table 
shows the number of genes in the dataset that associates with each 
function.  
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